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Vinigrol, an unusual diterpene, was isolated by Hashimoto and co-workers in 
1987, from the fungal strain Virgaria nigra F-5408. Biological test of vinigrol has 
revealed a number of interesting properties, such as antihypertension and platelet 
aggregation inhibition. Vinigrol is also a tumor necrosis factor (TNF) antagonist. The 
promising biological activities, combined with its unique terpene structure have 
attracted significant attention from the synthetic community. Herein, a total synthesis 
of vinigrol is described. The synthesis demonstrates the power of oxidative 
dearomatization and intramolecular Diels-Alder cycloaddition to construct complex 
molecules. Additionally, a few new synthetic strategies and tactics were developed, 
such as selenium dioxide mediated olefin isomerization and oxidation, stereoselective 
installation of an isopropyl group and strategic applications and deprotection of 
trifluoroethyl ethers.  
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1.1 Isolation and Biological Activity 
 Vinigrol (1.1, Figure 1.1), a novel diterpenoid, was first isolated in 1987 by 
Hashimoto, Ando and coworkers from a fungus strain, Virgaria nigra F-5408 in 
Japan.
1
 Its structure was determined by using spectroscopic measurements (MS, IR, 
NMR and CD) and X-ray crystal analysis of its derivatives.  
Vinigrol became of interest initially because of its antihypertensive and platelet 
aggregation inhibition properties.
2
 It was discovered that when injected intravenously 
in anesthetized normotensive rats, vinigrol decreased arterial blood pressure by 20% at 
a dose of 100 mg/kg. Given orally to spontaneously hypertensive rats, a 15% blood 
pressure reduction was observed at 2 mg/kg and the effect lasted over 6 hours. 
Vinigrol inhibited the platelet aggregation induced with epinephrine or platelet 
activating factor. The IC50 values are 1.7 × 10
-8
 M and 4.4 × 10
-7
 M on rabbit platelet 
and 5.2 × 10
-8
 M and 3.3 × 10
-8
 M on human platelet for each aggregation agent, 
respectively. However, vinigrol did not exhibit any inhibitory activity on ADP, 
thrombin and collagen induced rabbit platelet aggregation and neither revealed any 
inhibitory effect on ADP induced human platelet aggregation at 1 × 10
-6
 M. Studies 
revealed that vinigrol is a Ca
2+
 agonist showing inhibitory effects on Ca
2+
 movement 
at lower concentrations. However, further experimentation is required to conclusively 
define the mode of action of vinigrol on calcium channels and also to clarify the 
mechanism of its antihypertensive activity.  
In addition, vinigrol was shown to function as a potential tumor necrosis factor 
(TNF) antagonist agent.
3
 TNF is a protein which induces necrosis of tumor cells and 
acts as a mediator in the immune system. Blocking the action of TNF could therefore 
treat endotoxic shock, inflammation, muscle atrophy (cachexia) or inhibit the 
progression from AIDS-related complex to AIDS. In in-vitro binding studies on HL60 
 3 
cells, vinigrol at a concentration of 310 mM displayed 100% inhibition of [
125
I]-TNF 
binding at 2.1 nM. A significant reduction of TNF-induced cytotoxicity on L929 cells 
was also observed. This discovery stimulated further investigations on vinigrol 
applications. In 1995, Fujisawa Pharmaceutical Company Limited disclosed that 
vinigrol could be used as an alternative therapy for the treatment of HIV infectious 
diseases.
4
 Later, more studies showed that vinigrol could be used to treat inflammatory 
diseases, arthritic disorders and neurological diseases.
5
 Further investigations revealed 
that some derivatives of vinigrol also have GM-CSF (granulocyte-macrophage colony-
stimulating factor)-like activity, immunopotentiation activity, and antitumor activity.
6
  
 
 
 
 
Figure 1.1. Vinigrol  
1.2 Prior Art  
From a synthetic perspective, vinigrol possesses a unique tricyclic core 
containing a cis-fused [4.4.0] system bridged by an eight-membered ring with eight 
contiguous stereocenters. This unprecedented architecture, coupled with its promising 
biological profile, has attracted significant attention from the synthetic community. 
Over the past two decades, tremendous efforts towards its total synthesis have been 
executed, including studies from the Paquette,
7
 Corey,
8
 Mehta,
9
 Matsuda,
10
 Fallis,
11
 
Hanna,
12
 Baran
13
 and Barriault
14
 groups. In addition, two comprehensive reviews 
describing these efforts are available in the literature.
15
  
The Paquette group reported an anionic oxy-Cope reaction to construct the cis-
decalin portion of vinigrol (1.3) from a bicyclo[2.2.2]octenol precursor (1.2) (Scheme 
 4 
1.1). The initial strategy for the formation of the eight-membered ring was based on an 
intramolecular SN2 cyclization. Subjection of substrate 1.2, prepared from (S)-4-
isopropyl-2-oxazolidinone in 11 steps, to KHMDS and 18-crown-6 under thermal 
conditions afforded 1.3 in 72% yield. Subsequently, compound 1.3 was converted to 
cyclization precursor 1.4 using a series of standard manipulations. Unfortunately, all 
attempts to construct the eight-membered ring were met with failure. X-ray analysis of 
1.4 revealed that both decalin side chains are locked equatorially, positioning the 
nucleophilic center far from the electrophilic center for productive bond formation.  
Indeed, ab initio calculations of a model compound 1.6 revealed a largely unfavorable 
equilibrium between the two conformers, with the major diequatorial conformer 
lacking the stereoalignment needed for ring closure.  
 
 
 
 
 
 
 
Scheme 1.1. Paquette’s Approach toward Vinigrol  
Unable to meet the conformational requirements for an anionic SN2 
cyclization, the group explored other eight-membered ring formation strategies, such 
as ring-closing olefin metathesis, radical cyclization, ring contraction, and Dieckman 
reaction. However, all methods proved to be unsuccessful.   
 5 
The Corey group envisioned that the tricyclic core of vinigrol could be 
generated via an intramolecular Diels-Alder reaction of 1.9 followed by a Grob 
fragmentation of cycloadduct 1.8 to afford 1.7 (Scheme 1.2).  For this purpose, the 
Diels-Alder precursor 1.9 was synthesized from (R)-limonene in six steps. 
Unfortunately, all attempts at realizing the proposed Diels-Alder reaction were 
unsuccessful and resulted only in isomerization of the trisubstituted enol ether to the 
thermodynamically more favorable tetrasubstituted isomer. The electron-rich nature of 
both diene and dienophile, as well as the steric congestion in the transition state, were 
attributed to the failure of the intramolecular cycloaddition. The group also 
investigated a series of intermolecular inverse electron-demand Diels-Alder routes, all 
of which proved to be fruitless.   
 
 
 
 
 
 
 
 
Scheme 1.2. Corey’s Approach toward Vinigrol  
In 1993, the Hanna group reported the first construction of the tricyclic core of 
vinigrol. In this synthesis, the oxygenated tricyclic skeleton (1.12) of vinigrol was 
assembled via an anionic oxy-Cope rearrangement from a tricyclic vinyl carbinol 
precusor, such as 1.13 (Scheme 1.3).  
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Scheme 1.3. Hanna’s Approach toward Vinigrol  
 
 
 
 
 
 
 
Scheme 1.4. Synthesis of  epi-C8-Dihydrovinigrol 
Compound 1.13 was prepared in 12 steps form silyl protected phenol 1.14 
(Scheme 1.4). The proposed anionic oxy-Cope rearrangement proceeded smoothly 
after exposure of alcohol 1.13 to sodium hydride under reflux, delivering the tricyclic 
ketone 1.15 in good yield. In one nice operation, construction of the eight-membered 
ring and introduction of isopropenyl group at C12 with the correct stereochemistry 
were achieved. Following a series of functional group manipulations, allylic alcohol 
1.16 was then obtained. Discouragingly, all attempts to reduce the exocyclic olefin of 
1.16 resulted in the undesired C8 epimer. It appeared that in this reaction, addition of 
hydrogen occurred from the same side of hydroxyl group. Due to the presence of the 
carbon bridge, the approach of the catalyst from the other side was impeded by the 
severe steric hindrance.  Subsequently, Hanna and his team were able to demonstrate 
that 1.17 could be hydrolyzed to epi-C8-dihydrovinigrol 1.18, a derivative of the 
natural product.  
 7 
In the spirit of Corey’s approach, Baran’s successful total synthesis of vinigrol 
similarly relied on a key intramolecular Diels-Alder reaction (IMDA) and subsequent 
Grob fragmentation to construct the tricyclic core from intermediate 1.21 (Scheme 
1.5).  
 
 
 
 
 
 
 
Scheme 1.5. Baran’s Approach toward Vinigrol  
The synthesis began with a Diels-Alder reaction between a bis(silyloxy)diene 
(1.23) and (E)-methyl 4-methyl-2-pentenoate (1.24) to install the initial bicycle in 
reasonable yield and diastereomeric excess (Scheme 1.6).  To examine the key 
intramolecular Diels-Alder reaction, the diene unit (1.26) was introduced by coupling 
tributylvinylstannane with the corresponding enol triflate of 1.25. The dienophile was 
installed by converting the bridge ester to an aldehyde, followed by addition of 
allylmagnesium chloride.  Remarkably, the resultant triene underwent the desired 
Diels-Alder reaction under thermal conditions and generated the tetracyclic framework 
(1.27). Although neither the diene nor the dienophile are electronically activated, 
Baran postulated that this unprecedented reactivity originated from a combination of 
preorganization, diene strain, and tether stabilization of the substrate.
16
  
The C9 methyl group was diastereoselectively installed by alkylation after 
oxidation of the alcohol. Silyl group removal, directed reduction of the ketone and 
 8 
mesylation provided the Grob fragmentation precursor 1.20. A final base assisted 
Grob fragmentation efficiently afforded the tricyclic core (1.19).  
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.6. Synthesis of Tricyclic Core  
Due to the congested structural core of vinigrol, installation of the few 
remaining groups proved to be rather challenging (Scheme 1.7). Eventually, the C8 
methyl and C8a hydroxyl groups were incorporated by an unusual [3+2] cycloaddition 
of 1.19 with dibromoformaldooxime and subsequent reduction and deamination of the 
corresponding isocyanide (1.32). During this process, the C10-11 double bond was 
reduced by hydrogenation. The installation of the C4 alcohol was also accomplished in 
a multi-step fashion, including a reduction of ketone 1.29, followed by dehydration of 
the resultant epimeric alcohol (1.31) and substrate controlled dihydroxylation of the 
alkene (1.33). Lastly, the group utilized the Shapiro reaction to deliver the primary 
allylic alcohol after first selectively oxidizing the C3 alcohol (1.34) to ketone (1.35) 
with NaOCl and catalytic amount of TEMPO. Nearly 20 years after its isolation, the 
Baran group was able to complete the first total synthesis of vinigrol.   
 9 
 
 
 
 
 
 
 
 
 
Scheme 1.7. Completion of the Total Synthesis  
In 2007, the Barriault group reported a highly regioselective intramolecular 
Diels-Alder reaction of 1.36 to construct the tricyclic core of vinigrol (1.37) (Scheme 
1.8).  However, the natural product could not be accessed from 1.37. Thus, a 
functionalized core 1.39 was synthesized. Unfortunately, all attempts to install the 
trans C8 methyl and C8a hydroxyl groups, including cycloaddition, epoxide opening, 
hydration, or by an ene reaction with singlet oxygen, failed.  
 
 
 
 
 
 
 
Scheme 1.8. Barriault’s Apporach toward Vinigrol  
 10 
Inspired by the work of Baran, a des-methyl analogue of 1.39 was synthesized 
(1.40). Using Baran’s solution, 1.40 was converted to 1.41 (Scheme 1.9).  After the 
ketone was oxidized to the hydroxyl ketone (1.35), the formal synthesis of vinigrol 
was accomplished.  
 
 
 
Scheme 1.9. Formal Synthesis of Vinigrol 
It appears, from these approaches, that the major problem of achieving the total 
synthesis of vinigrol lies not only in the construction of the tricyclic core, but also in 
the transformation of functional groups present in this very congested structure. 
Nevertheless, three groups have now developed synthetic strategies that overcome the 
challenges of accessing this complex molecular scaffold; among which Baran’s first 
total synthesis stands as a landmark achievement. 
1.3 Initial Efforts from the Njardarson Group
17
 
Synthetic efforts toward the total synthesis of vinigrol were initiated by Dr. 
Jason Morton in the Njardarson group. The first retrosynthetic strategy involved the 
construction of an advanced vinigrol precursor 1.42 (Scheme 1.9). Due to the fact that 
a direct contraction of the eight-membered ring would be relatively infeasible, it was 
envisioned that the selective bond cleavage of a bicyclo[2.2.2]octane system as in 
1.43, would ‘unravel’ the latent cyclooctane. Functional group manipulations would 
afford 1.44, which could be generated from a 6-exo-trig or 6-exo-dig ring-closure and 
deoxygenation of 1.45. This bicyclic scaffold would arise from the intramolecular 
 11 
Diels-Alder cycloaddition of a diene containing o-benzoquinol 1.46, itself generated 
via oxidative dearomatization of a suitably substituted phenol 1.47. 
 
 
 
 
 
 
 
 
 
Scheme 1.10. Njardarson’s Wessely Oxidation Approach  
Unfortunately, the selective Wessely oxidative dearomatization (1.49, Scheme 
1.11) turned out to be rather difficult, despite extensive evaluation of suitable 
oxidants, solvents and temperatures. Although modification of the substrate in order to 
intramolecularly deliver the nucleophile at the proper position proved to be successful 
(1.51), the following Diels-Alder reaction failed to afford any desired product (1.52).  
 
 
 
 
 
 
 
 
Scheme 1.11. Wessely Oxidation Attempts  
 12 
A similar approach using an Adler-Becker oxidative dearomatization protocol 
was also pursued, but still without success (Scheme 1.12).  
 
 
 
 
 
 
 
Scheme 1.12. Adler-Becker Oxidation Attempts  
Having encountered difficulties with both the oxidative dearomatization and 
the Diels-Alder cycloaddition, a more robust route that would prove to successfully 
address both limitations was developed (Scheme 1.13). In this strategy, the core of 
vinigrol would be accessible from a retro-Michael reaction of 1.59. In turn, 1.59 would 
be derived from deoxygenation of 1.60, which would be delivered by a tandem 6-exo 
radical cyclization of 1.61. This intermediate would be assembled from oxidative 
dearomatization and intramolecular Diels-Alder union of pyrogallol derivative 1.64 
and arylic acid 1.63.  
 
 
 
 
 
 
 
 
Scheme 1.13. Njardarson’s Pyrogallol Approach  
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As expected, the oxidative dearomatization and intramolecular Diels-Alder 
sequence proceeded smoothly. However, the tandem cyclization failed to produce the 
desired outcome (Scheme 1.14). The second radical cyclization proved to be very 
challenging, which was perhaps not surprising in retrospect, considering the compact 
nature of the tetracyclic core of vinigrol.  
 
 
 
 
 
 
 
Scheme 1.14. Tandem Radical Attempts  
Due to the difficulty of realizing the tandem radical cyclization, a stepwise 
route that involved a sequential, rather than simultaneous, cyclization process was 
evaluated (Scheme 1.15). Cyclization substrate 1.72 was constructed using the 
oxidative dearomatization and intramolecular Diels-Alder strategy. Delightfully, 
treatment of 1.72 with n-Bu3SnH and AIBN provided the monocyclized adduct 1.73, 
with the desired stereochemistry for further cyclization. The ketone was then 
olefinated (1.74) and successfully cyclized under RCM conditions despite significant 
steric hindrance. Thereby, the vinigrol core 1.75 was constructed in 4 steps from 
commercially available starting material. A route based on this successful strategy 
toward vinigrol was immediately explored, which is the subject of the following 
chapters.  
 
 
 14 
 
 
 
 
 
 
 
Scheme 1.15. Stepwise Radical Approach  
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Chapter 2   
Radical Approaches to Construct the 
Vinigrol Core  
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2.1 Synthetic Strategy 
Base on earlier work in the Njardarson group, the vinigrol tetracyclic core 
could be constructed utilizing a stepwise cyclization strategy. Inspired by the success 
of synthesizing 2.2, we set out to realize the same for precursor 2.3 (Scheme 2.1).  It 
was hoped that this strategy could also be applied to the more functionalized substrate.  
 
 
 
 
 
 
 
Scheme 2.1. Modification of the Stepwise Cyclization Substrate 
2.2 Results and Discussion 
Preparation of cyclization precursor 2.3 commenced with the synthesis of 
known compound 2.9
1
 (Scheme 2.2). First, propargyl alcohol 2.6 was selectively 
trimethylsilylated (2.7). After cuprate addition, the resultant alcohol 2.8 was 
methylated to provide 2.9 in excellent yield. Iododesilylation of 2.9 afforded vinyl 
iodide 2.10, which was then dihydoxylated to afford diol 2.11. Oxidative cleavage of 
the diol and the subsequent E-selective Wittig reaction with phosphorane 2.13
2
 
furnished 2.14. Alcohol 2.15 was obtained by reduction of the ester, which was then 
coupled with commercially available phenol 2.16 using the same oxidative 
dearomatization and intramolecular Diels-Alder (OD/IMDA) protocol. Thus, the 
cyclization precursor 2.3 was prepared in fairly good yields.  
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Scheme 2.2. Synthesis of the Cyclization Precursor 
Product 2.3 was then submitted to radical cyclization conditions (AIBN or 
Et3B/O2 as initiators).  Surprisingly, none of the desired cyclization product was 
detected. 2D-NMR analyses of the isolated products suggested that the initially 
formed radical 2.17 underwent, instead of a 6-exo cyclization, a 1,7-hydrogen 
abstraction of the adjacent allylic hydrogen. Subsequent radical cyclization afforded 
products 2.19 and 2.21 (Scheme 2.3).
3
  Attempts to selectively mask the vinyl group 
and inhibit the unwanted hydrogen abstraction, such as hydrogenation, hydroboration, 
or epoxidation, were made, but these efforts met with no success.  
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Scheme 2.3. Unexpected Hydrogen Abstraction 
Disappointed by the unexpected hydrogen abstraction, we decided to seek 
alternative ways to construct the vinigrol tetracyclic core. Four different generic 
cyclization models, relying on either radical or palladium tandem 6-exo conditions, are 
shown in Scheme 2.4. The models differ only in the substitution pattern of the 
initiating species and whether the cyclization cascade starts from the back or from the 
front. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.4. Cyclization Options 
Before yielding on the radical approach, radical cyclizations proceeding from 
back to front were also evaluated (Scheme 2.5).  Compounds 2.22 and 2.25 would be 
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suitable cyclization precursors to test this idea. As having been shown previously, 
vinyl radicals are very reactive and could cyclize efficiently.
4
 The front aldehyde, like 
the ketone in 2.1, could serve as a synthetic handle to close the second ring.  
 
 
 
 
 
 
 
 
Scheme 2.5. Proposed Substrates for Back-to-Front Radical Cyclizations 
The synthesis of 2.22 commenced with Horner-Wadsworth-Emmons 
olefination between known phosphonate 2.28
5
 and aldehyde 2.29
6
 (Scheme 2.6). After 
DIBAL reduction and Mitsunobu coupling with 2.32,
7
 oxidative dearomatization 
precursor 2.33 was ready for the first key step. Careful screening of oxidants 
(phenyliodonium diacetate (PIDA) and phenyliodonium bis(trifluoroacetate) (PIFA)), 
solvents (THF, DCM, toluene, and MeOH), reaction temperatures and reagent 
addition rates (slow addition and one-portion addition) yielded an optimal OD/IMDA 
reaction procedure. By slowly adding PIDA to the pre-heated (refluxing) methanol 
solution of 2.33, cycloadduct 2.22 could be afforded directly in good yield. 
Unfortunately, the radical cyclization conditions did not afford any desired product. 
The aldehyde was then converted to alcohol 2.34, in the belief that the aldehyde was 
problematic. Exposure of 2.34 to radical reaction conditions (n-Bu3SnH and AIBN, 85 
°C) afforded two products (2.35 and 2.36, structures were assigned on the basis of 2D 
NMR and MS analyses) after silica gel column chromatography. However, no 
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indication of the existence of desired product 2.37 was detected. The results suggested 
that the radical cyclization did occur.  However, when the resultant radical 
intermediate was quenched, it generated undesired diastereomer of the primary 
alcohol, which could not serve as a precursor for the desired ring closure. Under the 
reaction condition, the axial primary alcohol attacked the adjacent ketone and formed 
hemiacetal 2.35. The second pathway that the radical intermediate underwent was 1,6-
hydrogen abstraction,  as it had been observed in the previous route, and subsequent 6-
exo cyclization to generate 2.36.  
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.6. Back-to-Front Stepwise Radical Cyclization 
In parallel with the synthesis of 2.22, the synthesis of substrate 2.25 was also 
pursued. Unlike in the previous route, diene 2.41 was generated by Wittig coupling of 
allylic bromide 2.38, phosphorane 2.39 and aldehyde 2.40. Then following a same 
synthetic sequence of DIBAL reduction, Mitsunobu coupling, OD/IMDA and Luche 
reduction, alcohol 2.44 was obtained. Unfortunately the same result was observed 
 24 
when 2.44 was treated with tributyltin hydride and AIBN, affording the undesired 
product 2.45. Clearly, in these two radical routes (Scheme 2.6 and 2.7), contrary to 
expectation and unlike for 1.72, the hydrogen radical trapped from the more steric 
hindered, convex, face of the rigid bicyclic carbon skeleton. This stereochemical 
outcome could possibly be rationalized by the thermodynamically unfavorable 
configuration of the desired diastereomers (2.37 and 2.46).  
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.7. 2
nd
 Back-to-Front Stepwise Radical Cyclization 
It was postulated that this problem could be alleviated by first homologating 
aldehyde 2.25 prior to radical cyclization, in hopes that the resultant tricyclic olefin 
could be reduced favorably. This idea inspired the synthesis of 2.47 as shown in 
Scheme 2.8. As expected, the desired tri-substituted olefin was efficiently afforded by 
radical cyclization (2.48). However, all the attempts at hydrogenation produced the 
undesired diastereomer (2.49), despite extensive testing of different conditions. 
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Further efforts to isomerize the tri-substituted olefin 2.48 to set stereochemistry 
correctly by DBU also proved to be unsuccessful (2.50).  
 
 
 
 
 
 
 
 
 
Scheme 2.8. Stepwise Radical Cyclization of Conjugated Ester 
2.3 Conclusion 
It was further demonstrated that strategic application of OD/IMDA reaction, 
followed by cyclization could be utilized to construct the vinigrol skeleton. However, 
the radical cyclizations suffered from either unwanted hydrogen abstraction or 
unfavorable diastereoselectivity. The prospect of overcoming this problem seemed 
daunting, and for that reason a revised synthetic strategy was developed.  
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Chapter 3   
Synthesis of the Vinigrol Core Using 
Palladium Chemistry 
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3.1 Heck-Stille Cascade  
3.1.1 Synthetic Strategy 
In the previous chapter, attempts to construct the vinigrol core using radical 
cyclization reactions did not afford the desired tricyclic products. For the radical 
substrates (aldehyde series) that did cyclize as planned, the radical unfortunately 
terminated to afford stereochemistry that precluded a second cyclization. It was 
postulated that this problem could be circumvented by employing a palladium 
catalyzed cyclization strategy using similar substrates (Scheme 3.1). Palladium 
chemistry became appealing because of its stereospecific syn addition. It was 
postulated that upon reaction of vinyl iodide 3.1 with palladium, the intermediate 
would undergo a favorable 6-exo-trig cyclization to form 3.2. C-Pd σ bond in 3.2 is 
anti to Ha and syn elimination becomes impossible, not to mention that a severely 
strained cage would prohibit C-C bond rotation. The newly formed palladium 
intermediate could then transmetalate with an active organometallic species, such as 
organostannane (3.3) to form a new C-C bond with the desired syn-stereochemisty 
(3.4).  
 
 
 
 
Scheme 3.1. Proposed Palladium Chemistry 
3.1.2 Results and Discussion 
In order to investigate this idea, an oxidative dearomatization/intramolecular 
Diels-Alder (OD/IMDA) approach was employed to access cyclization precursor 3.1 
(Scheme 3.2). Wittig olefination between aldehyde 3.7
1
 and in situ formed 
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phosphorane provided ester 3.8, which was reduced to allylic alcohol 3.9. After 
Mitsunobu reaction with phenol 3.10,
2
 acetonide 3.11 was reduced to benzylaldehyde 
3.12. The phenolic hydroxyl group was then protected as a β,β,β-trifluoroethyl ether 
(3.13) and the benzylaldehyde was converted to phenol (3.14) by a Dakin oxidation 
process.
3
 The OD/IMDA reaction proceeded smoothly using previously described 
reaction conditions to deliver 3.15, which set the stage for the key palladium reaction. 
The unusual trifluoroethyl group was selected as a protecting group to satisfy the 
electronic requirements of the Dakin oxidation and OD/IMDA reaction.  It is well 
understood that the Dakin oxidation works best if the aromatic aldehyde is electron 
rich. In addition, early experimentations had demonstrated that an electron-
withdrawing group was necessary to control the regioselectivity in the oxidative 
dearomatization reaction.
4
 Compared with other protecting groups, such as methyl, 
benzyl and tosyl groups, the trifluoroethyl group poses a fine balance between these 
two seemingly contradictory electronic demands.  
 
 
 
 
 
 
 
 
 
 
Scheme 3.2. Synthesis of the Heck-Stille Reaction Precursor 
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To test the critical Heck-Stille cascade reaction, a mixture of vinyl iodide 3.15 
and tributyl(vinyl)tin in THF was heated to 85 °C in the presence of palladium catalyst 
(Scheme 3.3). Gratifyingly, the reaction proceeded successfully and, more 
importantly, set the stereochemistry at C4a correctly, which was verified by NOESY 
(Figure 3.1). Furthermore, the palladium-π complex intermediate 3.17 was also 
isolated and its structure was established by 2D-NMR and 
31
P-NMR. In fact, a similar 
palladium-π complex 3.24 had been reported in the literature.5 Encouraged by this 
result, two more compounds (3.20, 3.22) were also synthesized using different 
organostannane coupling partners.   
 
 
 
 
 
 
 
 
Scheme 3.3. Successful Palladium Cascade 
 
 
 
 
Figure 3.1. NOE Correlations of 3.18 
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It was reported by Hanna’s group that stereocontrol of the C8 methyl group at 
late stage of their synthesis was troublesome;
6
 therefore, introduction of the C8 methyl 
group was then pursued at this relatively early stage.  First, a radical deoxygenation 
protocol was attempted (Scheme 3.4).
7
 The methyl group was incorporated using a 
Grignard addition reaction (3.25) and the resultant alcohol was converted to a xanthate 
(3.26). To achieve a stereoselective addition of methylmagnesium bromide to ketone 
3.22, different Lewis acid additives (MgBr2 and CeCl3) and solvents (THF and Et2O) 
were screened.
8
 Eventually, excellent selectivity was obtained by using diethyl ether 
as solvent in the presence of MgBr2 (benzene was used to assist in solubilizing MgBr2 
in ether). Unfortunately, upon treatment of 3.26 with n-Bu3SnH and AIBN, a mixture 
of two diastereomers 3.27 and 3.28 resulted, with the major one (3.27) being the 
undesired diastereomer. Using milder radical reaction conditions (n-Bu3SnH, Et3B, O2, 
-78 °C) the reaction was more stereoselective, however, again favoring the undesired 
diastereomer.  
 
 
 
 
 
 
 
 
 
Scheme 3.4. Installation of the C8 Methyl Group – Radical Approach 
The high temperature radical reaction conditions (n-Bu3SnH, AIBN, PhMe, 85 
°C) generated a trace amount of Chugaev elimination product 3.29,
9
 which presented 
 32 
us with an opportunity to use an olefin hydrogenation route to install the C8 methyl 
(Scheme 3.5). It was hoped that the adjacent furan oxygen could serve as a directing 
group during hydrogenation of the front terminal olefin, and the back tri-substituted 
olefin could also be hydrogenated simultaneously. Toward that end, xanthate 3.26 was 
heated to reflux in toluene and the olefin was generated in 82% yield. When the olefin 
was first treated with Pd/C catalyst under 1000 psi of H2, the reaction afforded a 6.5:1 
mixture of two diastereomers, favoring the undesired one (3.32). However, we were 
pleased to find that the back olefin was reduced as predicted in a substrate control 
manner, to set the C9 methyl correctly.  It is noteworthy that high pressure is 
necessary to reduce this tri-substituted olefin.  
Various heterogeneous and homogeneous hydrogenation conditions were then 
surveyed. Delightfully, it was found that the front terminal olefin was readily reduced 
to the desired diastereomer (3.30) using Pfaltz’s version of Crabtree’s catalyst.10 This 
complete reversal in selectivity confirmed the coordination of the iridium catalyst to 
the furanyl oxygen. By following this excellent result with a Pd/C hydrogenation, the 
installation of C8 and C9 methyl groups was successfully realized in two 
hydrogenation operations. During the second hydrogenation, the two benzyl groups 
were also removed to afford diol 3.31.   
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Scheme 3.5. Installation of the C8 Methyl Group – Hydrogenation Approach 
After the hydrogenation sequence to generate C8 methyl was validated, an 
effort to shorten the steps of converting 3.22 to 3.29 was initiated.  The most sensible 
solution was direct olefination. Therefore, variety of olefination conditions, including 
Wittig olefination, Horner-Wadsworth-Emmons olefination, Peterson olefination and 
olefinations employing Tebbe reagent, Petasis reagent and Nysted reagent
11
 were 
attempted, unfortunately, without success. However, it was found that alcohol 3.25 
could be transformed to 3.29 by dehydration under the conditions of SOCl2 in pyridine 
at room temperature or Burgess’s reagent12 in toluene at 110 °C.  Since these 
conditions were inferior to the xanthate route in terms of yields (33% and 34% 
respectively), further exploration was therefore discontinued. 
Subsequently, intramolecular aldol condensations were evaluated for the 
closure of the front ring. Delightfully, double oxidation of 3.31 afforded dialdehyde 
3.33, which upon treatment with dibenzylammonium trifluoroacetate
13
 at 45 °C for 16 
h, cyclized to tetracyclic cage 3.34. This aldol condensation product was then reduced 
with DIBAL to furnish 3.35. 
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Scheme 3.6. Synthesis of the Tetracyclic Core 
At this point, a route to construct the core of vinigrol, based on a Heck-Stille 
cascade reaction had been developed. With 3.35 in hand, we set out to incorporate the 
C4 hydroxyl group. Initial screening of a variety of oxidation conditions revealed that 
the C4 methylene group was quite unreactive toward oxidants (conditions included: 
SeO2, dioxane, 100 °C; SeO2, HCO2H, dioxane, 60 °C; C6F5SeO2H, PhH, 80°C;  TPP, 
O2, hν, CHCl3).
14
 In only a few cases, a reaction occurred, leading to either oxidation 
of the alcohol to aldehyde or the opening of the back acetal. The lack of reactivity of 
3.35 to allylic oxidation can possibly be attributed to the rigid cage structure. 
Alternatively, the trifluoroethyl group hanging above the core could prevent any 
enophile (SeO2 or singlet oxygen) from accessing the alkene during the first step (ene 
reaction) of allylic oxidation.  
Alternative approaches to install the C4 hydroxyl group (Scheme 3.7) were 
considered. For example, a directed epoxidation on 3.35 could be followed by 
protection and a base mediated epoxide opening. After acylation (3.38), the 
isomerization could be achieved with palladium catalyst to provide the desired 
acylated alcohol.
15
 Alternatively, the α,β- unsaturated aldehyde could be transformed 
into an amide. After deprotonation, the resultant anion could be captured with an 
 35 
electrophile, following the example of Beak,
 16
 to deliver 3.41, which could be further 
elaborated to 3.42. Although these seemed like reasonable options, we were concerned 
about the possibility that the steric hindrance of the core structure would not allow any 
manipulation at C4. We instead chose to follow a strategy that would afford a 
tetracyclic cage with an olefin in the C3-C4 position, which could enable a more 
feasible incorporation of a hydroxyl group at C4.  
 
 
 
 
 
 
 
Scheme 3.7. Other Possible Options to Install the C4 Hydroxyl Group 
 
3.2 Tandem Heck Reaction 
3.2.1 Synthetic Strategy 
Earlier (Chapter 2), it was demonstrated that the vinigrol core could be 
constructed using either front to back or back to front cyclization approaches. Building 
on the success of the of Heck-Stille cascade, we decided to explore a front to back 
approach using tandem Heck chemistry (Scheme 3.8).
17
 It was envisioned that after 
the first palladium insertion to the alkene, the σ-palladium (II) intermediate (3.44) 
would undergo a second intramolecular Heck reaction with the pendant terminal 
alkene to provide 3.45.  In addition to its conciseness to construct the vinigrol core, 
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one salient benefit of this approach was that it would generate a C3-C4 olefin, which 
would allow more attractive manipulations (epoxidation and ring opening) to 
introduce C4 the hydroxyl group.   
 
 
 
 
 
 
 
Scheme 3.8. Tandem Heck Reaction 
3.2.2 Results and Discussion 
The preparation of the tandem Heck reaction precursor utilized the same 
OD/IMDA strategy. The synthesis commenced with a Horner-Wadsworth-Emmons 
olefination between known phosphonate 3.51
18
 and previously prepared aldehyde 3.50 
(Scheme 3.9). This reaction proceeded in good yield but poor E/Z selectivity, despite 
extensive optimization. The E isomer (3.52) was separated by silica gel column 
chromatography and reduced to corresponding allylic alcohol (3.53), which was 
coupled with aromatic piece 3.10 to provide 3.54. As previously, following the 
reduction of the acetonide, protection with β,β,β-trifluoroethyl and Dakin oxidation, 
3.57 was ready for the key OD/IMDA reaction.  
 
 
 
 
 
 
 
 
 
 37 
 
 
 
 
 
 
 
 
 
 
Scheme 3.9. Synthesis of the OD/IMDA Precursor 
Attempts to apply the same OD/IMDA reaction conditions used before were 
met with little success, producing the desired product in only 10% yield (Table 3.1, 
entry 1). Changing the solvent did not make much difference (entry 2, 3). When the 
reaction was performed at 110 °C, it did not afford any detectable product (entry 4). It 
was found that the oxidant phenyliodonium diacetate (PIDA) slowly decomposed at 
high temperature. Using that clue, the oxidative dearomatization was then performed 
at lower temperatures (-78 °C and -40 °C) and the subsequent intramolecular Diels-
Alder was then allowed to proceed at higher temperatures (60 °C, entry 5, 6). These 
modifications resulted in slightly improved yields. It is well established
19
 that 
trifluoroethanol can be a beneficial solvent for oxidative aromatization reactions, 
which was also proven true in this case. When trifluoroethanol was used, the reaction 
yield doubled compared to the first run (entry 7). An inorganic base (NaHCO3) was 
then added to the reaction in an effort to buffer the reaction (the oxidant releases acid) 
and suppress unwanted decompositions (entry 8). As shown in Scheme 3.10, the 
oxidative dearomatization intermediate 3.60 can undergo acetal hydrolysis and extrude 
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allylic alcohol 3.53 in acidic environment. 2,6-lutidine also worked as efficiently as 
NaHCO3 (entry 9).  Later it was found that before heating the dearomatization 
product, dilution with more solvent greatly improved the yield, presumably by 
suppressing self-dimerization of the dearomatization intermediate (entry 10, 11). In a 
typical procedure, the starting material was dissolved in trifluoroethanol and cooled to 
-40 °C, 2,6-lutidine was then added, followed by dropwise addition of PIDA (1.05 
equivalent). After stirring at -40 °C for 1.0 h, the reaction solution was diluted with 
trifluoroethanol to the concentration of 0.0025 M. The solution was then heated to 60 
°C and stirred for 2 hours. Removal of solvent and 2,6-lutidine in vacuo and silica gel 
column chromatography afforded 64% yield of desired compound.  
Table 3.1. OD/IMDA Optimization
a 
 
 
 
 
Entry Solvent Temp (°C) 
(addition, stirring) 
Base Time (h)  
(addition, stirring) 
Final 
concentration(M) 
Yield (%) 
1 MeOH 60, 60 - 2.5, 4.0 0.01 10 
2 DCM 60, 60 - 2.0, 1.5 0.01 10 
3 toluene 60, 60 - 2.5, 4.0 0.01 6 
4 toluene 110, 110 - 1.5, 2.0 0.01 0 
5 MeOH -78, 60 - 1.0, 3.0 0.01 15 
6 MeOH -40, 60 - 1.0, 2.0 0.01 15 
7 CF3CH2OH -40, 60 - 1.0, 2.0 0.01 21 
8 CF3CH2OH -40, 60 NaHCO3 1.0, 2.0 0.01 30 
9 CF3CH2OH -40, 60 2,6-lutidine 1.0, 2.0 0.01 35 
10 CF3CH2OH -40, 60 2,6-lutidine 1.0, 2.0 0.005 53 
11 CF3CH2OH
b -40, 60 2,6-lutidine 1.0, 2.0 0.0025 64 
a Starting material was dissolved in the solvent (0.01 M), base was added, if applied, then PIDA in MeOH was added over 
indicated period of time at indicated temperature, the reaction was diluted with same solvent, if applied, then warmed to higher 
temperature and stirred for indicated period of time.  b For large-scale batches, the reaction was diluted with toluene, and as a 
result, the yield slightly decreased.  
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Scheme 3.10. Acid-mediated Decomposition Pathway of 3.57 during OD 
The subsequent tandem Heck reaction, employing catalytic palladium(II) 
acetate, triphenylphospine and triethylamine in trifluorotoluene at 150 °C, proceeded 
smoothly, furnishing a 5:1 mixture of exo/endo products (3.63/3.64, Scheme 3.11). 
Choosing trifluorotoluene as solvent was beneficial as far as the exo/endo ratio is 
concerned.  This solvent greatly accelerated the reaction rate, which result in less exo 
olefin being isomerized to the endo olefin. However this isomerization did not become 
an issue since both products were readily reduced to 3.65. After hydrogenation, the 
front ketone was converted to an alkene using the Chugaev elimination protocol (3.67) 
as before. Exposure of the alkene to hydrogen in the presence of Crabtree’s catalyst 
resulted in a 1.2:1 mixture of two diastereomers; remarkably, by changing the catalyst 
to Pfaltz’s catalyst,10 the hydrogenation proceeded with excellent stereocontrol, 
favoring the desired diastereomer. 
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 Scheme 3.11. Synthesis of the Tetracyclic Core – Tandem Heck Route 
With 3.68 in hand, attention was then directed to the installation of the C4-
hydroxyl group (Scheme 3.12). Removal of methyl ether was achieved by a selenium 
dioxide oxidation (3.70)
20
 and subsequent reduction of the aldehyde. When the 
resultant allylic alcohol (3.71) was treated with meta-chloroperoxybenzoic acid, one 
single product (3.72) was isolated by silica gel column chromatography. Although 
without definitive proof of the stereochemistry of product 3.72, complete facial 
selectivity of the directed epoxidation was expected, since the oxygen could only be 
delivered from outside the cage.  
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Scheme 3.12. Directed Epoxidation 
However, attempts to open epoxide 3.72 with bases or Lewis acids
21
 proved to 
be fruitless, leading to either unreacted starting material, decomposition of starting 
material or reductive cleavage of the epoxide, which again reflected the steric 
hindrance of the tetracyclic core of vinigrol (Scheme 3.13). 
 
 
 
 
 
 
 
 
Scheme 3.13. Failed Epoxide Opening Attempts 
Eventually, this problem was solved by adapting an exocyclic reductive ring-
opening strategy (Scheme 3.14). Alcohol 3.72 was transformed to an iodide (3.74), 
which was exposed to zinc powder upon heating in methanol to generate 3.75.
22
 
Isomerization and oxidation of the exocyclic olefin was accomplished under heating 
with selenium dioxide in p-dioxane, furnishing aldehyde 3.76 and 3.77, which were all 
reduced to alcohol 3.73.  
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Scheme 3.14. Installation of the C4 Hydroxyl Group 
The reaction proceeded presumably through an ene reaction and subsequent 
dissociation-recombination pathway (Scheme 3.15). Exocyclic olefin 3.75 was very 
responsive to the action of SeO2. Simple stirring 3.75 with SeO2 in CH2Cl2 for 2 h at 
r.t. produced a lower Rf spot on TLC plate (0.05 in 80% ethyl acetate/hexanes). 
Although no definitive characterization was taken on this intermediate, it is very likely 
to be seleninic acid 3.78. As proposed by Sharpless,
23
 this intermediate can undergo 
homolytic dissociation to form a radical pair 3.80 under thermal conditions. If 
recombination occurs at oxygen, 3.81 forms and produces 3.73 after hydrolysis. This 
high energy dissociation-recombination route could compete with the typical [2,3] 
sigmatropic rearrangement only because of the unfavorable steric interaction in the 
transition state of [2,3] sigmatropic rearrangement, which is especially true in this 
case.  
 
 
 
 
 
 
 
 43 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.15. Possible SeO2 Reaction Pathway 
3.3 Conclusion 
Two routes based on palladium cascade reactions have been explored to 
construct the vinigrol core. In both routes, the C9 methyl was set using substrate 
control while the C8 methyl was set using catalyst control. The tandem Heck reaction 
route enables us to incorporate the C4 hydroxyl group with correct stereochemistry.  
The final challenges that needed to be addressed were: 1) fragmentation of the core; 2) 
installation of isopropyl group; and 3) deprotection of the trifluoroethyl group.  
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Chapter 4   
Completion of the Synthesis of 
Vinigrol 
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4.1 Fragmentation 
4.1.1 Synthetic Strategies 
Having achieved a route to the core of vinigrol, we set out to tackle the task of 
opening up the tetracyclic cage via fragmentation. Two types of fragmentations 
appeared most tempting to us: a SmI2 mediated fragmentation (Scheme 4.1, 4.2, 4.4)
1
 
and a Grob type fragmentation (4.1, 4.3)
2
. In both cases, we envisioned that the 
fragmentation could be initiated by a carbanion or a ketyl radical from either the top or 
the bottom of the tetracyclic cage.  
 
 
 
 
 
 
 
Scheme 4.1. Fragmentation Options 
SmI2, as a one-electron donor, can be used in both one- and two-electron 
processes; it is remarkably selective and therefore tolerant of a variety of generally 
labile functional groups.
3
  Transformations carried out using SmI2 are often performed 
at low temperatures. The prospect of using this mild reagent was quite attractive, 
particularly at a late stage of the synthesis. 
Although the most common form of SmI2 mediated C-C cleavage is that of 
strained ring systems, especially cyclopropane and cyclobutane systems, and examples 
of greater ring systems or no-strain systems are rare in the literature,
4
 it was believed 
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that, in the case of vinigrol, the fragmentation is feasible, due to the potential of 
releasing great strain energy in the tetracyclic cage.  
4.1.2 Results and Discussion 
An easily accessible fragmentation substrate 4.9 was prepared (Scheme 4.2). 
Careful opening of the back acetal, without epimerization of the adjacent C8 
stereocenter, was accomplished by LiBF4 in acetonitrile and water.
5
  The resultant 
alcohol 4.6 was then oxidized to aldehyde 4.7. After Grignard addition and oxidation, 
diketone 4.9 was obtained in good yield.  
Surprisingly, when 4.9 was subjected to reaction condition, reported to be 
successful for 1,4-diketone fragmentations (SmI2 and HMPA in t-BuOH and THF), 
the expected C-C fragmentation did not occur, instead pinacol coupling product 4.10 
was the only product isolated. In addition to the convincing 2D-NMR characterization 
data, the identification of this product was further confirmed when it was treated with 
lead (IV) acetate and clearly reversed to 4.9.  It was reported that the presence of 
HMPA in the reaction could prevent or slow the chelate formation via the two 
carbonyl moieties onto the SmI2, required for C-C bond formation in such pinacol-
type reactions, thereby favoring the fragmentation pathway (the presence of HMPA 
does enhance the rate of reaction of SmI2 with carbonyl moieties).
6
 This reaction 
outcome could only be explained by the lower activation energy induced by the great 
proximity between two ketones, compensating the increase in strain of an already 
strained [2.2.2] system after pinacol formation.  
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Scheme 4.2. SmI2 Mediated Diketone Fragmentation Attempt 
Alternatively, another fragmentation substrate (4.13) was investigated, wherein 
the pinacol pathway was expected to be less favored. Ketone-ester 4.13 was 
synthesized in two steps from 4.7 employing a Pinnick oxidation, followed by an 
esterification. However, 4.13 also failed to afford any fragmentation product. Instead, 
two products lactone 4.14 and alcohol 4.15 were isolated.  
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Scheme 4.3. SmI2 Mediated Ketone-ester Fragmentation Attempt 
The unsuccessful attempts of SmI2 meditated fragmentation prompted 
investigation into a more reliable Wharton fragmentation strategy, wherein compound 
4.21 would be the target of synthesis. As shown in Scheme 4.4, dialdehyde 4.7 
underwent a selective Baeyer-Villiger oxidation, affording formate ester 4.17 in 
excellent yield. In line with previous experiments, the front olefin was found to be 
inert under the reaction conditions. Subsequent DIBAL reduction then furnished 1,3-
diol 4.18. Although diol 4.18 is potentially competent for fragmentation, the orbitals 
of the C7-epimer would be better aligned; therefore the C7 stereocenter was inverted 
by oxidation of the secondary alcohol (4.18), followed by a diastereoselective Evans-
Saksena reduction (4.20).
7
 Derivatization of the secondary alcohol as a mesylate 
(4.21) was then readily performed using methanesulfonyl chloride in pyridine.   
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Scheme 4.4. Synthesis of the Wharton Fragmentation Precursor 
Gratifyingly, when 4.21 was treated with potassium tert-butoxide in tert-
butanol, 4.22 was obtained in excellent yield (Scheme 4.5). Although the 
stereoelectronic all-anti arrangement is the general prerequisite for Grob-type 
fragmentations, there are a number of examples in the literature of syn and anti 
fragmentations showing similar reactivity.
8
 To explore this possibility, 4.23 was 
prepared from 4.18 and treated under the same reaction conditions. The reaction did 
occur, and efficiently produced the same product 4.22. It is interesting to note the 
difference in behavior between the two mesylates.  Mesylate 4.23 was formed much 
faster than its epimer 4.21 due to less steric crowding (3 hours vs. 15 hours employing 
the same reaction conditions: 10 eq. MsCl in pyridine, 0 °C), while its fragmentation 
was much slower as expected (15 h vs. 1.5 h, same reaction conditions: 3 eq. t-BuOK 
in t-BuOH, r.t.).  
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Scheme 4.5. Wharton Fragmentation 
4.2 Installation of the Isopropyl Group 
At this stage, after an efficient synthesis for the tricyclic core of vinigrol had 
been developed, the installation of the isopropyl group at C12 carbonyl seemed readily 
within reach, considering the well precedented approaches to address the similar tasks 
in the literature.
9
 Several options to install the isopropyl group are shown in Scheme 
4.6. However, it was soon discovered that option 1 was hampered by the impossibility 
of performing a Wittig condensation to form olefin 4.24. Following a brief exploration 
of option 2, it was also discontinued due to the inability of generating triflate 4.26. Our 
attention therefore turned to the third option. It was envisioned that tricyclic alcohol 
4.28, derived from addition of isopropenylmagnesium bromide to ketone 4.22, could 
be elaborated into 4.29 or 4.30 using standard xanthate formation or acylation 
conditions. Exposure of xanthate 4.29 to radical conditions would afford the desired 
isopropenyl product 4.31. In the case of allylic acetate 4.30, it could undergo a 
transition metal catalyzed reductive coupling to afford 4.31. Low level calculations 
(molecular mechanics) and modeling of vinigrol had revealed that C12 isopropyl 
group is positioned in a more thermodynamically stable position, therefore the desired 
stereochemistry should be accessed under thermodynamic conditions.  
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Scheme 4.6. Options for Installing the C12 Isopropyl Group 
As expected, the addition of isopropenylmagnesium bromide proceeded 
smoothly with the aid of cerium chloride,
10
 affording 4.28 as a single diastereomer 
(Scheme 4.7). When 4.28 was treated with potassium hydride followed by carbon 
disulfide and iodomethane, interestingly, a major product was isolated and proved to 
be undesired fragmentation product 4.32 by 
1
H-NMR analysis. Similarly, attempts to 
form acetate 4.30 using milder bases, such as triethylamine and pyridine, also suffered 
from the same issue of producing 4.32. It appeared that the alkoxide underwent a Grob 
fragmentation easily due to its propensity to release strain energy. This is the first 
reported example of a Grob fragmentation wherein a trifluoroethyl ether serves the 
role of a leaving group.  
 
 
 55 
 
 
 
 
Scheme 4.7. Unwanted Grob Fragmentation 
At this point, reaction conditions to navigate around this surprisingly facile 
fragmentation were highly desirable. Fortunately, it was discovered that after 
hydrogenation, compound 4.28 could be dehydrated to two regioisomers with 
Burgess’s reagent.11 Although these two compounds were not advanced due to the low 
yield of the reaction and their resistance to further hydrogenation, this promising 
preliminary result promoted us to devise a new approach to install the isopropyl group 
(Scheme 4.8). Following hydrogenation, 1-ethoxyvinyllithium was added to the 
ketone 4.33. The resultant enol ether was then carefully hydrolyzed to α-hydroxy 
ketone 4.34. Gratifyingly, Burgess dehydration afforded α,β-unsaturated ketone 4.36. 
Although the efficiency of this reaction was modest, the Burgess dehydration enabled 
us to circumvent the troublesome Grob fragmentation pathway. Furthermore, the 
resultant α,β-unsaturated ketone presented us with a perfect opportunity of precise 
stereo-control of its reduction.  
 
 56 
 
 
 
 
 
 
Scheme 4.8. Formation of α,β-Unsaturated Ketone 4.36 
First attempts to selectively reduce ketone 4.36 with Selectrides
12
 led to a 
mixture of unidentified compounds. Copper hydride reagent (Red-Al, CuBr, -20 °C)
13
 
generated primarily undesired 1,2-reduction product. Several hydrogenation 
conditions were then examined. Interestingly, stirring 4.36 with palladium on carbon 
or alumina under hydrogen atmosphere in ethyl acetate yielded one major product 
(4.37, Scheme 4.9), which was assigned by 2D-NMR as the undesired C12-epimer of 
the methyl ketone (Figure 4.1). Although it was possible to convert 4.37 to desired 
epimer by isomerization,
14
 this approach appeared not ideal, due to the facts that these 
hydrogenation conditions also generated some unidentified by-products and the 
reaction was found to be irreproducible.  Although the reason for this was unclear, it 
was speculated that the slightly acidic surface of the “neutral” catalyst was resulting in 
the partial decomposition of the vinigrol framework. To alleviate the problems, 
hydrogenation was then performed in the presence of potassium hydroxide.
15
 
Delightfully, these alkaline hydrogenation conditions furnished the desired C12-
epimer (4.38) in excellent yield.  Following a Wittig olefination and reduction, the 
installation of the C12-isopropyl group was then completed (4.25). 
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Scheme 4.9. Installation of the C12 Isopropyl Group 
 
 
 
 
Firgure 4.1. NOE Correlations of 4.37 
4.3 Installation of the C4 Hydroxyl Group 
The same protocol we had developed previously for the C4 hydroxyl 
installation (Chapter 3, Scheme 3.12, 3.14) was then employed on 4.25 (Scheme 4.10). 
Thus, following a sequence of methoxy group removal (4.41), directed epoxidation of 
the allylic alcohol (4.42), iodination (4.43) and reductive ring opening of the epoxide, 
exocyclic olefin 4.44 was obtained. It was noteworthy that the ring opening of 4.43 
proceeded only with the assistance of sonication in this case.
16
  
 
 
 58 
 
 
 
 
 
 
 
Scheme 4.10. Installation of the C4 Hydroxyl Group 
Surprisingly, when 4.44 was exposed to selenium dioxide in refluxing benzene, 
none of the desired product was detected. A similar intermediate (4.45) as observed 
earlier was seen, judging by 
1
H-NMR and its low Rf on TLC plate (0.05 in 80% ethyl 
acetate/hexanes). Conditions to oxidize the C16-selenium group to a primary alcohol 
were therefore sought. Based on limited literature on this subject, it was suggested that 
seleninic acids could be oxidized to selenonic acids by sodium periodate
17
 or 
dimethyldioxirane (DMDO)
18
 and then displaced by a nucleophile, such as I
-
 or H2O. 
To probe the reactivity of seleninic acid intermediate 4.45, tert-butyl hydropeoxide, a 
widely used co-oxidant in selenium dioxide oxidation systems,
19
 was first chosen as an 
oxidant (Scheme 4.11). Pleasingly, after stirring 4.45 with tert-butyl hydroperoxide in 
CH2Cl2 at room temperature for 16 hours, the desired alcohol 4.46 was detected in the 
crude 
1
H-NMR spectrum. Purification of the crude product also revealed small 
amounts of other by-products, most notably 4.47, which could be converted to 4.46 by 
DIBAL reduction, and 4.48.  
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Scheme 4.11. SeO2 Mediated Isomerization and Oxidation 
Alternatively, hydrogen peroxide was also explored as oxidant with 
expectation that 4.48 should not be generated. Delightfully, the reaction proceeded 
smoothly, furnishing 4.46 and 4.47. And most importantly, the front trisubstituted 
olefin was intact, without epoxidation products being generated.
20
  
4.4 Cleavage of the Trifluoroethyl Group 
With the installation of the C4-hydroxyl group behind us, the final obstacle of 
the total synthesis of vinigrol we faced was the cleavage of the trifluoroethyl group. 
First, it is worth noting that a trifluoroethyl group has never been used as a protecting 
group in synthesis. With very few scattered examples of this rather stable motif being 
explored in the literature, deprotection conditions that were compatible with the rest of 
the vinigrol architecture were sought. It is reported that trifluoroethyl ethers can be 
converted to base-labile esters by trifluroacetic acid.
21
 Vinigrol’s susceptibility to acid 
obviously precluded this harsh approach. A reductive approach using sodium 
naphthalene as reducing agent only resulted in unreacted starting material. It is also 
known that trifluoroethyl ethers can be converted to acetylenic esters using 
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alkyllithium reagents,
22
 via a difluorovinyllithium intermediate. This is especially 
interesting to us because in Baran’s approach to vinigrol, he demonstrated that vinigrol 
was compatible with strong bases such as n-BuLi.
23
 We were curious to learn what 
product would result if protected vinigrol intermediate 4.46 was submitted to strong 
bases (Scheme 4.12). If difluorovinyl ether 4.51 was to be obtained, it could 
potentially be cleaved under oxidative condidtion. If acetylenic ether 4.52 was 
obtained, this acid vulnerable compound could be converted to ester then cleaved by 
hydrolysis or reduction to vinigrol. Alternatively, difluorovinyllithium intermediate 
4.49, if long lived enough, could also be trapped with an electrophilic oxygen and 
converted to vinigrol the same way. 
 
 
 
 
 
 
 
 
 
 
Scheme 4.12. Strategies for Removing Trifluoroethyl Group 
To evaluate the feasibility of these plans, an early intermediate 4.54 was 
treated with large excess of tert-butyl lithium in diethyl ether at -40 °C (Scheme 4.13). 
To our delight, compound 4.55 was observed, although the yield of the reaction was 
not ideal (31%). Brief exposure of 4.55 to acid then afforded ester 4.56, which was 
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reduced to free alcohol 4.57. Interestingly, the back acetal was also opened during 
DIBAL reduction, presumably due to the Lewis acidity of aluminum.  
 
 
 
 
 
 
 
Scheme 4.13. Early Success of Removing Trifluoroethyl Group 
Encouraged by this early success in deprotecting the trifluoroethyl group, 
vinigrol precursor 4.46 was subjected to the same conditions (Scheme 4.14). This 
time, the reaction proceeded only to the stage of difluorovinyllithium intermediate 
4.49.  All attempts to trap this intermediate with electrophilic oxygen reagents, such as 
molecular oxygen,
24
 2-sulfonyloxaziridine (Davis’s oxiziridine),25 molybdenum 
peroxide-pyridine-hexamthylphophoramide (MoOPH)
26
 and bis(trimethylsilyl)-
peroxide (TMSOOTMS)
27
 to form difluoroether 4.50 met without success. Eventually, 
difluorovinyl ether 4.51 was isolated by silica gel column chromatography and 
oxidized using osmium tetraoxide
28
 to form osmate ester 4.58, which was then 
hydrolyzed in situ during work-up to furnish vinigrol. 
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Scheme 4.14. Synthesis of Vinigrol- Removal of the Trifluoroethyl Group 
4.5 Conclusion 
A total synthesis of vinigrol has been accomplished.
29
 A key step in this 
synthesis utilized a strategic oxidative dearomatization/intramolecular Diels-Alder 
reaction,
30
 which coupled with a Heck cyclization cascade, affording the tetracyclic 
core of vinigrol in only two steps from a simple precursor.  The synthesis endeavors 
feature a number of notable transformations such as: 1) a directed hydrogenation in a 
very complex and hindered setting, 2) selenium dioxide mediated olefin isomerization 
and oxidation, 3) Wharton fragmentation, 4) stereoselective installation of an 
isopropyl group and 5) unique strategic applications and deprotection of trifluoroethyl 
ethers.  Efforts are underway to render the oxidative transformation asymmetric, 
which would provide access to vinigrol enantiomers.   
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APPENDIX 1 
A1.1 General Information 
 The general information discussed in this section applies to Appendix 2 and 3. 
All reactions were performed using flame-dried glassware under an 
atmosphere of nitrogen with dry solvents, unless otherwise stated. Dry tetrahydrofuran 
(THF), diethyl ether, dichloromethane (CH2Cl2), toluene (PhMe), methanol (MeOH), 
acetonitrile (CH3CN) were obtained by passing these previously degassed solvents 
through activated alumina columns. Benzene (PhH) was distilled from 
sodium/benzophenone.  All other commercial reagents were used as provided. 
Reactions were monitored by thin layer chromatography (TLC) carried out on EMD 
silica gel 60-F254 plates. Visualization was performed by UV light irradiation and 
ceric ammonium molybdate, or anisaldehyde, or potassium permanganate stain and 
heat. SiliaFlash F60 silica (particle size 40-63μm) was used for flash column 
chromatography.  Preparative thin layer chromatography (prep-TLC) separations were 
also carried out on EMD silica gel 60-F254 plates. 
1
H and 
13
C NMR data was acquired 
on Varian Inova 400, 500, or 600 (Cornell University) or Bruker DRX 400, 500, or 
600 (University of Arizona) spectrometer and the spectra were calibrated using 
residual solvents as an internal reference (CDCl3: 7.26 ppm for 
1
H NMR, 77.16 ppm 
for 
13
C NMR; C6D6: 7.16 ppm for 
1
H NMR, 128.06 ppm for 
13
C NMR; CD3OD: 3.31 
ppm for 
1
H NMR, 49.00 ppm for 
13
C NMR).  The following abbreviations (or 
combinations thereof) were used to explain the multiplicities: s = singlet, d = doublet, t 
= triplet, q = quartet, m = multiplet, b = broad.  Infrared spectra were recorded on a 
 69 
Shimadzu Prestige FT-IR. High resolution mass spectra were acquired at the 
University of Arizona Mass Spectral Facility. 
A1.2 Experimental Procedures for Chapter 2  
 
A solution of propargyl alcohol (12.0 mL, 203.1 mmol) in THF (775 mL) was 
cooled to -78 °C, and n-BuLi (2.5 M in hexanes, 170.6 mL, 426.5 mmol) was added 
slowly. After stirring for 30 min at -78 °C, trimethylsilyl chloride (57.1 mL, 446.8 
mmol) was added dropwise. Once the addition was completed, the cold bath was 
removed, and the reaction was stirred at r.t. for 2.0 h. The reaction was cooled to 0 °C, 
quenched by water (100 mL), and then 1 N HCl solution (300 mL) was added to the 
crude reaction mixture and stirred at r.t. for 1.5h. The complete consumption of the 
TMS ether was observed by TLC (Rf 0.90 in 10% ethyl acetate/hexanes). The reaction 
mixture was poured into a separatory funnel, the organic layer was separated and the 
aqueous layer was extracted with diethyl ether (4 × 150 mL).  The combined organic 
layers were washed with brine (200 mL), dried over anhydrous Na2SO4, filtered, and 
concentrated in vacuo. Purification by vacuum distillation (15 mtor, 50 °C) provided 
the desired alcohol (25.9 g, 99%) as a pale yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 
4.27 (d, J = 6.1 Hz, 2H), 1.53 (t, J = 6.1 Hz, 1H), 0.18 (s, 9H). The spectrum data is 
consistent with the reported literature data.
1
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A mixture of 3-(trimethylsilyl)prop-2-ynol (11.9 g, 93.0 mmol), diethyl ether 
(200 mL), and copper iodide (1.92 g, 10.1 mmol) was stirred and cooled at -10 °C 
(salt/ice bath) and freshly prepared allylmagnesium bromide (0.085M, 300 mL)  was 
added slowly via cannula. The reaction mixture turned from grey to brown to black 
over time. After the addition was completed, the reaction was warmed to r.t. naturally 
and stirred for 12 h totally. The reaction mixture was cooled to 0 °C and quenched by 
saturated NH4Cl solution (100 mL) and diluted with water (300 mL). After phase 
separation, the aqueous phase was filtered through a Celite pad to remove the 
precipitate. The solution was then extracted with diethyl ether (3 × 150 mL). All 
organic phases were combined and washed with brine (200 mL), dried over anhydrous 
Na2SO4 and concentrated. The crude product was distilled under vacuum (15 mtor, 72-
73 °C) to afford a light yellow oil (14.2 g, 90%). 
1
H NMR (500 MHz, CDCl3) δ 5.77 
(ddt, J = 17.1, 10.1, 6.5 Hz, 1H), 5.62 (t, J = 1.6 Hz, 1H), 5.08 (dq, J = 17.1, 1.7 Hz, 
1H), 5.04 (dq, J = 10.1, 1.5 Hz, 1H), 4.06 (dd, J = 6.2, 1.5 Hz, 2H), 2.93 (dt, J = 6.5, 
1.6 Hz, 2H), 1.57 (t, J = 6.2 Hz, 1H), 0.14 (s, 9H). The spectrum data is consistent 
with the reported literature data.
2
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To a suspension of NaH (60 wt%, 5.36 g, 133.9 mmol) and iodomethane (25.1 
mL, 401.9 mmol) in THF (160 mL), alcohol (15.2 g, 89.3 mmol) in THF (20 mL) was 
added dropwise. The reaction mixture was then stirred at 45 °C for 16 h. After that 
period of time, the starting material was still present by TLC analysis. More NaH 
(3.56 g, 89.3 mmol) and iodomethane (5.6 mL, 89.3 mmol) were added and stirring 
continued for 5.0 h. The reaction was cooled to 0 °C and quenched by saturated 
NH4Cl solution (50 mL) and diluted with water (50 mL). The organic layer was 
separated and the aqueous layer was extracted with diethyl ether (3 × 80 mL).  The 
combined organic layers were washed with brine (100 mL), dried over anhydrous 
Na2SO4 and concentrated. Purification by column chromatography (5% diethyl 
ether/pentane) afforded a light yellow oil (15.6 g, 95%). 
1
H NMR (600 MHz, CDCl3) 
δ 5.77 (ddt, J = 17.1, 10.1, 6.5 Hz, 1H), 5.61 (t, J = 1.5 Hz, 1H), 5.07 (dq, J = 17.1, 1.7 
Hz, 1H), 5.03 (dq, J = 10.1, 1.5 Hz, 1H), 3.83 (d, J = 1.4 Hz, 1H), 3.33 (s, 3H), 2.90 
(dt, J = 6.5, 1.5 Hz, 1H), 0.13 (s, 9H). The spectrum data is consistent with the 
reported literature data.
2
 
 
To the solution of TMS-diene (12.1 g, 65.6 mmol) in acetonitrile (230 mL) 
was added N-Iodosuccinimide (17.1g, 76.0 mmol) in portions at 0 °C. After 40 min at 
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0 °C, the reaction mixture was warmed to r.t., covered with aluminum foil and stirred 
for 40 h. After that period of time, the reaction was quenched by 10% Na2S2O3 
solution (200 mL). Two phases were separated and the aqueous phase was extracted 
with pentane (3 × 150 mL) and the organic phase was also extracted with pentane (6 × 
200 mL). The combined extracts were washed with brine (200 mL), dried over 
anhydrous Na2SO4 and carefully concentrated on rotovap. The crude product with 
residual pentane was used in next step without any further purification. 
1
H NMR (400 
MHz, CDCl3) δ 6.34 (tt, J = 1.4, 0.5 Hz, 1 H), 5.75 (ddt, J = 17.1, 10.0, 6.6 Hz, 1 H), 
5.15 (dq, J = 17.1, 1.6 Hz, 1 H), 5.09 (ddt, J = 10.0, 1.8, 1.3 Hz, 1 H), 3.91 (d, J = 1.4 
Hz, 2 H), 3.30 (s, 3 H), 2.98 (dt, J = 6.6, 1.5 Hz, 2 H); 
13
C NMR (100 MHz, CDCl3) δ 
146.11, 133.26, 117.06, 79.49, 74.80, 58.12, 39.43; IR (film) 3059, 2980, 2928, 2926, 
2820, 1639, 1211, 1095, 993, 916, 781 cm
-1 
; HRMS (EI) m/z calcd. for C7H11IO [M]
+
: 
237.9855, found: 237.9861. 
 
N-Methylmorpholine N-oxide monohydrate (9.34 g, 69.1 mmol) was dissolved 
in water (140 mL) and cooled to 0 °C, and iododiene from the previous step dissolved 
in tert-butanol (140 mL) was added, followed by a solution of osmium tetroxide (2.5 
wt%, 12.0 mL, 1.73 mmol) in tert-butanol. The reaction was stirred at 0 °C for 8 h 
then quenched by 15% NaHSO3 solution (250 mL) and extracted with ethyl acetate (6 
× 200 mL). The combined extracts were washed with brine (2 × 200 mL), dried over 
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anhydrous Na2SO4 and concentrated in vacuo. The crude product was purified by 
column chromatography (60% ethyl acetate/hexanes) to afford a light brown oil (10.5 
g, 59% yield over 2 steps). 
1
H NMR (400 MHz, CDCl3) δ 6.49 (td, J = 1.1, 0.7 Hz, 
1H), 4.00 (d, J = 1.1 Hz, 2H), 3.93 (ddtd, J = 8.8, 6.5, 3.8, 3.3 Hz, 1H), 3.70 (ddd, J = 
11.2, 6.8, 3.3 Hz, 1H), 3.61 (d, J = 3.9 Hz, 1H), 3.53 (ddd, J = 11.2, 6.5, 5.4 Hz, 1H), 
3.37 (s, 3H), 2.69 (dd, J = 6.8, 5.4 Hz, 1H), 2.51 (ddd, J = 13.9, 3.9, 0.7 Hz, 1H), 2.40 
(dd, J = 13.9, 8.8 Hz, 1H); 
13
C NMR (100 MHz, CDCl3) δ 145.17, 83.47, 76.70, 
70.57, 66.63, 58.28, 39.84; IR (film) 3358, 2926, 2885, 2821, 1610, 1192, 1087, 1033, 
910, 783 cm
-1 
; HRMS (ESI) m/z calcd. for C7H13INaO3 [M+Na]
+
: 294.9802, found: 
294.9807. 
 
Compound *** was prepared according to literature protocol.
3
  
A mixture of 4-bromo-1-butene (5.4 mL, 52.7 mmol) and triphenylphosphine 
(10.6 g, 40.5 mmol) in toluene (150 mL) was heated at reflux for 24 h. The reaction 
mixture was then cooled to r.t. and filtered over a Buchner funnel. A white solid was 
collected, which was washed with toluene (2 × 35 mL) then dried under high vacuum 
to afford desired product A1.1 (16.0 g, quantitative yield). 
To a solution of phosphonium salt (500 mg, 1.25 mmol) in THF (7.0 mL) was 
added potassium bis(trimethylsilyl)amide (1.0 M in THF, 5.0 mL) dropwise at -78 °C. 
After stirring for 1.0 h, methyl chloroformate (0.48 mL, 6.25 mmol) was added. The 
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reaction mixture was stirred at the same temperature for 30 min. then warmed to r.t. 
and stirred for 1.0 h. The reaction was quenched by saturated NaHCO3 and diluted 
with dichloromethane. The organic phase was separated and the aqueous phase was 
extracted with dichloromethane three times. The combined organic phases were dried 
over anhydrous MgSO4, filtered and concentrated. The crude product was purified by 
column chromatography (15% ethanol/ethyl acetate) to afford an off-white solid (348 
mg, 74% yield). 
1
H NMR (400 MHz, CDCl3) δ 7.64 – 7.40 (m, 15H), 5.82 (ddt, J = 
17.0, 10.0, 6.0 Hz, 1H), 4.67 (ddt, J = 10.0, 2.6, 1.4 Hz, 1H), 4.56 (dq, J = 17.0, 1.7 
Hz, 1H), 3.33 (s, 3H), 2.69 (ddt, J = 18.6, 6.0, 1.4 Hz, 2H); 
13
C NMR (125 MHz, 
CDCl3) δ 170.52, 140.93, 133.42 (d, J = 9.7 Hz, 6C), 131.48 (d, J = 2.8 Hz, 3C), 
128.26 (d, J = 12.0 Hz, 6C), 127.61 (d, J = 90.4 Hz, 3C), 111.65, 49.17, 37.43 (d, J = 
122.0 Hz), 31.14; IR (film) 3057, 2941, 1627, 1600, 1435, 1323, 1159, 1101, 746, 
715, 692, 569, 516 cm
-1
; HRMS (ESI) m/z calcd. for C24H24O2P [M+H]
+
: 375.1508, 
found: 375.1505. 
 
To an ice-water cooled solution of diol (82.0 mg, 0.301 mmol) in CH2Cl2 (3.0 
mL) was added lead (IV) acetate (155 mg, 0.332 mmol) in one portion. After the 
addition was completed, the reaction mixture was allowed to warm to r.t. and stirred 
for 1.0 h. The mixture was poured directly over a silica gel pad, filtered and the filter 
cake was washed with ethyl acetate. After the filtrate was concentrated on rotovap, the 
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residue was taken up in diethyl ether and filtered through a Celite pad and washed 
with ether. The filtrate was concentrated again on rotovap and then placed under high 
vacuum briefly to remove the residual solvents and formaldehyde. The resultant 
aldehyde crude product was used immediately. 
A mixture of phosphorane (281 mg, 0.753 mmol) and the aforementioned 
aldehyde in benzene (3.0 mL) was placed in a high-pressure tube, capped and heated 
at 80 °C for 1.0 h. The reaction mixture was cooled to r.t. and concentrated. The 
residue was purified by column chromatography (10 % ethyl acetate/hexanes) to 
afford a colorless oil (53.0 mg, 52% yield). 
1
H NMR (400 MHz, CDCl3) δ 6.72 (t, J = 
7.5 Hz, 1H), 6.41 (s, 1H), 5.84 (ddt, J = 17.2, 10.1, 6.1 Hz, 1H), 5.12 – 4.98 (m, 2H), 
3.89 (d, J = 1.3 Hz, 2H), 3.74 (s, 2H), 3.30 (s, 3H), 3.18 (dt, J = 6.1, 1.7 Hz, 2H), 3.15 
(d, J = 7.5 Hz, 2H); 
13
C NMR (125 MHz, CDCl3) δ 167.73, 145.54, 138.44, 135.08, 
131.85, 115.59, 80.67, 75.05, 58.15, 52.02, 34.71, 31.20; IR (film) 2949, 2926, 1712, 
1435, 1276, 1205, 1132, 1093, 914, 783, 765 cm
-1
; HRMS (ESI) m/z calcd. for 
C12H18IO3 [M+H]
+
: 337.0295, found: 337.0292. 
 
To a solution of ester (455 mg, 1.35 mmol) in dichloromethane (14.0 mL) 
cooled at -78 °C, DIBAL (1.0 M in CH2Cl2, 2.98 mL, 2.98 mmol) was added 
dropwise. After stirring at -78 °C for 3 h the reaction was quenched by 10% Rochelle's 
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salt (4.0 mL) and warmed to r.t. The mixture was partitioned between ethyl acetate (25 
mL) and Rochelle' salt solution (25 mL) and vigorously stirred for 2 h. The organic 
layer was separated and the aqueous layer was extracted with ethyl acetate three times. 
The combined organic layers were washed with brine and dried over anhydrous 
Na2SO4. After filtration and concentration, the residue was purified by column 
chromatography (30% ethyl acetate/hexanes) to afford a light yellow oil (349 mg, 84% 
yield). 
1
H NMR (400 MHz, CDCl3) δ 6.30 (td, J = 1.4, 0.6 Hz, 1H), 5.80 (ddt, J = 
17.1, 10.0, 6.4 Hz, 1H), 5.45 (dddt, J = 8.1, 7.4, 2.2, 1.1 Hz, 1H), 5.10 (dq, J = 17.1, 
1.7 Hz, 1H), 5.04 (dq, J = 10.0, 1.7 Hz, 1H), 4.07 – 4.02 (m, 2H), 3.89 (d, J = 1.4 Hz, 
2H), 3.29 (s, 2H), 3.02 (d, J = 7.4 Hz, 2H), 2.95 (d, J = 6.4 Hz, 2H), 1.68 (s, 1H); 
13
C 
NMR (125 MHz, CDCl3) δ 146.87, 139.07, 135.52, 122.26, 115.94, 79.22, 74.91, 
66.72, 58.08, 33.73, 32.84; IR (film) 3404, 2976, 2924, 2821, 1635, 1612, 1450, 1375, 
1298, 1284, 1265, 1192, 1087, 995, 914, 777, 673 cm
-1
; HRMS (ESI) m/z calcd. for 
C11H17IO2Na [M+Na]
+
: 331.0165, found: 331.0163. 
 
To a solution of alcohol (32.0 mg, 0.104 mmol) and phenol (61.2 mg, 0.312 
mmol) in 1,1,1,3,3,3-hexafluoropropan-2-ol (5.0 mL) was added at r.t. a solution of 
phenyliodine bis(trifluoroacetate) (134 mg, 0.312 mmol) in 1,1,1,3,3,3-
hexafluoropropan-2-ol (1.0 mL) over 2.0 h via syringe pump. After the addition was 
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completed, the reaction solution was stirred for further 30 min., then partitioned 
between ethyl acetate and saturated NaHCO3 solution. The organic phase was 
separated, and the aqueous phase was extracted with ethyl acetate three times. The 
combined organic phase was washed with brine, dried over anhydrous Na2SO4, 
filtered and concentrated. The crude product was purified by column chromatography 
(25% ethyl acetate/hexanes) to provide a light yellow oil (18.0 mg, 34% yeild). 
1
H 
NMR (400 MHz, CDCl3) δ 7.13 (dd, J = 2.2, 1.1 Hz, 1H), 6.31 (t, J = 1.1 Hz, 1H), 
5.86 (ddt, J = 17.2, 10.1, 7.2 Hz, 1H), 5.24 – 5.17 (m, 1H), 5.09 (dq, J = 16.9, 1.5 Hz, 
1H), 4.09 (d, J = 8.2 Hz, 1H), 4.03 (dd, J = 3.5, 1.0 Hz, 2H), 4.00 (d, J = 2.2 Hz, 1H), 
3.86 (d, J = 8.2 Hz, 1H), 3.56 (s, 3H), 3.46 (s, 3H), 3.29 (s, 3H), 2.94 (t, J = 7.2 Hz, 
1H), 2.42 (s, 3H), 2.36 (ddd, J = 7.6, 2.7, 1.1 Hz, 2H), 2.21 (dd, J = 14.5, 7.6 Hz, 1H), 
2.09 (dd, J = 14.5, 6.9 Hz, 1H); 
13
C NMR (125 MHz, CDCl3) δ 198.60, 194.07, 
146.95, 139.83, 139.16, 132.60, 120.39, 99.24, 87.20, 80.82, 77.99, 75.55, 57.94, 
53.77, 51.32, 49.24, 45.09, 42.33, 35.72, 33.32, 25.12; IR (film) 2976, 2941, 2893, 
1766, 1749, 1674, 1249, 1228, 1192, 1089, 1014, 877 cm
-1
; HRMS (ESI) m/z calcd. 
for C21H28IO6 [M+H]
+
: 503.0925, found: 503.0916. 
 
A solution of vinyl iodide (27.0 mg, 0.0538 mmol) in dry toluene (0.80 mL) 
was heated to 80 °C, to which tributyltin hydride (0.63 M in toluene, 0.10 mL) and 
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azobisisobutyronitrile (0.11 M in toluene, 0.10 mL) were added simultaneously via 
syringe pumps over 2.0 h. The reaction was stirred for additional 3.0 h then cooled to 
r.t. and concentrated. The crude product was purified by column chromatography 
(25% ethyl acetate/hexanes) to afford two compounds: 2.19 (higher Rf, colorless oil, 
9.0 mg, 44% yield) and 2.20 (lower Rf, colorless oil, 8.0 mg, 40% yield). 
Compound 2.19: 
1
H NMR (600 MHz, CDCl3) δ 6.99 (t, J = 1.7 Hz, 1H), 5.53 
(dt, J = 16.7, 10.2 Hz, 1H), 5.22 (dd, J = 10.0, 2.0 Hz, 1H), 5.13 (dd, J = 16.7, 2.0 Hz, 
1H), 4.07 (d, J = 7.7 Hz, 1H), 3.94 (d, J = 2.1 Hz, 1H), 3.88 (d, J = 7.7 Hz, 1H), 3.60 
(s, 3H), 3.43 (s, 3H), 3.24 (s, 3H), 3.02 (d, J = 9.3 Hz, 1H), 2.92 (d, J = 9.3 Hz, 1H), 
2.88 (m, 1H), 2.39 (s, 3H), 2.05 (d, J = 10.2 Hz, 1H), 1.65 (dd, J = 13.0, 7.6 Hz, 1H), 
1.50 (t, J = 12.2 Hz, 1H), 0.90 (s, 3H); 
13
C NMR (CDCl3, extracted from HSQC and 
HMBC) δ 198.9, 194.5, 140.9, 138.7, 132.2, 120.7, 98.00, 86.1, 77.9, 76.3, 59.2, 57.2, 
53.6, 53.3, 51.1, 47.0, 46.0, 41.5, 37.5, 24.8, 19.5; IR (film) 2954, 2927, 2873, 1759, 
1714, 1195, 1109, 1087, 1016, 871.86 cm
-1
; HRMS (ESI) m/z calcd. for C21H29O6 
[M+H]
+
: 377.1958, found: 377.1958. 
Compound 2.20: 1H NMR (600 MHz, CDCl3) δ 5.67 (dt, J = 16.8, 10.1 Hz, 
1H), 5.20 (dd, J = 16.9, 1.8 Hz, 1H), 5.16 (dd, J = 10.2, 1.8 Hz, 1H), 3.94 (d, J = 8.7 
Hz, 1H), 3.67 (d, J = 8.7 Hz, 1H), 3.52 (s, 3H), 3.46 (s, 3H), 3.29 (s, 3H), 3.26 (d, J = 
9.3 Hz, 1H), 3.21 (d, J = 9.3 Hz, 1H), 2.79 (d, J = 1.3 Hz, 1H), 2.45 (d, J = 10.1 Hz, 
1H), 2.34 (m, 1H), 2.30 (m, 2H), 2.18 (s, 3H), 2.08 (dt, J = 13.9, 1.6 Hz, 1H), 1.88 
(ddd, J = 14.1, 10.2, 1.9 Hz, 1H), 1.83 (d, J = 2.7 Hz, 2H); 
13
C NMR (CDCl3, 
extracted from HSQC and HMBC) δ 225.0, 208.2, 132.9, 119.4, 103.4, 79.4, 76.7, 
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72.7, 59.2, 58.8, 52.8, 51.7, 51.3, 49.0, 47.8, 46.9, 45.9, 41.8, 35.0, 31.1, 25.0; IR 
(film) 2929, 1756, 1706, 1447, 1354, 1198, 1109, 1008 cm
-1
; HRMS (ESI) m/z calcd. 
for C21H29O6 [M+H]
+
: 377.1958, found: 377.1962. 
 
3-cyanopropanal 2.29 was prepared according to literature protocol.
4
  
To a solution of acetonitrile (1.0 mL, 20.0 mmol) in THF (50 mL), n-BuLi (1.6 
M in hexanes, 12.8 mL, 20.5 mmol) was added dropwise at -78 °C while the solution 
gradually turned to opaque yellow. After stirring for 15 min, 1-bromo-3-methyl-2-
butene (2.2 mL, 19.0 mmol) in THF (25 mL) was added dropwise. The reaction 
mixture was stirred at -78 °C for 4.5 h, then quenched by saturated NH4Cl solution (30 
mL) and warmed to r.t. The organic phase was separated and the aqueous phase was 
extracted with diethyl ether (3 × 50 mL). The combined organic phases were washed 
with brine, dried over anhydrous Na2SO4, filtered and carefully concentrated in vacuo 
to afford a light yellow oil.  This crude product was used directly in the next step 
without further purification. 
1
H NMR (400 MHz, CDCl3) δ 5.22 – 5.05 (m, 1H), 2.34 
(m, 4H), 1.73 (s, 3H), 1.66 (s, 3H).  
The crude product from the previous step was dissolved in dichloromethane 
(80 mL) and purged with ozone at -78 °C until the reaction solution turned blue. The 
mixture was then purged with N2 for 15 min and stirred with dimethyl sulfide (5.0 
mL) at r.t. for 1.5 h. After evaporation of the solvent, the desired product 3-
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cyanopropanal (1.19 g, 75% yield over 2 steps) was obtained, which was used without 
further purification. 
1
H NMR (300 MHz, CDCl3) δ 9.80 (s, 1H), 2.92 (t, J = 7.0 Hz, 
2H), 2.64 (t, J = 7.0 Hz, 2H). 
 
A solution of Red-Al in toluene (65 wt% in toluene, 150.8 mL, 497.6 mmol) 
was added dropwise to a stirred solution of 2-butyn-1-ol (15.0 mL, 199.0 mmol) in 
ethyl ether (720 mL) at 0 °C. The resultant clear solution was warmed to r.t. and 
stirred for 18 h. After cooling to 0 °C, ethyl acetate (29.2 mL) was added and stirred 
for 30 min. The solution was cooled to -78 °C and iodine (75.8 g, 298.5 mmol) in THF 
(250 mL) was added slowly. After the addition was completed, the reaction mixture 
was allowed to warm to r.t. and stirred for 2 h. The reaction was cooled to 0 °C and 
saturated Na2S2O3 (250 mL) was added. The upper organic phase was decanted and 
the rest was extracted with ethyl ether (3 × 250 mL).  The combined organic phases 
were washed successively with saturated Na2S2O3 (2 × 250 mL), water (250 mL), and 
brine (250 mL), dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The 
resultant crude product was purified by column chromatography (30% ethyl 
ether/pentane) to afford a light yellow oil (36.8g, 94% yield). 
1
H NMR (400 MHz, 
CDCl3) δ 5.76 (tq, J = 6.0, 1.5 Hz, 1H), 4.16 (dq, J = 6.0, 1.2 Hz, 2H), 2.53 (dt, J = 
1.5, 1.2 Hz; 3H). Spectrum data is consistent with the reported literature data.
5
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To a solution of allylic alcohol (67.6 g, 270.5 mmol) in ethyl ether (550 mL) 
was added phosphorus tribromide (12.8 mL, 135.2 mmol) dropwise at 0 °C. The 
reaction mixture was stirred at 0 °C for 1 h then quenched by brine (100 mL). The 
organic phase was separated and washed with water (100 mL) and brine (100 mL), 
dried over anhydrous Na2SO4, filtered and concentrated. The resultant crude product 
was purified by column chromatography (pure pentane) to afford a colorless oil (57.1 
g, 81%), which rapidly turned purple in air. 
1
H NMR (400 MHz, CDCl3) δ 5.77 (tq, J 
= 7.8, 1.6 Hz, 1H), 3.99 (dq, J = 7.8, 0.8 Hz, 2H), 2.58 (dt, J = 1.6, 0.8 Hz, 3H). 
Spectrum data is consistent with the reported literature data.
6
 
 
Compound 2.28 was prepared according to literature procedure.
7
 To a 
suspension of NaH (60 wt%, 1.38 g, 34.4 mmol) in THF (60 mL) was added triethyl 
phosphonoacetate (6.21 mL, 31.3 mmol) dropwise at 0 °C. After stirring for 30 min, 
(Z)-1-bromo-3-iodo-but-2-ene (8.99 g, 34.4 mmol) was added dropwise at the same 
temperature. The reaction was allowed to warm up to r.t. and stirred for 4 h then 
quenched by saturated NH4Cl solution (20 mL). The organic phase was separated and 
the aqueous phase was extracted with ethyl acetate (3 × 20 mL). The combined 
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organic phases were washed with brine, dried over anhydrous Na2SO4, filtered and 
concentrated in vacuo. The residue was purified by column chromatography (75% 
ethyl acetate) to afford a colorless oil (6.23 g, 49% yield). 
1
H NMR (400 MHz, 
CDCl3) δ 5.48 (dddd, J = 6.7, 5.5, 1.9, 0.7 Hz, 1H), 4.28 – 4.10 (m, 6H), 3.04 (ddd, J = 
22.3, 10.4, 4.7 Hz, 1H), 2.81 – 2.67 (m, 1H), 2.67 – 2.55 (m, 1H), 2.49 (m, 3H), 1.35 
(tdd, J = 7.1, 2.1, 0.6 Hz, 6H), 1.29 (t, J = 7.1 Hz, 3H). The bis-alkylation product was 
also isolated as a yellow oil (3.66 g, 20% yield). 
 
To a solution of phosphonate (2.89 g, 7.16 mmol) in toluene (20 mL), 
potassium tert-butoxide (803.5 mg, 7.16 mmol) was added at 0 °C in portions. After 
stirring at 0 °C for 30 min, the mixture was cooled to -78 °C and aldehyde (169.5 mg, 
2.04 mmol) in toluene (15 mL) was added dropwise. The reaction was stirred at -78 
°C for 1.5 h then quenched by saturated NH4Cl solution (20 mL) and warmed to r.t. 
The organic phase was separated and the aqueous phase was extracted with ethyl 
acetate (2 × 20 mL). The combined organic phases were washed with brine (20 mL), 
dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by 
flash column chromatography (25% ethyl acetate/hexanes) to afford a light yellow oil 
(4:1 E/Z mixture, 486.3 mg, 72% yield). The E isomer could be isolated by second 
column chromatography (10% ethyl acetate/hexanes) and characterized: 
1
H NMR (500 
MHz, CDCl3) δ 6.76 (t, J = 7.5 Hz, 1H), 5.45 (tq, J = 6.6, 1.5 Hz, 1H), 4.23 (q, J = 7.1 
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Hz, 2H), 3.14 (dt, J = 6.6, 1.2 Hz, 2H), 2.65 (q, J = 7.3 Hz, 2H), 2.52 – 2.47 (m, 5H), 
1.32 (t, J = 7.1 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 166.80, 138.12, 132.97, 
132.37, 118.71, 101.71, 61.16, 35.21, 33.64, 25.13, 16.89, 14.37; IR (film) 2960, 
2916, 2247, 1712, 1427, 1282, 1203, 1114, 1093, 1051, 758 cm
-1
; HRMS (EI) m/z 
calcd. for C12H16INO2 [M]
+
: 333.0226, found: 333.0237. 
 
To a solution of ester (2.35 g, 7.05 mmol) in THF (35 mL) at -78 °C, was 
added DIBAL (1.2 M in toluene, 12.2 mL, 14.8 mmol) dropwise. The reaction was 
stirred at -78 °C for 2.5 h and 0 °C for 2 h. After the reaction was diluted with THF 
(40 mL), water (0.56 mL), 20% NaOH (0.56 mL) and water (1.2 mL) were added in 
sequence at 0 °C. The mixture was allowed to warm up to r.t. and stirred for 15 min 
before anhydrous MgSO4 was added. After stirring for another 15 min, the solid was 
filtered off and washed with diethyl ether. The filtrate was concentrated and purified 
by column chromatography (50% ethyl acetate/hexanes) to afford a colorless oil (1.60 
g, 88% yield). 
1
H NMR (500 MHz, CDCl3) δ 5.51 (tt, J = 7.1, 1.4 Hz, 1H), 5.41 (tq, J 
= 6.7, 1.5 Hz, 1H), 4.05 (s, 2H), 2.91 (dt, J = 6.7, 1.3 Hz, 2H), 2.51 (q, J = 1.4 Hz, 
3H), 2.49 – 2.40 (m, 4H), 2.30 (s, 1H); 13C NMR (125 MHz, CDCl3) δ 139.94, 132.32, 
122.43, 119.39, 102.33, 66.13, 36.12, 33.54, 23.78, 17.52; IR (film) 3419, 2949, 2914, 
2866, 2245, 1423, 1139, 1097, 1074, 1006, 850, 580 cm
-1
; HRMS (EI) m/z calcd. for 
C10H14INO [M]
+
: 291.0120, found: 291.0111. 
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Compound 2.32 was prepared according to literature protocol.
8
  
In a 500-mL round-bottom flask equipped with a reflux condenser and a Dean-
Stark trap containing 5Å molecular sieves, a mixture of triethylorthoformate (16.7 mL, 
100 mmol) and p-toluene sulfonic acid (500 mg) in toluene (250 mL) was heated to 
reflux for 30 min. After the mixture was cooled below refluxing temperature, 2, 3, 4-
trihydroxybenzaldehyde (7.71 g, 50 mmol) was added and the mixture was then 
heated to reflux and stirred for 3 h. The reaction was cooled again and another portion 
of triethylorthoformate (16.7 mL, 100 mmol) was added and the mixture was refluxed 
for 16 h. The reaction was cooled to r.t., before cesium carbonate (750 mg) was added, 
filtered through a Celite pad and washed with toluene (50 mL). The filtrate was 
concentrated to afford an off-white solid, which was purified by column 
chromatography (15-20% ethyl acetate/hexanes) to afford a white solid (10.3 g, 98%). 
1
H NMR (600 MHz, CDCl3) δ 11.05 (s, 1H), 9.75 (s, 1H), 7.19 (d, J = 8.1 Hz, 1H), 
6.99 (s, 1H), 6.63 (d, J = 8.1 Hz, 1H), 3.78 (qq, J = 9.4, 7.1 Hz, 2H), 1.29 (t, J = 7.1 
Hz, 3H). 
To a solution of phenol (10.3 g, 49.0 mmol) and benzoyl chloride (6.88 mL, 
53.9 mmol) in THF (240 mL) was added triethylamine (10.2 mL, 73.5 mmol) 
dropwise at 0 °C. A white precipitate formed immediately upon addition. The reaction 
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was warmed to r.t. and stirred for 30 min. After that period of time, the reaction 
mixture was diluted with ethyl acetate and washed with water and brine, dried over 
anhydrous Na2SO4, filtered and concentrated in vacuo. The residue was purified by 
column chromatography (10% ethyl acetate/hexanes) to afford a white solid (15.1 g, 
98%). 
1
H NMR (300 MHz, CDCl3) δ 10.03 (s, 1H), 8.30 – 8.19 (m, 2H), 7.73 – 7.63 
(m, 1H), 7.59 – 7.50 (m, 3H), 7.03 (s, 1H), 6.94 (d, J = 8.2 Hz, 1H), 3.77 (qq, J = 9.4, 
7.1 Hz, 2H), 1.28 (t, J = 7.1 Hz, 3H). 
A solution of orthoester (0.27 g, 0.86 mmol) in MeOH/H2O (2:1 v/v, 8.6 mL) 
was treated with 2N HCl (16.0 mL, 4.30 mmol) at r.t. for 1 h. The reaction was then 
concentrated on rotovap. The residue was taken up in ethyl acetate (30 mL) and 
washed with water (2 × 20 mL) and brine (20 mL), dried over anhydrous Na2SO4, 
filtered and concentrated in vacuo. The crude product was purified by column 
chromatography (50 % ethyl acetate/hexanes) to afford a white solid (0.22g, 98%). 
1
H 
NMR (500 MHz, CDCl3) δ 11.59 (s, 1H), 9.77 (s, 1H), 8.35 – 8.19 (m, 2H), 7.74 – 
7.64 (m, 1H), 7.59 – 7.51 (m, 2H), 7.41 (d, J = 8.7 Hz, 1H), 6.71 (d, J = 8.7 Hz, 1H), 
6.04 (s, 1H); 
13
C NMR (125 MHz, CDCl3) δ 194.92, 164.15, 155.59, 155.41, 134.48, 
132.45, 130.80 (2C), 128.96 (2C), 128.17, 126.23, 116.04, 109.15; IR (film) 3290, 
1730, 1627, 1502, 1448, 1317, 1240, 1089, 1055, 796, 704 cm
-1
; HRMS (MALDI) m/z 
calcd. for C14H10O5 [M+H]
+
: 259.0601, found: 259.0601. 
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A mixture of alcohol (800.0 mg, 2.75 mmol), phenol (852.1mg, 3.30 mmol) 
and triphenylphosphine (865.6 mg, 3.30 mmol) in THF (15 mL) was cooled to 0 °C 
and diisopropyl azodicarboxylate (0.64 mL, 3.30 mmol) was added dropwise. After 
the addition was completed, the reaction was stirred at 0 °C for 2 h, then warmed to 
r.t. and stirred for 16 h. The reaction was concentrated and purified by flash column 
chromatography (30% ethyl acetate/hexanes) to provide a light yellow oil (1.15 g, 
79% yield). 
1
H NMR (500 MHz, CDCl3) δ 11.32 (s, 1H), 9.80 (s, 1H), 8.29 – 8.22 (m, 
2H), 7.68 – 7.62 (m, 1H), 7.53 (dd, J = 8.4, 7.2 Hz, 2H), 7.47 (d, J = 8.8 Hz, 1H), 6.66 
(d, J = 8.8 Hz, 1H), 5.52 (ddd, J = 8.3, 6.7, 1.3 Hz, 1H), 5.32 (tq, J = 6.9, 1.5 Hz, 1H), 
4.56 (s, 2H), 2.88 (d, J = 6.9 Hz, 2H), 2.40 (q, J = 7.2 Hz, 2H), 2.35 (q, J = 1.3 Hz, 
3H), 2.29 – 2.24 (m, 2H); 13C NMR (126 MHz, Chloroform-d) δ 194.92, 164.06, 
157.31, 155.26, 134.81, 133.83, 132.65, 131.60, 130.53 (2C), 128.90, 128.72 (2C), 
127.44, 125.93, 119.07, 116.52, 104.99, 103.14, 72.29, 36.20, 33.46, 23.97, 17.18; IR 
(film) 3458,3269, 3062, 2951, 2848, 2752, 2247, 1741, 1645, 1446, 1269, 1176, 1095, 
1076, 1056, 1002, 912, 852, 786, 731, 705, 646, 542 cm
-1
; HRMS (MALDI) m/z 
calcd. for C24H22INO5Li [M+Li]
+
: 538.0697, found: 538.0685. 
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A solution of phenol (10.0 mg, 0.0188 mmol) in methanol (0.90 mL) was 
heated to 67 °C, to which a solution of iodobenzene diacetate (13.3 mg, 0.0414 mmol) 
in methanol (0.70 mL) was added over 40 min via syringe pump. After the addition 
was completed, the reaction was stirred for additional 2 h then cooled to r.t. and 
concentrated. The crude product was purified by column chromatography (50-75% 
diethyl ether/hexanes) to afford a white solid (6.4 mg, 61% yield). 
1
H NMR (400 
MHz, CDCl3) δ 9.69 (s, 1H), 8.11 (d, J = 7.7 Hz, 2H), 7.67 – 7.57 (m, 1H), 7.56 – 7.40 
(m, 2H), 7.13 (d, J = 7.0 Hz, 1H), 5.45 (td, J = 6.7, 1.6 Hz, 1H), 4.18 (d, J = 8.7 Hz, 
1H), 4.11 – 3.95 (m, 1H), 3.63 (s, 3H), 3.31 (d, J = 7.0 Hz, 1H), 2.66 – 2.55 (m, 1H), 
2.60 (q, J = 1.3 Hz, 3H), 2.29 (qd, J = 16.4, 15.8, 6.7 Hz, 2H), 1.96 – 1.80 (m, 1H), 
1.80 – 1.63 (m, 1H), 1.39 – 0.95 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 193.75, 
187.06, 164.92, 139.48, 133.88, 130.16 (2C), 129.31, 128.82 (2C), 128.74 (2C), 
119.29, 107.60, 98.49, 86.64, 78.57, 53.51, 50.72, 49.74, 48.39, 40.20, 34.09, 23.79, 
17.46; IR (film) 2954, 2924, 2853, 2245, 1767, 1727, 1692, 1451, 1274, 1175, 1088, 
1067, 1049, 710 cm
-1
; HRMS (ESI) m/z calcd. for C25H25INO6 [M+H]
+
: 562.0721, 
found: 562.0721. 
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Sodium borohydride (1.94 mg, 0.0513 mmol) in methanol (1.0 mL) was added 
to a solution of α,β-unsaturated aldehyde (57.6 mg, 0.103 mmol) in dichloromethane 
(0.50 mL) and methanol (1.0 mL) at 0 °C. After stirring at 0 °C for 30 min, the 
reaction was warmed to r.t. and stirred for 10 min., then quenched with 0.1 M HCl 
(2.5 mL), extracted with ethyl acetate for three times. The extracts were washed with 
brine, dried over anhydrous Na2SO4, filtered and concentrated. The residue was 
purified by column chromatography (50 % ethyl acetate/hexanes) to afford a white 
solid (36.2 mg, 62% yield). 
1
H NMR (400 MHz, CDCl3) δ 8.13 – 7.98 (m, 2H), 7.68 – 
7.56 (m, 1H), 7.54 – 7.41 (m, 2H), 6.26 (dt, J = 6.9, 1.6 Hz, 1H), 5.46 (td, J = 6.7, 1.6 
Hz, 1H), 4.45 (dd, J = 5.8, 1.6 Hz, 2H), 4.22 – 4.02 (m, 2H), 3.61 (s, 3H), 3.48 (t, J = 
6.2 Hz, 1H), 3.07 (d, J = 6.9 Hz, 1H), 2.58 (q, J = 1.3 Hz, 3H), 2.49 (ddd, J = 16.8, 
9.1, 6.2 Hz, 1H), 2.40 – 2.21 (m, 3H), 1.99 – 1.77 (m, 3H); 13C NMR (125 MHz, 
CDCl3) δ 192.83, 164.56, 140.67, 134.05, 130.05 (2C), 129.44, 129.21, 128.94 (2C), 
123.50, 119.21, 106.91, 99.69, 89.34, 79.67, 60.85, 53.05, 50.42, 48.23, 46.21, 39.76, 
34.10, 23.57, 17.46; IR (film) 3493, 2955, 2924, 2853, 2247, 1758, 1727, 1450, 1267, 
1175, 1089, 1061, 711 cm
-1
; HRMS (ESI) m/z calcd. for C25H27INO6 [M+H]
+
: 
564.0877, found: 564.0878. 
 89 
 
A solution of vinyl iodide (10.0 mg, 0.0178 mmol) in benzene (0.50 mL) was 
heated to 85 °C, to which tributyltin hydride (0.10 M in benzene, 0.43 mL) and 
azobisisobutyronitrile (0.01 M in benzene, 0.36 mL) were added simultaneously via 
syringe pumps over 1 h. After the addition was completed, the reaction was stirred for 
30 min. then cooled to r.t. and concentrated. The crude product was purified by 
column chromatography (50-60% ethyl acetate/hexanes) to give product 2.35 (higher 
Rf, colorless oil, 0.4 mg, 5% yield) and 2.36 (lower Rf, 2.9 mg, colorless oil, 37% 
yield). 
Compound 2.35: 
1
H NMR (600 MHz, C6D6) δ 8.14 – 8.07 (m, 2H), 7.15 – 7.04 
(m, 3H), 4.93 (d, J = 4.9 Hz, 1H), 4.34 (dd, J = 7.6, 3.7 Hz, 1H), 3.95 (s, 1H), 3.67 (s, 
3H), 3.52 (d, J = 7.4 Hz, 1H), 3.47 (d, J = 7.7 Hz, 1H), 3.36 (d, J = 7.4 Hz, 1H), 3.21 
(d, J = 8.3 Hz, 1H), 2.03 (d, J = 4.1 Hz, 1H), 1.91 (d, J = 3.7 Hz, 1H), 1.89 – 1.75 (m, 
2H), 1.74 – 1.68 (m, 2H), 1.61 – 1.52 (m, 1H), 1.52 – 1.46 (m, 1H), 1.45 – 1.37 (m, 
1H), 1.36 (s, 3H); 
13
C NMR (C6D6, extracted from HSQC and HMBC) δ 166.35, 
136.74, 132.96, 130.02, 129.94 (2C), 128.41 (2C), 120.13, 119.24, 107.49, 106.55, 
91.00, 80.70, 73.53, 53.18, 46.51, 42.55, 42.06, 41.12, 40.96, 29.31, 22.98, 21.2, 
17.81; IR (film) 3498, 2948, 2927, 2892, 2247, 1713, 1450, 1292, 1257, 1195, 1112, 
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1070, 994, 958, 710 cm
-1
; HRMS (ESI) m/z calcd. for C25H27NNaO6 [M+Na]
+
: 
460.1730, found: 460.1731. 
Compound 2.36: 
1
H NMR (600 MHz, C6D6) δ 8.26 – 8.21 (m, 2H), 7.15 – 7.04 
(m, 3H), 4.07 (dd, J = 8.1, 4.4 Hz, 1H), 4.01 (s, 1H), 3.68 (s, 3H), 3.21 – 3.17 (m, 2H), 
3.02 (d, J = 7.3 Hz, 1H), 2.91 (dd, J = 11.9, 7.3 Hz, 1H), 2.75 (d, J = 4.4 Hz, 1H), 2.51 
(d, J = 6.1 Hz, 1H), 1.90 (ddd, J = 14.8, 7.2, 1.6 Hz, 1H), 1.73 (q, J = 3.7 Hz, 1H), 
1.52 (t, J = 4.2 Hz, 1H), 1.46 (ddd, J = 14.8, 11.9, 6.4 Hz, 1H), 1.29 (dd, J = 13.2, 3.1 
Hz, 1H), 1.25 (d, J = 4.1 Hz, 1H), 1.02 – 0.95 (m, 1H), 0.53 (d, J = 7.1 Hz, 3H), 0.43 – 
0.36 (m, 1H); 
13
C NMR (C6D6, extracted from HSQC and HMBC) δ 166.34, 133.15, 
131.39, 130.09 (2C), 128.38 (2C), 123.44, 107.68, 107.66, 88.36, 78.00, 73.50, 53.11, 
49.39, 40.85, 39.60, 37.58, 36.87, 36.30, 35.87, 27.49, 22.89, 21.46, 15.19; IR (film) 
3499, 2948, 2927, 2875, 2235, 1713, 1454, 1269, 1195, 1112, 1100, 982, 710 cm
-1
; 
HRMS (ESI) m/z calcd. for C25H28NO6 [M+H]
+
: 438.1911, found: 438.1911. 
 
A mixture of methyl (triphenylphosphoranylidene)acetate (5.22 g, 15.6 mmol), 
vinyl bromide (4.15 g, 15.9 mmol) and cesium carbonate (5.08 g, 15.6 mmol) in 
acetonitrile (80 mL) was heated at 85 °C for 4 h, and then the hot reaction mixture was 
filtered through a Celite pad. The filtrate was concentrated on rotovap and placed 
under vacuum for 15 min to remove any residual bromide. The resultant phosphorane 
intermediate was re-dissolved in acetonitrile (80 mL) and (tert-butyldimethylsilyloxy) 
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acetaldehyde (2.72 g, 15.6 mmol) was added. The solution was stirred at 85 °C for 15 
h and cooled to r.t. Acetonitrile was removed on rotovap, and hexanes were added to 
the residue while a solid crushed out, which was filtered off and washed with ethyl 
acetate. The filtrate was concentrated and purified by column chromatography (25% 
diethyl ether/hexanes) to afford a light yellow oil (4.50 g, 70% yield). 
1
H NMR (500 
MHz, CDCl3) δ 6.85 (t, J = 5.6 Hz, 1H), 5.39 (tq, J = 6.5, 1.5 Hz, 1H), 4.43 (d, J = 5.6 
Hz, 2H), 3.76 (s, 2H), 3.07 (d, J = 6.5 Hz, 2H), 2.48 (q, J = 1.5 Hz, 2H), 0.91 (s, 9H), 
0.09 (s, 6H); 
13
C NMR (125 MHz, CDCl3) δ 167.61, 144.14, 132.48, 128.55, 101.41, 
61.10, 52.11, 35.49, 33.64, 26.05 (3C), 18.45, -5.06 (2C); IR (film) 2953, 2927, 2856, 
2362, 1716, 1463, 1436, 1251, 1205, 1107, 1085, 1041, 837, 777 cm
-1
; HRMS (ESI) 
m/z calcd. for C15H28IO3Si [M+H]
+
: 411.0847, found: 411.0850. 
 
To a solution of ester (7.82 g, 19.1 mmol) in dichloromethane (45 mL) at -78 
°C, was added DIBAL (1.0 M in dichloromethane, 47.2 mL) dropwise. The reaction 
was stirred at -78 °C for 3 h then quenched by saturated Rochelle's salt solution (20 
mL) and diluted with ethyl acetate (300 mL). The mixture was allowed to warm to r.t. 
and stirred vigorously until two clear layers formed. The organic layer was separated 
and the aqueous layer was extracted with ethyl acetate (3 × 50 mL). The combined 
organic layers were washed with brine (100 mL), dried over anhydrous Na2SO4, 
filtered and concentrated. The residue was purified by column chromatography (10% 
ethyl acetate/hexanes) to afford a colorless oil (4.93 g, 68% yield). 
1
H NMR (500 
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MHz, CDCl3) δ 5.64 (ttd, J = 5.3, 1.4, 0.6 Hz, 1H), 5.37 (tq, J = 6.8, 1.5 Hz, 1H), 4.27 
(dt, J = 6.2, 1.2 Hz, 2H), 4.06 (s, 2H), 2.90 (dt, J = 6.8, 1.2 Hz, 2H), 2.50 (q, J = 1.4 
Hz, 3H), 1.47 (s, 1H), 0.91 (s, 9H), 0.09 (s, 6H); 
13
C NMR (125 MHz, CDCl3) δ 
137.47, 132.74, 127.32, 102.12, 66.71, 60.12, 36.48, 33.68, 26.17 (3C), 18.58, -4.92 
(2C); IR (film) 3365, 2953, 2927, 2856, 1463, 1255, 1107, 1066, 835 777 cm
-1
; 
HRMS (ESI) m/z calcd. for C14H27IO2SiLi [M+Li]
+
: 389.0980, found: 389.0976. 
 
To a solution of triphenylphosphine (850 mg, 3.24 mmol) in THF (8.0 mL) 
was added diisopropyl azodicarboxylate (0.63 mL, 3.24 mmol) dropwise at 0 °C. After 
stirring for 30 min., a solution of alcohol (411 mg, 1.08 mmol) and phenol (837 mg, 
3.24 mmol) in THF (2.5 mL) was added dropwise. The reaction was allowed to warm 
to r.t. naturally and stirred for total 24 h t. Removal of solvent and purification by 
column chromatography (20% ethyl acetate/hexanes) afforded a light yellow oil (353 
mg, 53% yield). 
1
H NMR (500 MHz, CDCl3) δ 11.33 (s, 1H), 9.76 (s, 1H), 8.31 – 8.18 
(m, 2H), 7.70 – 7.57 (m, 1H), 7.54 – 7.46 (m, 2H), 7.43 (d, J = 8.8 Hz, 1H), 6.66 (d, J 
= 8.8 Hz, 1H), 5.70 (tt, J = 6.0, 1.1 Hz, 1H), 5.28 (tq, J = 6.8, 1.5 Hz, 1H), 4.54 (d, J = 
1.3 Hz, 2H), 4.22 (d, J = 6.0 Hz, 2H), 2.86 (d, J = 6.8 Hz, 2H), 2.30 (q, J = 1.5 Hz, 
3H), 0.87 (s, 9H), 0.02 (s, 6H); 
13
C NMR (125 MHz, CDCl3) δ 194.85, 163.98, 
157.58, 155.23, 133.71, 132.55, 132.00, 131.98, 131.22, 130.52 (2C), 128.92, 128.64 
(2C), 127.40, 116.40, 104.99, 102.47, 72.80, 59.94, 36.40, 33.40, 26.00 (3C), 18.36, -
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5.08 (2C); IR (film) 2953, 2927, 2854, 1743, 1647, 1506, 1242, 1105, 1058, 835, 705 
cm
-1
; HRMS (ESI) m/z calcd. for C28H36IO6Si [M+H]
+
: 623.1320, found: 623.1330. 
 
A solution of phenol (153.0 mg, 0.246 mmol) in methanol (16.0 mL) was 
heated to 60 °C, to which a solution of iodobenzene diacetate (174.2 mg, 0.541mmol) 
in methanol (8.0 mL) was added over 2.5 h via syringe pump. After stirring for 
additional 2 h the reaction was cooled to r.t. and concentrated. The crude product was 
purified by column chromatography (20% diethyl ether/hexanes) to afford a light 
yellow solid (108.8 mg, 68% yield). 
1
H NMR (400 MHz, CDCl3) δ 9.72 (s, 1H), 8.16 
(d, J = 7.7 Hz, 2H), 7.65 – 7.56 (m, 1H), 7.52 – 7.42 (m, 2H), 7.08 (d, J = 7.1 Hz, 1H), 
5.53 (td, J = 7.0, 1.5 Hz, 1H), 4.15 (d, J = 8.2 Hz, 1H), 4.04 – 3.87 (m, 2H), 3.75 (dd, 
J = 11.5, 5.9 Hz, 1H), 3.62 (s, 3H), 3.35 (d, J = 7.0 Hz, 2H), 2.71 – 2.42 (m, 2H), 2.59 
(d, J = 1.5 Hz, 3H), 0.82 (s, 9H), -0.03 (s, 6H); 
13
C NMR (125 MHz, CDCl3) δ 193.15, 
185.85, 164.46, 139.68, 138.55, 133.68, 130.24 (2C), 129.69 (2C), 129.54, 128.63 
(2C), 106.61, 99.13, 78.81, 59.60, 53.25, 51.68, 48.83 (2C), 37.07, 34.17, 26.17 (3C), 
18.45, -5.41, -5.46; IR (film) 2954, 2929, 2856, 1766, 1729, 1695, 1470, 1451, 1274, 
1179, 1091, 912, 837, 780, 709 cm
-1
; HRMS (ESI) m/z calcd. for C29H37INaO7Si 
[M+Na]
+
: 675.1245, found: 675.1250. 
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To an ice-water cooled mixture of α,β-unsaturated aldehyde (20.0 mg, 0.0307 
mmol) and cerium (III) chloride heptahydrate (57.0 mg, 0.153 mmol) in methanol 
(0.62 mL) was added sodium borohydride (3.5 mg, 0.0925 mmol) in one portion. The 
reaction was stirred at 0 °C for 2 h then quenched by saturated NH4Cl solution (0.2 
mL) and extracted with ethyl acetate (3 × 2 mL). The combined organic layers were 
washed with brine (2 mL), dried over anhydrous Na2SO4, filtered and concentrated. 
The residue was purified by column chromatography (25% ethyl acetate/hexanes) to 
afford a colorless oil (15.7 mg, 78% yield). 
1
H NMR (500 MHz, CDCl3) δ 8.14 – 7.98 
(m, 2H), 7.69 – 7.53 (m, 1H), 7.47 (m, 2H), 6.18 (dt, J = 6.8, 1.6 Hz, 1H), 5.51 (td, J = 
7.5, 7.0, 1.8 Hz, 1H), 4.45 (qd, J = 14.8, 4.0 Hz, 2H), 4.09 (d, J = 8.1 Hz, 1H), 4.05 (d, 
J = 8.1 Hz, 1H), 3.84 (dd, J = 11.3, 5.2 Hz, 1H), 3.74 (dd, J = 11.3, 5.2 Hz, 1H), 3.62 
(s, 3H), 3.58 (t, J = 5.4 Hz, 1H), 3.07 (d, J = 6.8 Hz, 1H), 2.59 – 2.51 (m, 1H), 2.56 (s, 
3H), 2.42 – 2.33 (m, 1H), 2.05 (t, J = 5.8 Hz, 1H), 0.76 (s, 9H), -0.11 (s, 3H), -0.12 (s, 
3H); 
13
C NMR (125 MHz, CDCl3) δ 193.29, 163.96, 140.98, 133.55, 130.26, 130.01 
(2C), 129.96, 128.65 (2C), 122.07, 105.68, 99.82, 87.66, 79.59, 60.96, 60.43, 52.92, 
49.82, 47.95 (2C), 38.21, 34.07, 26.06 (3C), 18.45, -5.40, -5.49; IR (film) 3488, 2954, 
2927, 2855, 1759, 1729, 1451, 1275, 1251, 1093, 1004, 837, 780, 709 cm
-1
; HRMS 
(ESI) m/z calcd. for C29H40IO7Si [M+H]
+
: 655.1582, found: 655.1579. 
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A solution of vinyl iodide (15.0 mg, 0.0229 mmol) in toluene (1.30 mL) was 
heated to 80 °C, to which tributyltin hydride (0.10 M in toluene, 0.55 mL) and 
azobisisobutyronitrile (0.01 M in toluene, 0.46 mL) were added simultaneously via 
syringe pumps over 1 h. After the addition was completed, the reaction was stirred for 
additional 2h then cooled to r.t. and concentrated. The crude product was purified by 
column chromatography (20% ethyl acetate/hexanes) to afford a colorless oil (5.6 mg, 
46% yield). 
1
H NMR (500 MHz, CDCl3) δ 7.99 (m, 2H), 7.61 – 7.52 (m, 1H), 7.47 – 
7.39 (m, 2H), 5.51 (dt, J = 5.1, 1.7 Hz, 1H), 4.41 (dd, J = 7.9, 3.7 Hz, 1H), 4.29 (s, 
1H), 3.87 (d, J = 7.1 Hz, 1H), 3.76 – 3.69 (m, 3H), 3.60 (dd, J = 10.6, 3.1 Hz, 1H), 
3.58 (s, 3H), 3.18 (dd, J = 10.0, 3.1 Hz, 1H), 2.85 – 2.77 (m, 1H), 2.59 (d, J = 3.5 Hz, 
1H), 2.30 (d, J = 4.1 Hz, 1H), 2.02 – 1.92 (m, 1H), 1.96 (d, J = 4.2 Hz, 1H), 1.77 (dt, J 
= 2.7, 1.4 Hz, 3H), 0.80 (s, 9H), -0.11 (s, 3H), -0.12 (s, 3H); 
13
C NMR (125 MHz, 
CDCl3) δ 166.12, 135.77, 133.38, 130.74, 129.91 (2C), 128.57 (2C), 121.67, 107.81, 
107.06, 89.16, 81.58, 73.84, 61.28, 52.86, 45.18, 44.97, 42.43, 42.34, 41.17, 28.34, 
25.93 (3C), 21.99, 18.14, -5.37, -5.53; IR (film) 3529, 2952, 2927, 2855, 1722, 1259, 
1093, 1070, 993, 837, 777, 708 cm
-1
; HRMS (ESI) m/z calcd. for C29H41O7Si [M+H]
+
: 
529.2616, found: 529.2615. 
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To a solution of triethyl phosphonoacetate (0.041 mL, 0.284 mmol) in THF 
(0.80 mL) was added potassium tert-butoxide (31.9 mg) in portions at 0 °C. After 
stirring for 15 min., the mixture was cooled to -78 °C and aldehyde (58.0 mg, 0.0945 
mmol) in THF (0.20 mL) was added dropwise. The reaction was stirred at -78 °C for 4 
h then quenched by saturated NH4Cl solution (1 mL) and extracted with ethyl acetate 
(3 × 2 mL). The combined extracts were washed with brine (2 mL), dried over 
anhydrous Na2SO4, filtered and concentrated. The crude product was purified by 
column chromatography (20% ethyl acetate/hexanes) to afford a light yellow oil (56.7 
mg, 1:1 E/Z mixture, 85% yield). 
 
A solution of vinyl iodide (53.0 mg, 0.0733 mmol) in benzene (4.0 mL) was 
heated to 80 °C, to which tributyltin hydride (0.10 M in benzene, 1.80 mL) and 
azobisisobutyronitrile (0.01 M in benzene, 1.50 mL) were added simultaneously via 
syringe pumps over 2 h. After the addition was completed, the reaction was stirred for 
additional 2 h then cooled to r.t. and concentrated. The crude product was purified by 
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column chromatography (20% ethyl acetate/hexanes) to afford a colorless oil (32.8 
mg, 75% yield). 
1
H NMR (600 MHz, CDCl3) δ 8.15 – 8.01 (m, 2H), 7.65 – 7.52 (m, 
1H), 7.46 (m, 2H), 6.33 (td, J = 7.5, 1.7 Hz, 1H), 5.65 – 5.54 (m, 1H), 4.18 (q, J = 7.1 
Hz, 2H), 4.08 (d, J = 7.4 Hz, 1H), 3.94 (d, J = 7.4 Hz, 1H), 3.68 (s, 3H), 3.67 – 3.57 
(m, 2H), 3.49 (dd, J = 8.6, 3.9 Hz, 1H), 3.33 – 3.28 (m, 3H), 2.86 (ddd, J = 18.0, 5.2, 
1.8 Hz, 1H), 2.40 (d, J = 3.9 Hz, 1H), 2.11 (d, J = 18.6 Hz, 1H), 1.87 (s, 3H), 1.28 (t, J 
= 7.1 Hz, 3H), 0.75 (s, 9H), -0.17 (s, 3H), -0.20 (s, 3H); 
13
C NMR (125 MHz, CDCl3) 
δ 194.47, 170.72, 163.68, 134.83, 133.28, 132.57, 130.42, 130.01 (2C), 128.54 (2C), 
124.04, 121.40, 104.14, 85.49, 82.21, 61.31, 61.16, 53.16, 47.22, 45.40, 43.19, 36.48, 
35.45, 29.71, 25.91 (3C), 24.34, 18.13, 14.30, -5.40, -5.48; IR (film) 2953, 2930, 
2856, 1759, 1729, 1268, 1252, 1176, 1091, 1001, 837, 777, 707 cm
-1
; HRMS (ESI) 
m/z calcd. for C33H45O8Si [M+H]
+
: 597.2878, found: 597.2879. 
 
In a 4-mL vial, diene (3.0 mg, 0.00503 mmol) was dissolved in ethanol (0.20 
mL) and palladium on carbon (10 wt%, 3.0 mg) was added. The vial was placed in a 
hydrogenation bomb and stirred at r.t. under 500 psi of H2 for 16 h.  The reaction 
mixture was then filtered through a Celite pad and washed with ethyl acetate. The 
filtrate was concentrated and purified by column chromatrography (20% ethyl 
acetate/hexanes) to afford a colorless oil (2.6 mg, 86% yield). 
1
H NMR (500 MHz, 
CDCl3) δ 8.07 – 8.00 (m, 2H), 7.58 – 7.52 (m, 1H), 7.47 – 7.39 (m, 2H), 4.16 (q, J = 
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7.1 Hz, 2H), 4.02 (dd, J = 10.9, 7.8 Hz, 1H), 3.84 (d, J = 6.8 Hz, 1H), 3.80 (dd, J = 
10.9, 5.3 Hz, 1H), 3.71 (dd, J = 6.8, 0.8 Hz, 1H), 3.70 (s, 3H), 3.57 (dd, J = 7.7, 5.4 
Hz, 1H), 2.57 (ddd, J = 15.7, 8.6, 6.9 Hz, 1H), 2.45 (ddd, J = 15.7, 8.6, 6.3 Hz, 1H), 
2.32 (m, 1H), 2.11 (q, J = 6.6 Hz, 1H), 2.01 (ddt, J = 15.1, 8.7, 6.4 Hz, 1H), 1.89 (d, J 
= 2.7 Hz, 1H), 1.86 – 1.82 (m, 1H), 1.75 – 1.61 (m, 2H), 1.46 – 1.25 (m, 3H), 1.27 (t, 
J = 7.1 Hz, 3H), 1.02 (d, J = 6.6 Hz, 3H), 0.75 (s, 9H), -0.14 (s, 3H), -0.17 (s, 3H); 
13
C 
NMR (126 MHz, Chloroform-d) δ 200.10, 173.40, 164.15, 133.08, 130.48, 130.00 
(2C), 128.45 (2C), 103.95, 85.71, 82.20, 60.52, 58.94, 53.22, 53.16, 44.51, 44.25, 
38.92, 36.02, 35.26, 32.91, 28.81, 27.96, 27.71, 25.92 (3C), 19.55, 18.23, 14.44, -5.54 
(2C); IR (film) 2953, 2929, 2856, 1759, 1729, 1266, 1256, 1090, 837, 778, 707 cm
-1
; 
HRMS (ESI) m/z calcd. for C33H49O8Si [M+H]
+
: 601.3191, found: 601.3192. 
 
A mixture of diene (27.7 mg, 0.0464 mmol) and 1, 8-diazabicyclo [5.4.0] 
undec-7-ene (0.02 mL, 0.139 mmol) in THF (0.20 M, 0.05 mL) was heated to 67 °C 
and stirred for 3 h. The reaction mixture was then cooled to r.t. and concentrated. 
Purification by column chromatography (10-20% ethyl acetate/hexanes) provided a 
colorless oil (13.2 mg, 48%) and recovered starting material (8.2 mg, 30%). 
1
H NMR 
(500 MHz, CDCl3) δ 7.97 – 7.90 (m, 2H), 7.60 – 7.51 (m, 1H), 7.46 – 7.34 (m, 2H), 
6.72 (dd, J = 15.5, 9.3 Hz, 1H), 5.99 (dd, J = 15.5, 1.0 Hz, 1H), 5.54 (d, J = 4.4 Hz, 
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1H), 4.30 – 4.11 (m, 2H), 4.02 (d, J = 7.1 Hz, 1H), 3.89 (d, J = 7.1 Hz, 1H), 3.81 (dd, 
J = 10.6, 9.7 Hz, 1H), 3.75 – 3.70 (m, 1H), 3.69 (s, 3H), 3.54 – 3.48 (m, 1H), 2.88 
(ddd, J = 18.2, 4.9, 1.7 Hz, 1H), 2.67 (dd, J = 9.2, 2.9 Hz, 1H), 2.38 (m, 1H), 2.30 (d, 
J = 3.7 Hz, 1H), 2.16 – 2.08 (m, 1H), 1.78 (dt, J = 2.8, 1.5 Hz, 3H), 1.29 (t, J = 7.1 Hz, 
3H), 0.80 (s, 9H), -0.12 (s, 3H), -0.12 (s, 3H); 
13
C NMR (125 MHz, CDCl3) δ 197.32, 
165.76, 163.92, 145.82, 136.87, 133.34, 130.04, 129.93 (2C), 128.52 (2C), 124.49, 
121.07, 103.59, 83.83, 82.43, 60.77, 60.28, 53.06, 47.47, 47.34, 45.55, 43.12, 36.46, 
28.84, 25.91 (3C), 22.10, 18.12, 14.39, -5.33, -5.47; IR (film) 2952, 2928, 2894, 2855, 
1757, 1727, 1263, 1095, 836, 707 cm
-1
; HRMS (ESI) m/z calcd. for C33H45O8Si 
[M+H]
+
: 597.2878, found: 597.2877. 
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Table A1.1. 2D-NMR Data of Compound 2.19 
 
 
 
 
 
Position δ 13C 
(ppm) 
δ 1H 
(ppm) 
Type COSY correlations HMBC correlations ROESY correlations 
1 98.0  Cq    
2a 76.3 4.07 CH2 H-2b, H-4 C-7 H-12, H-20 
2b  3.88 CH2 H-2a, H-4, H-7 C-1, C-12 H-7 
3 57.2  Cq    
4 53.6 2.05 CH H-2a, H-2b, H-17, H-20, 
H-21b 
C-3, C-5, C-12, C-20, 
C-21 
H-6b, H-12, H-18b, H-
21b 
5 46.0  Cq    
6a 37.5 1.65 CH2 H-6b, H-7 C-3, C-4, C-17 H-7, H-14 
6b  1.51 CH2 H-6a, H-7, H-17 C-5, C-7, C-9, C-17 H-4, H-10 
7 47.0 2.88 CH H-2b, H-6a, H-6b,  H-10 C-2, C-9, C-10 H-2b, H-6a, H-18a, H-18b 
8 198.9  Cq    
9 86.1  Cq    
10 140.9 6.99 CH3 H-7, H-12 C-15 H-6b, H-14, H-16 
11 138.7  Cq    
12 41.5 3.94 CH H-10 C-1, C-3, C-8, C-10, 
C-11 
H-2a, H-4 
13 51.1 3.43 CH3  C-1  
14 53.3 3.60 CH3  C-9 H-6a, H-10 
15 194.5  Cq    
16 24.8 2.39 CH3  C-11, C-15 H-10 
17 19.5 0.91 CH3 H-4, H-6b, H-18a C-4, C-5, C-6, C-18 H-2b, H-6a, H-7, H-18a, 
H-18b, H-20 
18a 77.9 3.02 CH2 H-17, H-18b C-5, C-6, C-19 H-7 
18b  2.92 CH2 H-18a C-5, C-6, C-17, C-19 H-4, H-7 
19 59.2 3.24 CH3  C-18  
20 132.2 5.53 CH H-4, H-21a, H-21b  H-17, H-2a 
21a 120.7 5.22 CH2 H-20, H-21b   
21b  5.13 CH2 H-4, H-20, H-21a C-4 H-4 
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Table A1.2. 2D-NMR Data of Compound 2.21 
 
 
 
 
 
Position δ 13C 
(ppm) 
δ 1H 
(ppm) 
Type COSY correlations HMBC correlations ROESY correlations 
1 103.4  Cq    
2a 72.7 3.95 CH2 H-2b C-3, C-4, C-7 H-4, H-13 
2b  3.67 CH2 H-2a C-1, C-3, C-7, C-13 H-7 
3 51.7  Cq    
4 58.8 2.34 CH H-6a C-6, C-20, C-21 H-11, H-13, H-21a 
5 49.0  Cq    
6a 31.1 2.08 CH2  C-3, C-4, C-9 H-6b, H-10b 
6b  1.88 CH2  C-5, C-9, C-11 H-6a, H-20 
7 41.8 2.46 CH H-6b C-9, C-10 H-2b, H-6b 
8 225.0  Cq    
9 79.4  Cq    
10a 35.0 2.30 CH2 H-10b C-9, C-11, C-12  
10b  2.29 CH2 H-10a C-9, C-11, C-12 H-6a, H-11 
11 45.9 1.83 CH2  C-4, C-5, C-6, C-10, C-
12, C-13 
H-4, H-6a, H-10b, H-
18b 
12 47.8  Cq    
13 46.9 2.80 CH  C-1, C-3, C-7, C-12 H-2a, H-4, H-11, H-14 
14 51.3 3.52 CH3  C-1, C-8 H-13 
15 52.8 3.46 CH3  C-8, C-9 H-7, H-10a, H-10b 
16 208.2  Cq    
17 25.0 2.18 CH3  C-12, C-16 H-11, H-13 
18a 76.7 3.28 CH2 H-18b C-5, C-6, C-11  
18b  3.23 CH2 H-18a C-4, C-5, C-11 H-11 
19 59.2 3.29 CH3  C-18  
20 132.9 5.68 CH H-4, H-21a, H-21b C-4, C-3, C-20 H-6b 
21a 119.4 5.20 CH2 H-20, H-21b C-4 H-4 
21b  5.16 CH2 H-21a C-4  
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Table A1.3. 2D-NMR Data of Compound 2.35 
 
 
 
Position δ 13C 
(ppm) 
δ 1H 
(ppm) 
Type COSY correlations HMBC correlations NOESY correlations 
1 107.49  Cq    
2a 80.7 3.36 CH2 H-2b C-14, C-13, C-4, C-9, C-8 H-2b, H-4, H-8a 
2b  3.53  H-2a C-1, C-4, C-3, C-9 H-2a, H-9 
3 42.06  Cq    
4 46.51 1.72 CH H-5 C-1, C-14, C-12, C-9, C-8 H-2a, H-8a 
5 40.96 2.03 CH H-8a, H-4 C-7, C-13, C-15, C-4, C-
12, C-3, C-17 
H-15a, H-4, H-17 
6 136.74  Cq    
 123 
7 120.13 4.93 CH H-8b, H-8a, H-17 C-3, C-17 H-8b, H-8a, H-17 
8a 29.31 1.5 CH2 H-7, H-5, H-8b, H-17  H-2a, H-8b 
8b  1.71  H-7, H-8a, H-17 C-7, C-4 H-7 
9 41.12 3.22 CH H-10a C-13, C-2, C-12, C-3, C-
10, C-11 
H-26, H-11a, H-11b, 
H-10a 
10a 22.98 1.41 CH2 H-9, H-11a, H-11b, H-
10b 
C16, C-3, C-9, C-11 H-10b 
10b  1.57  H-9, H-11a, H-11b, H-
10a 
C16, C-13, C-3, C-9, C-11 H-9, H-10a 
11a 17.81 1.82 CH2 H-10a, H-10b C-16, C-9, C-10 H-9 
11b  1.85  H-10a, H-10b C-16, C-9, C-10 H-9 
12 42.55 1.91 CH H-15b C-14, C-13, C-15, C-4, C-9 H-19b, H-19a, H-17 
13 91  Cq    
14 106.55  Cq    
15a 73.53 3.47 CH2 H-15b C-14, C-13, C-12, C-5 H-15b, H-5 
15b  4.34  H-15a, H-12 C-1, C-12, C-5 H-15a, H-12 
16 119.24  Cq    
17 21.2 1.36 CH3 H-7, H-8b, H-8a C-7, C-5 H-7 
18 53.18 3.67 CH3  C-1  
19 166.35  Cq    
20 130.02  Cq    
21 129.94 8.1 CH H-22 C-19, C-23, C-25 H-22, H-5b 
22 128.41 7.07 CH H-21, H-23 C-20, C-24 H-21 
23 132.96 7.13 CH H-21, H-25, H-22, H-
24 
C-21, C-25  
24 128.41 7.07 CH    
25 129.94 8.1 CH    
26  3.96 OH  C-1, C-14 H-9 
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Table A1.4. 2D-NMR Data of Compound 2.36 
 
 
Position δ 13C 
(ppm) 
δ 1H 
(ppm) 
Type COSY correlations HMBC correlations ROESY correlations 
1 107.66  Cq    
2a 78 3.02 CH2 H-2b C-1, C-4, C-3, C-9 H-2b, H-9, H-8b 
2b  3.19  H-2a C-1, C-9, C-8 H-2a, H-8b, H-8a 
3 39.6  Cq    
4 49.39 1.25 CH H-5 C-14, C-5, C-3, C-9, C-
12, C-8 
H-2b, H-5, H-6, H-8a 
5 40.85 1.52 CH H-7, H-4, H-6 C-13, C-4, C-3, C-7, C-
17, C-6 
H-15a, H-12, H-4, H-6, H-
17 
6 36.3 0.98 CH H-7, H-5, H-17 C-12, C-11 H-7, H-5, H-4, H-17, H-8a 
7 36.87 1.73 CH H-5, H-8b, H-6, H-8a C-16, C-5, C-3, C-6, C-
8, C-10, C-11 
H-11, H-8b, H-6, H-17, H-
8a 
8a 27.49 0.4 CH2 H-7, H-8b C-4, C-3, C-9, C-11, C-
17 
H-2b, H-7, H-8b, H-6 
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8b  1.29  H-7, H-8a C-4, C-3, C-7, C-6, C-
11 
H-7, H-8a 
9 37.58 2.5 CH H-10b, H-10a C-13, C-2, C-3, C-12, 
C-10, C-11 
H-2a, H-10b, H-10a 
10a 22.89 1.47 CH2 H-11, H-9, H-10a C-16, C-13, C-9, C-11 H-11, H-9, H-10b, H-8b 
10b  1.91  H-10b, H-10a C-3, C-9 H-11, H-9, H-10a 
11 21.46 2.92 CH H-15b C-16, C-7, C-8, C-10 H-12, H-10b, H-10a, H-17, 
H-7 
12 35.87 2.74 CH  C-14, C-13, C-4, C-5, 
C-6 
H-15b, H-15a, H-11, H-5, 
H-17 
13 88.36  Cq    
14 107.68  Cq    
15a 73.5 3.19 CH2 H-15b C-14, C-13, C-5, C-12 H-15b, H-12, H-5 
15b  4.07  H-15a, H-12 C-4, C-5, C-12 H-15a, H-12 
16 123.44  Cq    
17 15.19 0.53 CH3 H-6 C-5, C-7 H-11, H-12, H-7, H-5, H-6 
18 53.11 3.68 CH3  C-1 H-4 
19 166.34  Cq    
20 131.39  Cq    
21 130.09 8.24 CH H-22 C-19, C-23 H-22 
22 128.38 7.07 CH H-21, H-24 C-20 H-21 
23 133.15 7.12 CH H-21, H-25, H-22, H-
24 
C-21  
24 128.38 7.07 CH    
25 130.09 8.24 CH    
26  4.01 OH  C-14 H-9 
 128 
 
 
 129 
 
 
 130 
 
 
 131 
 
   
 132 
 
  
 133 
 
 134 
 
 
 135 
 
 
 136 
 
 
 137 
                                                 
References 
(1) Langille, N. F.; Jamison, T. F. Org. Lett. 2006, 8, 3761-3764. 
(2) Labaudinihe, L.; Hanaizi, J.; Normant, J. J. Org. Chem. 1992, 57, 6903-6908. 
(3) Bestmann, H. J.; Schulz, H. Chem. Ber. 1962, 95, 2921- 2927. 
(4) Shrestha-Dawadi, P. B.; Lugtenburg, J. Eur. J. Org. Chem. 2003, 4654-4663.  
(5) Kulyk, S.; Dougherty, W. G.; Kassel, W.S.; Zdilla, M. J.; Sieburth, S. M. Org. 
Lett. 2011, 13, 2180-2183. 
(6) Paquette, L. A.; Hormuth, S.; Lovely, C. J. J. Org. Chem. 1995, 60, 4813-
4821. 
(7) Morton, J. G. M.; Draghici, C.; Njardarson, J. T. Org. Lett. 2009, 11, 4492-
4495. 
(8) Mills, S. J.; Dozol, H.; Vandeput, F.; Backers, K.; Woodman, T.; Erneux, C.; 
Spiess, B.; Potter, B. V. L. ChemBioChem 2006, 7, 1696-1706. 
 
 
138 
APPENDIX 2 
A2.1 Experimental Procedures for Chapter 3  
 
Compound A2.2 was prepared according to literature protocol.
1
 
To a suspension of sodium hydride (60 wt%, 8.04g, 201.1 mmol) in THF (600 
mL) 2,3-O-isopropylideneglycerol (20.0 mL, 160.9 mmol) was added dropwise over 1 
h at r.t. After stirring for 4 h, benzyl bromide (21.1 mL, 177.0 mmol) was added and 
the reaction mixture was heated to reflux (72 °C) for 18 h. After the reaction was 
cooled to r.t. and the solvent was removed, hexanes (600 mL) were added to the 
residue. The solid was filtered off and the filtrate was washed with water and brine, 
dried over anhydrous Na2SO4, and concentrated. The crude product was purified by 
column chromatography (10% ethyl acetate/hexanes) to afford a yellow oil (34.4 g, 
96% yield). 
1
H NMR (400 MHz, CDCl3) δ 7.40 – 7.24 (m, 5H), 4.64 – 4.51 (m, 2H), 
4.30 (tt, J = 6.3, 5.6 Hz, 1H), 4.06 (dd, J = 8.2, 6.3 Hz, 1H), 3.75 (dd, J = 8.2, 6.3 Hz, 
1H), 3.56 (dd, J = 9.8, 5.6 Hz, 1H), 3.48 (dd, J = 9.8, 5.6 Hz, 1H), 1.42 (q, J = 0.7 Hz, 
3H), 1.37 (q, J = 0.7 Hz, 3H). 
A solution of acetonide (14.6 g, 65.5 mmol) in THF (60.0 mL) was treated 
with 2N HCl (33.0 mL, 65.5 mmol) for 4.0 h at r.t. The reaction was concentrated, 
taken up in dichloromethane (180 mL) and washed with saturated NaHCO3 (3 × 150 
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mL). The volume of the organic solution was reduced to 90 mL and sodium 
metaperiodate (28.0 g, 131.0 mmol) in water (180 mL) was added. The two-phase 
mixture was stirred at r.t. for 18 h. The organic phase was separated and the aqueous 
phase was extracted with dichloromethane (50 mL). The combined organic phases 
were washed with water and brine, dried over anhydrous Na2SO4 and concentrated to 
afford the desired aldehyde (7.83g, 80% yield), which was used without further 
purification. 
1
H NMR (400 MHz, CDCl3) δ 9.73 (t, J = 0.9 Hz, 1H), 7.45 – 7.27 (m, 
5H), 4.64 (s, 2H), 4.10 (d, J = 0.9 Hz, 2H). 
 
A mixture of methyl (triphenylphosphoranylidene)acetate (18.0 g, 53.8 mmol), 
bromide (22.1 g, 64.6 mmol) and cesium carbonate (17.5g, 53.8 mmol) in acetonitrile 
(225 mL) was heated at 85 °C for 5 h then aldehyde (7.61g, 50.7 mmol) in acetonitrile 
(25 mL) was added dropwise over 1 h. After stirring at 85 °C for 18 h the reaction was 
cooled to r.t. The solid was filtered off and the filtrate was concentrated. Hexanes were 
added to the residue and a solid crushed out, which was filtered off and washed with 
ethyl acetate. This operation was repeated once. The resultant filtrate was concentrated 
and purified by column chromatography (10% ethyl acetate/hexanes) to afford a 
colorless oil (16.1 g, 82% yield), which turned light brown while standing in air. 
1
H 
NM R (400 MHz, CDCl3) δ 7.41 – 7.26 (m, 5H), 6.93 (t, J = 5.9 Hz, 1H), 5.39 (tq, J = 
6.5, 1.4 Hz, 1H), 4.55 (s, 2H), 4.29 (d, J = 5.9 Hz, 2H), 3.75 (s, 3H), 3.07 (d, J = 6.5 
 140 
Hz, 2H), 2.45 (q, J = 1.4 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 167.37, 140.40, 
137.81, 132.31, 130.72, 128.57 (2C) , 127.97, 127.93 (2C), 101.54, 73.01, 67.22, 
52.12, 35.48, 33.58; IR (film) 2949, 2912, 2854, 1712, 1647, 1452, 1435, 1311, 1274, 
1205, 1105, 1124, 1047, 738, 698 cm
-1 
; HRMS (ESI) m/z calcd. for C16H20IO3 
[M+H]
+
: 387.0452, found: 387.0457. 
 
To a solution of ester (12.3 g, 31.9 mmol) in CH2Cl2 (250 mL) was added 
DIBAL (1.0 M in CH2Cl2, 70.2 mL) dropwise at -78 °C. The reaction was stirred at -
78 °C for 5 h then quenched by 10% Rochelle's salt solution (100 mL). The mixture 
was warmed to r.t. and stirred vigorously until two clear layers formed. The organic 
layer was separated and the aqueous layer was extracted with dichloromethane (3 × 50 
mL). The combined organic layers were washed with brine, dried over Na2SO4, 
filtered and concentrated to provide a colorless oil (11.2 g, 98% yield). 
1
H NMR (400 
MHz, CDCl3) δ 7.40 – 7.25 (m, 5H), 5.73 (dddd, J = 6.6, 5.2, 1.7, 0.9 Hz, 1H), 5.35 
(tq, J = 6.9, 1.4 Hz, 1H), 4.53 (s, 2H), 4.12 (dt, J = 6.6, 1.1 Hz, 2H), 4.05 (s, 2H), 2.89 
(d, J = 6.9 Hz, 2H), 2.47 (q, J = 1.4 Hz, 3H), 1.79 (br s, 1H); 
13
C NMR (100 MHz, 
CDCl3) δ 140.54, 138.27, 132.60, 128.53 (2C), 127.97 (2C), 127.80, 123.35, 102.24, 
72.66, 66.39, 66.35, 36.41, 33.61; IR (film) 3385, 2912, 2856, 1452, 1425, 1363, 
1109, 1070, 1004, 736, 698 cm
-1 
; HRMS (ESI) m/z calcd. for C15H19INaO2 [M+Na]
+
: 
381.0322, found: 381.0316. 
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Compound 3.10 was prepared according to literature procedure.
2
 A solution of 
2, 6-dihydroxybenzoic acid (30.0 g, 194.6 mmol), 4-dimethylaminopyridine (1.19 g, 
9.74 mmol) and acetone (18.6 mL, 252.9 mmol) in dimethoxyethane (150 mL) was 
cooled to 0 °C and thionyl chloride (18.4 mL, 252.9 mmol) was added dropwise.  
Upon completion of the addition, the resultant solution was allowed to stir at 0 °C for 
1 h then r.t. 20 h. The reaction solution turned from light yellow to brown to red over 
time. The reaction was then cooled to 0°C, quenched by slow addition of saturated 
NaHCO3 (100 mL). The organic layer was separated and the aqueous layer was 
extracted with diethyl ether (3 × 150 mL). The combined organic layers were washed 
with brine (200 mL), dried over anhydrous Na2SO4, filtered and concentrated. The 
resultant solid was triturated with hexanes and collect by vacuum filtration to afford a 
light yellow solid (32.0 g, 93% yield). 
1
H NMR (500 MHz, CDCl3) d 10.34 (s, 1H), 
7.41 (t, J = 8.3 Hz, 1H), 6.64 (dd, J = 8.5, 1.0 Hz, 1H), 6.44 (dd, J = 8.1, 0.9 Hz, 1H), 
1.75 (s, 6H). 
 
To a solution of alcohol (5.30 g, 14.8 mmol), phenol (3.14 g, 17.8 mmol) and 
triphenylphosphine (4.67 g, 17.8 mmol) in THF (100 mL) was added diisopropyl 
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azodicarboxylate (3.45 mL, 17.8 mmol) at 0 °C over 30 min. After the addition was 
completed, stirring continued for 1.0 h at 0 °C, and then the reaction was warmed to 
r.t. and stirred overnight. The reaction was concentrated and the residue was taken up 
in ethyl acetate. The solid was filtered off and the filtrate was concentrated again. The 
residue was purified by column chromatography (10% ethyl acetate/hexanes) to 
provide a colorless oil (7.38 g, 93% yield). 
1
H NMR (400 MHz, CDCl3) δ 7.42 (t, J = 
8.4 Hz, 1H), 7.37 – 7.25 (m, 5H), 6.59 (dd, J = 8.5, 0.9 Hz, 1H), 6.55 (dd, J = 8.3, 0.9 
Hz, 1H), 6.02 (tt, J = 6.5, 1.2 Hz, 1H), 5.62 (tq, J = 7.1, 1.4 Hz, 1H), 4.56 (d, J = 1.2 
Hz, 2H), 4.54 (s, 2H), 4.20 (d,  J = 6.5 Hz, 2H), 3.02 (d, J = 7.1 Hz, 2H), 2.48 (q, J = 
1.4 Hz, 3H), 1.70 (s, 6H); 
13
C NMR (100 MHz, CDCl3) δ 160.43, 157.96, 157.94, 
138.34, 136.40, 135.31, 132.65, 128.55 (2C), 128.04 (2C), 127.78, 126.85, 109.54, 
106.71, 105.35, 103.73, 102.40, 72.64, 72.59, 66.47, 36.82, 33.67, 25.80 (2C); IR 
(film) 2995, 2941, 2912, 2854, 1737, 1606, 1583, 1481, 1454, 1377, 1330, 1259, 
1205, 1080, 921, 802, 738, 690 cm
-1 
; HRMS (ESI) m/z calcd. for C25H27INaO5 
[M+Na]
+
: 557.0795, found: 557.0791. 
 
To a solution of acetonide (13.2 g, 24.7 mmol) in CH2Cl2 (170 mL) cooled at -
78 °C, DIBAL/CH2Cl2 (1.0M, 74.2 mL) was added dropwise. The reaction solution 
was stirred at -78 °C for 3 h and then quenched by ethyl acetate (25 mL) and saturated 
Rochelle's salt solution (150 mL). After more ethyl acetate (300 mL) was added, the 
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mixture was warmed to r.t. and stirred overnight. Two clear layers formed and the 
upper organic layer was decanted and the rest aqueous layer was extracted with ethyl 
acetate (2 × 200 mL). The combined organic layers were washed with water (3 × 150 
mL) and brine (150 mL) and dried over anhydrous Na2SO4. Filtration and removal of 
solvent provided a light yellow oil (11.6 g, 98% yield). This crude product was used 
without further purification. 
1
H NMR (400 MHz, CDCl3) δ 11.96 (s, 1H), 10.39 (s, 
1H), 7.41 – 7.25 (m, 5H), 7.37 (t, J = 8.4 Hz, 1H), 6.52 (dt, J = 8.5, 0.7 Hz, 1H), 6.34 
(dd, J = 8.3, 0.7 Hz, 1H), 5.86 (tt, J = 6.4, 1.2 Hz, 1H), 5.35 (tq, J = 6.8, 1.4 Hz, 1H), 
4.54 (s, 2H), 4.51 (q, J = 1.0 Hz, 2H), 4.16 (d, J = 6.4 Hz, 2H), 2.99 (d, J = 6.8 Hz, 
2H), 2.47 (q, J = 1.4 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 194.36, 163.77, 161.45, 
138.40, 138.04, 135.37, 131.86, 128.56 (2C), 127.96 (2C), 127.88, 127.14, 111.08, 
110.15, 103.04, 102.11, 72.79, 71.85, 66.16, 36.58, 33.61; IR (film) 3219, 3061, 3028, 
2883, 2856, 2791, 1643, 1494, 1462, 1334, 1311, 1238, 1170, 1091, 1028, 837, 783, 
719, 499 cm
-1 
; HRMS (ESI) m/z calcd. for C22H24IO4 [M+H]
+
: 479.0714, found: 
479.0722. 
 
In a high-pressure flask was charged phenol (12.8 g, 26.8 mmol), cesium 
carbonate (8.73 g, 26.8 mmol), 2, 2, 2-trifluoroethyl trifluoromethanesulfonate (5.80 
mL, 40.2 mmol) and dry acetonitrile (250 mL). The flask was flushed with N2 for 5 
min., capped and heated to 85 °C (bath temperature). The reaction mixture was stirred 
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at 85 °C for 3.0 h and the solution gradually turned from light yellow to colorless. 
After cooling to r.t., the reaction mixture was partitioned between ethyl acetate (300 
mL) and water (200 mL). The organic phase was separated and the aqueous phase was 
washed with saturated NaHCO3 (3 × 100 mL). The aqueous phase was back-extracted 
with ethyl acetate (100 mL). The combined organic phases were washed with brine 
(100 mL), dried over anhydrous Na2SO4 and concentrated. The residue was purified 
by column chromatography (15% ethyl acetate/hexanes) to afford a light yellow oil 
(14.3 g, 95% yield). 
1
H NMR (400 MHz, CDCl3) δ 10.54 (s, 1H), 7.43 (t, J = 8.5 Hz, 
1H), 7.37 – 7.26 (m, 5H), 6.68 (d, J = 8.5 Hz, 1H), 6.56 (d, J = 8.3 Hz, 1H), 5.92 (tt, J 
= 6.5, 1.1 Hz, 1H), 5.45 (tq, J = 6.8, 1.4 Hz, 1H), 4.53 (s, 2H), 4.53 (s, 2H), 4.41 (q, J 
= 8.1 Hz, 2H), 4.17 (d, J = 6.5 Hz, 2H), 2.99 (d, J = 6.8 Hz, 2H), 2.48 (q, J = 1.4 Hz, 
3H); 
13
C NMR (100 MHz, CDCl3) δ 188.31, 161.12, 159.58, 138.17, 135.66, 135.31, 
132.15, 128.54 (2C), 127.99 (2C), 127.83, 126.95, 123.24 (q, J = 278.4 Hz), 116.01, 
107.54, 106.97, 102.77, 72.69, 72.29, 67.34 (q, J = 35.9 Hz), 66.28, 36.61, 33.60; IR 
(film) 2860, 2775, 1689, 1597, 1473, 1454, 1284, 1246, 1165, 1122, 1028, 975, 825, 
777, 738, 698, 667 cm
-1 
; HRMS (ESI) m/z calcd. for C24H25F3IO4 [M+H]
+
: 561.0744, 
found: 561.0737. 
 
In a high-pressure flask, 10 M sulfuric acid (7.6 mL, 76.0 mmol) was added to 
a suspension of boric acid (2.36 g, 38.2 mmol) in THF (60 mL) with stirring. Heat was 
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generated during addition. After the flask was cooled to r.t. in air, hydrogen peroxide 
(30 wt% in water, 1.30 mL, 11.5 mmol) was added slowly. After stirring at r.t. for 1.0 
h, aldehyde (4.28 g, 7.64 mmol) in THF (16 mL) was added. The high-pressure flask 
was then capped and immersed in 50 °C oil bath and heated for 4.0 h. The reaction 
was cooled to r.t., diluted with ethyl acetate (100 mL), and washed with water (3 × 50 
mL) and brine (2 × 50 mL). The organic phase was dried over anhydrous Na2SO4, 
filtered and concentrated. The crude product was purified by column chromatography 
(10% ethyl acetate/hexanes) to yield a light yellow oil (3.40 g, 81%). 1H NMR (400 
MHz, CDCl3) δ 7.39 – 7.25 (m, 5H), 6.74 (t, J = 8.3 Hz, 1H), 6.63 (td, J = 8.1, 1.4 Hz, 
2H), 5.84 (tt, J = 6.4, 1.1 Hz, 1H), 5.57 (s, 1H), 5.37 (tq, J = 6.8, 1.5 Hz, 1H), 4.52 (s, 
2H), 4.51 (s, 2H), 4.42 (q, J = 8.3 Hz, 2H), 4.15 (d, J = 6.4 Hz, 2H), 2.98 (d, J = 6.8 
Hz, 2H), 2.47 (q, J = 1.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 146.81, 145.33, 
138.11, 136.81, 135.80, 132.08, 128.55 (2C), 127.98 (2C), 127.87, 127.19, 123.56 (q, 
J = 278.6 Hz), 119.23, 110.22, 108.39, 102.87, 72.77, 72.68, 67.86 (q, J = 35.3 Hz), 
66.22, 36.62, 33.60; IR (film) 3520, 3030, 2947, 2916, 2858, 1610, 1504, 1479, 1454, 
1359, 1280, 1211, 1165, 1112, 1087, 968, 736, 698 cm
-1
; HRMS (ESI) m/z calcd. for 
C23H24F3INaO4 [M+Na]+: 571.0564, found: 571.0562. 
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To a 500-mL 3-necked round-bottom flask equipped with a reflux condenser 
was charged a solution of iodobenzene diacetate (3.03 g, 9.41 mmol) in methanol (290 
mL). The solution was heated to 60 °C and a solution of s.m. (1.72 g, 3.14 mmol) in 
methanol (24 mL) was added over 2.5 h via syringe pump. Upon the completion of 
addition, the reaction was stirred at 60 °C for 2 h then cooled to r.t. and concentrated. 
The crude product was purified by column chromatography (15% ethyl 
acetate/hexanes) to provide a light yellow oil (1.14g, 63% yield). 
1
H NMR (400 MHz, 
CDCl3) δ 7.38 – 7.22 (m, 5H), 6.24 – 6.10 (m, 2H), 5.48 (ddq, J = 7.9, 6.5, 1.4 Hz, 
1H), 4.44 (s, 2H), 4.32 – 4.11 (m, 2H), 4.01 (d, J = 8.2 Hz, 1H), 3.82 (d, J = 8.2 Hz, 
1H), 3.76 (dd, J = 10.3, 2.4 Hz, 1H), 3.53 (s, 3H), 3.52 – 3.43 (m, 1H), 3.07 (dd, J = 
6.6, 1.9 Hz, 1H), 2.68 (ddq, J = 15.2, 6.5, 1.4 Hz, 1H), 2.54 (m, 1H), 2.53 (q, J = 1.4 
Hz, 3H), 2.37 (ddd, J = 15.2, 7.7, 1.2 Hz, 1H); 
13
C NMR (101 MHz, Chloroform-d) δ 
198.39, 137.82, 130.22, 129.67, 128.63, 128.50 (2C), 127.96 (2C), 127.87, 123.65 (q, 
J = 277.8 Hz), 105.74, 99.49, 85.17, 78.72, 73.54, 66.45, 64.03 (q, J = 35.1 Hz), 
52.16, 50.31, 49.17, 47.24, 37.80, 34.06; IR (film) 2949, 2914, 2887, 1755, 1365, 
1282, 1205, 1161, 1118, 1091, 1028, 985, 966, 889, 736, 698 cm
-1 
; HRMS (ESI) m/z 
calcd. for C24H27F3IO5 [M+H]
+
: 579.0849, found: 579.0843. 
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In a 4-mL clear vial was charged a solution of vinyl iodide (5.0 mg, 0.00865 
mmol) in THF (0.5 mL). After flushing the solution with N2 for 10 min, 
tetrakis(triphenylphosphine)palladium(0) (10 mg, 0.00865 mmol) was added. The vial 
was capped and heated at 85 °C for 1 h. After which, the reaction was cooled to r.t. 
and tributyl(vinyl)tin (0.0051 mL, 0.0173 mmol) was added under N2.  The reaction 
was heated again at 85 °C for 16 h, then cooled to r.t. and concentrated. The residue 
was purified by column chromatography (15% ethyl acetate/hexanes) to provide a 
colorless oil (3.0 mg, 72% yield). 
1
H NMR (400 MHz, CDCl3) δ 7.39 – 7.25 (m, 5H), 
5.54 (ddq, J = 3.8, 2.6, 1.3 Hz, 1H), 5.34 (dt, J = 16.1, 10.0 Hz, 1H), 5.18 – 5.15 (m, 
1H), 5.15 – 5.10 (m, 1H), 4.51 – 4.41 (m, 2H), 4.19 (dq, J = 10.8, 8.6 Hz, 1H), 3.96 
(dq, J = 10.8, 8.6 Hz, 1H), 3.89 (d, J = 7.3 Hz, 1H), 3.78 (d, J = 7.3 Hz, 1H), 3.67 (dd, 
J = 9.5, 1.8 Hz, 1H), 3.58 (s, 3H), 3.60 – 3.52 (m, 1H), 2.79 (m, 1H), 2.71 – 2.66 (m, 
1H), 2.62 (ddq, J = 18.4, 4.7, 1.7 Hz, 1H), 2.46 (dt, J = 9.9, 1.7 Hz, 1H), 2.23 (d, J = 
3.8 Hz, 1H), 2.07 (dtd, J = 18.2, 2.6, 1.5 Hz, 1H), 1.71 (dt, J = 2.8, 1.5 Hz, 3H); 
13
C 
NMR (125 MHz, CDCl3) δ 203.20, 137.97, 134.90, 133.60, 128.53 (2C), 127.92, 
127.90 (2C), 123.73 , 123.72 (q, J = 277.8 Hz), 120.94, 103.37, 81.99, 78.84, 73.15, 
68.19, 61.85 (q, J = 35.0 Hz), 52.09, 46.43, 45.43, 43.73, 42.13, 35.30, 29.83, 25.25; 
IR (film) 2948, 2923, 2890, 1748, 1454, 1284, 1219, 1161, 1101, 1076, 993, 922, 888, 
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736, 696 cm
-1 
; HRMS (ESI) m/z calcd. for C26H30F3O5 [M+H]
+
: 479.2039, found: 
479.2037. 
 
In a high-pressure tube was charged a solution of vinyl iodide (25.0 mg, 
0.0432 mmol) in DMF (2.2 mL). After flushing the solution with N2 for 10 min, 
tetrakis(triphenylphosphine)palladium(0) (0.5 mg, 0.000432 mmol) and (E)-methyl 3-
(tributylstannyl)acrylate (32 mg, 0.864 mmol) were added successively. The tube was 
flushed with N2 for 10 min again, capped and heated at 85 °C for 18 h. After cooling 
to r.t. the reaction mixture was poured onto water (10 mL) and extracted with ethyl 
acetate (3 × 5 mL). The combined extracts were washed with brine (10 mL), dried 
over anhydrous MgSO4, filtered and concentrated. The residue was purified by column 
chromatography (15% ethyl acetate/hexanes) to provide a light yellow solid, which 
was further purified by trituration with methanol. The resultant white solid was 
collected by vacuum filtration (17.3 mg, 75% yield). 
1
H NMR (400 MHz, CDCl3) δ 
7.40 – 7.26 (m, 5H), 6.43 (dd, J = 15.2, 10.6 Hz, 1H), 5.88 (dd, J = 15.2, 0.7 Hz, 1H), 
5.58 (tt, J = 2.8, 1.4 Hz, 1H), 4.47 (s, 2H), 4.19 (dq, J = 10.9, 8.5 Hz, 1H), 3.91 (d, J = 
7.3 Hz, 1H), 3.81 (d, J = 7.3 Hz, 1H), 3.75 (dq, J = 10.9, 8.5 Hz, 1H), 3.75 (s, 3H), 
3.64 – 3.52 (m, 2H), 3.60 (s, 3H), 2.95 – 2.84 (m, 1H), 2.74 – 2.67 (m, 1H), 2.62 (ddd, 
J = 18.4, 4.4, 1.7 Hz, 1H), 2.50 – 2.44 (m, 1H), 2.27 (d, J = 3.8 Hz, 1H), 2.09 (dq, J = 
18.3, 2.3 Hz, 1H), 1.65 (dt, J = 2.8, 1.5 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 
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202.29, 166.21, 143.43, 137.70, 134.07, 128.57 (2C), 128.14 (2C), 128.04, 126.13, 
124.70, 123.49 (q, J = 277.7 Hz), 103.24, 81.99, 79.17, 73.36, 67.72, 61.94 (q, J = 
35.4 Hz), 52.33, 51.77, 45.75, 44.93, 42.88, 42.24, 35.09, 29.76, 24.79; IR (film) 
2950, 2890, 1761, 1722, 1653, 1436, 1283, 1240, 1163, 1092, 991, 733, 700 cm
-1 
; 
HRMS (ESI) m/z calcd. for C28H31F3NaO7 [M+Na]
+
: 559.1914, found: 559.1914. 
 
In a 15-mL high-pressure tube was charged a solution of vinyl iodide (400.0 
mg, 0.692 mmol) in toluene (7.0 mL). After flushing the solution with N2 for 15 min., 
tetrakis(triphenylphosphine)palladium(0) (40.0 mg, 0.0346 mmol) and (E)-(3-
(benzyloxy)prop-1-en-1-yl)tributylstannane (0.4 mL, 0.900 mmol) were added 
successively. The tube was flushed with N2 for 10 min. again, capped and heated at 
150 °C for 18 h. The reaction solution turned from yellow to olive over time and in 
some occasions a black precipitate formed on the glass wall. After cooling to r.t. the 
reaction mixture was filtered through a Celite pad and the filtrate was concentrated 
and purified by column chromatography (10% ethyl acetate/hexanes) to provide a light 
yellow oil (375.2 mg, 91% yield). 
1
H NMR (400 MHz, CDCl3) δ 7.42 – 7.20 (m, 
10H), 5.68 (dt, J = 15.2, 5.5 Hz, 1H), 5.54 (dt, J = 4.0, 2.2 Hz, 1H), 5.24 (ddt, J = 
15.2, 10.2, 1.5 Hz, 1H), 4.48 (d, J = 4.0 Hz, 2H), 4.41 (d, J = 1.4 Hz, 2H), 4.24 (dq, J 
= 11.0, 8.6 Hz, 1H), 4.00 (ddd, J = 5.5, 2.3, 1.5 Hz, 2H), 3.95 – 3.85 (m, 2H), 3.79 (d, 
J = 7.3 Hz, 1H), 3.63 (dd, J = 9.4, 1.7 Hz, 1H), 3.59 (s, 3H), 3.54 (dd, J = 9.7, 9.4 Hz, 
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1H), 2.84 (dd, J = 10.7, 10.2 Hz, 1H), 2.68 (dd, J = 10.7, 3.8 Hz, 1H), 2.61 (ddd, J = 
18.4, 4.4, 2.1 Hz, 1H), 2.47 (dt, J = 9.7, 1.7 Hz, 1H), 2.25 (d, J = 3.8 Hz, 1H), 2.08 (d, 
J = 18.4 Hz, 1H), 1.70 (dt, J = 2.7, 1.5 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 
203.08, 138.67, 137.89, 134.94, 133.00, 128.55 (2C), 128.50 (2C), 127.98, 127.94 
(2C), 127.87, 127.64, 127.58 (2C), 123.83, 123.77 (q, J = 277.6 Hz), 103.41, 82.03, 
79.11, 73.18, 71.60, 69.86, 68.13, 61.90 (q, J = 35.1 Hz), 52.17, 45.51, 45.34, 43.33, 
42.18, 35.30, 29.83, 25.25; IR (film) 2943, 2887, 2850, 1751, 1452, 1282, 1161, 1070, 
991, 887, 736, 698 cm
-1 
; HRMS (ESI) m/z calcd. for C34H37F3NaO6 [M+Na]
+
: 
621.2434, found: 621.2439. 
 
Magnesium bromide diethyl etherate (542.0 mg, 2.10 mmol) in a flask was 
dried by heating gently under vacuum. After the flask was cooled to r.t., ketone (837.6 
mg, 1.40 mmol) in anhydrous ethyl ether (12.0 mL) was added, followed by 
anhydrous benzene (2.5 mL). The mixture turned into a clear solution. (Note: When 
MgBr2 dissolves in diethyl ether it forms two layers of liquid. The button layer 
contains MgBr2 at 39 wt% and the top layer 3 wt%. Addition of benzene can increase 
the solubility and make a clear solution. This operation does not seem to affect the 
yield or stereoselectivity of the reaction and therefore could be omitted.) The solution 
was cooled to 0 °C with vigorous stirring. Grignard reagent (3.0 M, 0.70 mL, 2.10 
mmol) was added dropwise while the reaction solution turned form colorless to light 
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yellow. After the addition was completed, the reaction mixture was warmed to r.t. and 
stirred for 1.0 h, then quenched by saturated NH4Cl solution at 0 °C and diluted with 
water and ethyl acetate. The organic layer was separated and the aqueous layer was 
extracted with ethyl acetate three times. The combined organic layers were washed 
with brine, dried over anhydrous Na2SO4, filtered and concentrated under reduced 
pressure. The crude product was purified by flash column (10-15% ethyl 
acetate/hexanes) to afford a colorless oil (790.2 mg, 92% yield), which solidified 
under high vacuum. 
1
H NMR (400 MHz, CDCl3) δ 7.40 – 7.19 (m, 10H), 5.74 (dt, J = 
15.3, 5.6 Hz, 1H), 5.53 – 5.39 (m, 2H), 4.48 (s, 2H), 4.47 (d, J = 11.9 Hz, 1H), 4.39 
(d, J = 11.9 Hz, 1H), 4.23 (dq, J = 11.3, 8.5 Hz, 1H), 4.02 (dq, J = 11.3, 8.5 Hz, 1H), 
3.99 (dd, J = 5.6, 1.4 Hz, 2H), 3.95 (dd, J = 8.9, 1.9 Hz, 1H), 3.80 (td, J = 11.3, 2.0 
Hz, 1H), 3.71 (d, J = 6.8 Hz, 1H), 3.55 (m, 1H), 3.53 (d, J = 6.8 Hz, 1H), 3.35 (s, 3H), 
3.35 (s, 1H), 2.51 (dd, J = 11.3, 3.5 Hz, 1H), 2.47 (m, 1H), 2.19 (dt, J = 10.3, 2.0 Hz, 
1H), 1.96 (dtd, J = 18.6, 2.7, 1.2 Hz, 1H), 1.89 (d, J = 3.5 Hz, 1H), 1.65 (dt, J = 2.9, 
1.6 Hz, 3H), 1.30 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 138.71, 138.53, 135.69, 
131.88, 131.47, 128.48 (2C), 128.43 (2C), 127.71 (2C), 127.62, 127.60, 127.51 (2C), 
124.27 (q, J = 277.7 Hz), 122.45, 107.10, 81.38, 79.56, 79.49, 72.69, 71.85, 70.40, 
69.10, 61.96 (q, J = 34.0 Hz), 49.99, 47.83, 40.78, 39.98, 35.43, 35.10, 29.62, 25.59, 
17.48; IR (film) 3535, 2939, 2858, 1452, 1282, 1163, 1118, 1095, 1016, 960, 856, 
734, 696 cm
-1 
; HRMS (ESI) m/z calcd. for C35H42F3O6 [M+H]
+
: 615.2928, found: 
615.2926. 
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Potassium hydride (30 wt% in mineral oil, 0.98 g, 7.34 mmol) was washed 
with dry pentane under N2 for three times, suspended in THF (15 mL) and cooled to 0 
°C. Alcohl (1.13 g, 1.83 mmol) in THF (3.3 mL) was added dropwise. After the 
reaction was stirred at 0 °C for 2.0 h, freshly distilled carbon disulfide (1.11 mL, 18.3 
mmol) was added dropwise. The reaction was stirred at 0 °C for 30 min. and r.t. 4.0h.  
After that period of time, the reaction was cooled to 0 °C again and methyl iodide 
(1.14 mL, 18.3 mmol) was added dropwise. The resultant mixture was allowed to 
warm up to r.t. and stirred for 20 h. The reaction was quenched by water at 0 °C and 
diluted with ethyl acetate. The organic layer was separated and the aqueous layer was 
extracted with ethyl acetate three times. The combined organic layers were washed 
with brine, dried over anhydrous Na2SO4, filtered and concentrated. The crude product 
was triturated with hexane and an off-white solid was collected by vacuum filtration. 
The filtrate was concentrated and purified by flash column chromatography (15% 
ethyl acetate/hexanes) to afford another crop of white solid. All solids were combined 
and weighed 1.13g (88% yield). 
1
H NMR (400 MHz, CDCl3) δ 7.43 – 7.20 (m, 10H), 
5.82 (dt, J = 15.2, 5.5 Hz, 1H), 5.53 – 5.37 (m, 2H), 4.51 (s, 2H), 4.44 (q, J = 11.8 Hz, 
2H), 4.12 – 3.96 (m, 3H), 3.94 – 3.77 (m, 3H), 3.73 (d, J = 7.0 Hz, 1H), 3.62 – 3.54 
(m, 1H), 3.54 (d, J = 7.2 Hz, 1H), 3.24 (s, 3H), 2.65 (d, J = 11.8, 3.5 Hz, 1H), 2.54 (s, 
3H), 2.52 – 2.41 (m, 1H), 2.20 (dt, J = 10.3, 2.0 Hz, 1H), 2.03 (s, 3H), 2.01 – 1.93 (m, 
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1H), 1.95 (d, J = 3.5 Hz, 1H), 1.69 (dt, J = 2.8, 1.5 Hz, 3H); 
13
C NMR (100 MHz, 
CDCl3) δ 212.63, 138.60, 138.35, 135.55, 132.83, 130.06, 128.51 (2C), 128.47 (2C), 
127.72 (2C), 127.70, 127.67, 127.50 (2C), 123.84 (q, J = 277.8 Hz), 122.67, 107.94, 
97.60, 81.57, 80.64, 72.79, 72.24, 70.33, 69.04, 61,90 (q, J = 34.3 Hz), 49.18, 47.30, 
40.95, 40.48, 35.81, 34.94, 29.52, 25.57, 20.08, 15.50; IR (film) 2935, 2860, 1282, 
1222, 1163, 1109, 1016, 962, 734, 696 cm
-1 
; HRMS (ESI) m/z calcd. for 
C37H44F3O6S2 [M+H]
+
: 705.2526, found: 705.2521. 
 
A mixture of xanthate (45.0 mg, 0.0638 mmol), tributyltin hydride (0.085 mL, 
0.319 mmol) and azobisisobutyronitrile (5.4 mg, 0.0319 mmol) in toluene (1.3 mL) 
was heated at 85 °C for 1 h, then cooled to r.t. and concentrated. The crude product 
was purified by column chromatography (10-15% ethyl acetate/hexanes) to afford 
product 3.27 (lower Rf, white solid, 31.2 mg, 82% yield) and 3.28 (higher Rf, white 
solid, 6.0 mg, 16% yield). 
Compound 3.27: 
1
H NMR (500 MHz, CDCl3) δ 7.43 – 7.19 (m, 10H), 5.68 (dt, 
J = 15.3, 5.6 Hz, 1H), 5.50 – 5.36 (m, 2H), 4.49 (s, 2H), 4.48 (d, J = 11.8 Hz, 1H), 
4.40 (d, J = 11.8 Hz, 1H), 4.07 – 3.89 (m, 3H), 3.87 (dd, J = 9.0, 1.9 Hz, 1H), 3.73 (d, 
J = 7.0 Hz, 1H), 3.67 (dq, J = 10.2, 8.1 Hz, 1H), 3.58 (d, J = 7.0 Hz, 1H), 3.52 (dd, J = 
10.4, 9.0 Hz, 1H), 3.31 (s, 3H), 2.68 (td, J = 11.0, 1.8 Hz, 1H), 2.58 (dd, J = 11.3, 3.6 
Hz, 1H), 2.52 (ddd, J = 18.4, 4.3, 2.0 Hz, 1H), 2.21 (dt, J = 10.4, 1.9 Hz, 1H), 2.02 (q, 
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J = 6.8 Hz, 1H), 1.96 (m, 2H), 1.65 (dt, J = 2.9, 1.6 Hz, 3H), 0.98 (d, J = 6.8 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 138.57, 138.53, 134.70, 131.64, 131.32, 128.53 (2C), 
128.45 (2C), 127.77 (2C), 127.69, 127.65, 127.56 (2C), 123.53, 124.05 (q, J = 277.1 
Hz), 109.63, 81.53, 77.20, 72.78, 71.98, 70.25, 68.64, 59.93 (q, J = 34.5 Hz), 49.62, 
48.81, 47.52, 46.32, 40.87, 40.49, 35.66, 30.24, 25.60, 7.69; IR (film) 2923, 2855, 
1454, 1281, 1161, 1114, 1013, 966, 926, 735, 696 cm
-1 
; HRMS (ESI) m/z calcd. for 
C35H42F3O5 [M+H]
+
: 599.2978, found: 599.2980. 
Compound 3.28: 
1
H NMR (600 MHz, CDCl3) δ 7.40 – 7.20 (m, 10H), 5.62 (dt, 
J = 15.1, 5.9 Hz, 1H), 5.44 (dt, J = 4.3, 2.0 Hz, 1H), 5.27 (dd, J = 15.1, 10.1 Hz, 1H), 
4.49 (d, J = 12.2 Hz, 1H), 4.43 (d, J = 12.3 Hz, 2H), 4.37 (d, J = 11.7 Hz, 1H), 4.02 
(ddd, J = 12.8, 5.8, 1.4 Hz, 1H), 3.96 (ddd, J = 12.8, 5.8, 1.4 Hz, 1H), 3.77 (d, J = 6.9 
Hz, 1H), 3.66 – 3.52 (m, 3H), 3.50 (dd, J = 9.6, 1.6 Hz, 1H), 3.36 (t, J = 9.8 Hz, 1H), 
3.32 (s, 3H), 2.72 (t, J = 10.6 Hz, 1H), 2.46 – 2.39 (m, 2H), 2.24 (q, J = 7.1 Hz, 1H), 
2.12 (d, J = 10.0 Hz, 1H), 2.01 (d, J = 18.2 Hz, 1H), 1.89 (d, J = 3.6 Hz, 1H), 1.66 (s, 
3H), 0.96 (d, J = 7.1 Hz, 3H); 
13
C NMR (CDCl3, extracted for HSQC and MHBC) 
128.5 (2C), 127.86(2C), 127.77(3C), 127.5 (3C), 138.94, 138.07, 136.05, 131.73, 
130.47, 124.03, 122.26, 108.77, 81.06, 77.01, 73.11, 71.08, 70.42, 68.32, 59.23, 49.87, 
47.97, 47.66, 40.14, 39.00, 38.97, 34.78, 29.77, 25.26, 9.07; IR (film) 2923, 2853, 
1454, 1368, 1279, 1161, 1114, 1016, 968, 916, 735, 698 cm
-1 
; HRMS (ESI) m/z calcd. 
for C35H42F3O5 [M+H]
+
: 599.2978, found: 599.2978. 
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A mixture of xanthate (10.0 mg, 0.0142 mmol), tributyltin hydride (0.009 mL, 
0.0355 mmol) and triethylborane (1.0 M in THF, 0.01 mL) in toluene (1.4 mL) was 
cooled to -78 °C and O2 was bubbled through for 5 min. The reaction was stirred at -
78 °C for 1.0 h under O2 atmosphere, then warmed to r.t. and concentrated.  Crude 
1
H-
NMR showed the ratio of 3.27 to 3.28 is about 17:1. The major product 3.27 was 
isolated by column chromatography (10% ethyl acetate/hexanes) as a white solid (14.3 
mg, 84% yield). 
 
A solution of xanthate (3.02 g, 4.28 mmol) in toluene (43.0 mL) was heated at 
110 °C for 4 h. After cooling to r.t. the reaction mixture was concentrated. The residue 
was triturated with 5% ethyl acetate/hexanes. A white solid was collected by vacuum 
filtration. The filtrate was concentrated and purified by flash column (10-15% ethyl 
acetate/hexanes) to afford another crop of white solid. The solids are combined and 
weighed 2.09 g (82% yield). 
1
H NMR (400 MHz, CDCl3) δ 7.41 – 7.22 (m, 10H), 5.63 
(dtd, J = 15.1, 5.8, 0.6 Hz, 1H), 5.47 (m, 1H), 5.46 (d, J = 0.7 Hz, 1H), 5.25 (ddt, J = 
15.1, 10.3, 1.5 Hz, 1H), 5.05 (s, 1H), 4.50 (d, J = 12.1 Hz, 1H), 4.46 (d, J = 11.8 Hz, 
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1H), 4.44 (d, J = 12.1 Hz, 1H), 4.36 (d, J = 11.8 Hz, 1H), 4.05 – 3.93 (m, 3H), 3.80 (d, 
J = 7.0 Hz, 1H), 3.64 (d, J = 7.1 Hz, 1H), 3.56 – 3.37 (m, 3H), 3.40 (s, 3H), 2.71 – 
2.62 (m, 1H), 2.60 – 2.54 (m, 1H), 2.50 – 2.41 (m, 1H), 2.24 (dt, J = 9.4, 1.9 Hz, 1H), 
2.16 (d, J = 3.5 Hz, 1H), 2.05 (dtd, J = 18.2, 2.5, 1.2 Hz, 1H), 1.67 (dt, J = 2.8, 1.5 Hz, 
3H); 
13
C NMR (100 MHz, CDCl3) δ 151.30, 138.85, 137.87, 136.06, 132.23, 129.82, 
128.52 (2C), 128.42 (2C), 127.97, 127.92 (2C), 127.61 (2C), 127.53, 124.07 (q, J = 
277.8 Hz), 122.78, 105.96, 104.75, 81.33, 77.79, 73.14, 71.23, 70.26, 67.85, 60.17 (q, 
J = 34.4 Hz), 50.60, 49.78, 45.37, 41.62, 41.41, 35.60, 30.00, 25.31; IR (film) 2931, 
2852, 1452, 1367, 1282, 1166, 1103, 1010, 923, 854, 734, 696 cm
-1 
; HRMS (ESI) m/z 
calcd. for C35H40F3O5 [M+H]
+
: 597.2822, found: 597.2828. 
 
In a 4-mL clear glass vial, triene (124.7 mg, 0.209 mmol) was dissolved in 
CH2Cl2 (1.0 mL), and iridium catalyst
3
 (8.0 mg, 0.00522 mmol, 0.025 eq.) was added. 
The resultant red solution was bubbled with H2 for 1.0 min. and the color was 
discharged immediately. Six of this vial was placed in a hydrogenation bomb and 
stirred at r.t. under 700 psi of H2 for 16 h. The combined reaction mixture was 
concentrated under reduced pressure and the residue was purified by column 
chromatography (10% ethyl acetate/hexanes) to afford a white solid (688.6 mg, 91% 
yield). 
1
H NMR (600 MHz, CDCl3) δ 7.38 – 7.26 (m, 10H), 5.50 – 5.42 (m, 1H), 4.50 
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(d, J = 11.9 Hz, 1H), 4.47 (d, J = 11.8 Hz, 1H), 4.46 (d, J = 11.9 Hz, 1H), 4.40 (d, J = 
11.8 Hz, 1H), 3.74 (d, J = 7.0 Hz, 1H), 3.64 – 3.54 (m, 2H), 3.54 – 3.50 (m, 1H), 3.52 
(d, J = 7.0 Hz, 1H), 3.46 (ddd, J = 9.5, 7.8, 5.5 Hz, 1H), 3.38 (dt, J = 9.6, 7.1 Hz, 1H), 
3.30 (s, 3H), 3.28 (t, J = 10.0 Hz, 1H), 2.53 – 2.45 (m, 2H), 2.19 (q, J = 7.1 Hz, 1H), 
2.07 (dt, J = 10.6, 1.9 Hz, 1H), 2.00 – 1.89 (m, 2H), 1.88 (d, J = 3.6 Hz, 1H), 1.78 – 
1.68 (m, 1H), 1.74 (s, 3H), 1.63 – 1.54 (m, 1H), 1.47 (dtd, J = 14.0, 8.2, 2.5 Hz, 1H), 
1.11 (dtd, J = 13.0, 7.8, 4.9 Hz, 1H), 0.89 (d, J = 7.1 Hz, 3H); 
13
C NMR (100 MHz, 
CDCl3) δ 138.81, 138.25, 136.23 , 128.43 (2C), 128.4 (q, J = 278.1 Hz), 128.34 (2C), 
127.73, 127.69 (2C), 127.64 (2C), 127.45, 123.19, 108.65, 81.09, 77.91, 73.00, 72.82, 
70.48, 68.18, 59.06 (q, J = 34.5 Hz), 49.85, 48.01, 47.82, 40.53, 40.43, 35.51, 34.38, 
31.85, 29.87, 25.48, 21.10, 8.82; IR (film) 3028, 2929, 2856, 1496, 1454, 1365, 1280, 
1201, 1163, 1112, 966, 916, 734, 696 cm
-1
; HRMS (ESI) m/z calcd. for C35H44F3O5 
[M+H]
+
: 601.3135, found: 601.3132. 
 
In a 2-mL clear glass vial, palladium on carbon (10 wt%, 35.0 mg, 0.0328 
mmol) was added to a solution of alkene (19.7 mg, 0.0328 mmol) in ethyl acetate 
(0.82 mL). Seven of this reaction vial were placed in a hydrogenation bomb and 
stirred at r.t. under 1000 psi H2 for 22 h.  The reaction mixtures were filtered through a 
Celite pad and the filtrates were combined and triturated with 30% ethyl 
acetate/hexanes. A white solid was collected by vacuum filtration and the filtrate was 
 158 
concentrated and purified by column chromatography (50% ethyl acetate/hexanes) to 
afford another crop of white solid. The solids were combined and weighed 89.3 mg 
(92% yield). 
1
H NMR (400 MHz, CD3OD) δ 3.99 – 3.71 (m, 4H), 3.60 – 3.49 (m, 1H), 
3.57 (d, J = 6.5 Hz, 1H), 3.48 – 3.40 (m, 1H), 3.37 (d, J = 6.5 Hz, 1H), 3.28 (s, 3H), 
2.31 – 2.24 (m, 1H), 2.22 – 2.16 (m, 1H), 2.14 (q, J = 7.1 Hz, 1H), 2.03 (dt, J = 10.6, 
2.5 Hz, 1H), 1.98 – 1.90 (m, 1H), 1.77 – 1.56 (m, 5H), 1.59 (d, J = 2.5 Hz, 1H), 1.54 – 
1.36 (m, 3H), 1.22 (d, J = 6.4 Hz, 3H), 0.87 (d, J = 7.1 Hz, 3H); 
13
C NMR (100 MHz, 
CDCl3) δ 124.28 (q, J = 277.6 Hz), 108.35, 81.35, 80.88, 62.20, 59.78 (q, J = 34.3 
Hz), 59.15, 49.97, 49.35, 47.17, 47.15, 41.65, 38.23, 35.42, 34.50, 33.21, 28.81, 27.91, 
21.24, 18.89, 9.07; IR (film) 3373, 2941, 2875, 2499, 1390, 1282, 1159, 1122, 1045, 
983, 970 cm
-1
; HRMS (ESI) m/z calcd. for C21H34F3O5 [M+H]
+
: 423.2353, found: 
423.2346.  
 
In a 2-mL clear glass vial, palladium on carbon (10 wt%, 17.8 mg, 0.0168 
mmol) was added to a solution of diene (10.0 mg, 0.0168 mmol) in ethyl acetate (0.60 
mL).  Five of this vial were placed in a hydrogenation bomb and stirred at r.t. under 
1000 psi H2 for 36 h. The reaction mixtures were filtered through a Celite pad and the 
filtrates were combined, concentrated and purified by column chromatography (70% 
ethyl acetate/hexanes) to afford a white solid (6.5:1 inseparable mixture, 29.7 mg, 
84% yield). Major diastereomer: 
1
H NMR (500 MHz, CD3OD) δ 4.02 (dd, J = 11.0, 
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3.6 Hz, 1H), 3.87 – 3.79 (m, 2H), 3.63 (dq, J = 11.0, 8.5 Hz, 1H), 3.55 (d, J = 6.5 Hz, 
1H), 3.51 (t, J = 6.4 Hz, 2H), 3.40 (d, J = 6.5 Hz, 1H), 3.27 (s, 3H), 2.33 (m, 2H), 2.07 
– 2.00 (m, 1H), 1.97 – 1.84 (m, 3H), 1.83 – 1.56 (m, 4H), 1.70 (d, J = 2.7 Hz, 1H), 
1.53 – 1.34 (m, 3H), 1.23 (d, J = 6.7 Hz, 3H), 0.94 (d, J = 6.7 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 123.90 (q, J = 277.7 Hz), 109.06, 82.95, 81.23, 62.76, 60.30, 60.30 (q, 
J = 34.6 Hz), 49.43, 48.81, 47.22, 47.17, 44.38, 41.96, 38.67, 35.49, 33.13, 29.04, 
28.50, 21.63, 20.77, 7.37; IR (film) 3413, 2944, 2917, 2875, 2514, 1458, 1281, 1163, 
1118, 1093, 1025, 966 cm
-1
;  HRMS (ESI) m/z calcd. for C21H34F3O5 [M+H]
+
: 
423.2353, found: 423.2355. 
 
To a mixture of diol (51.7 mg, 0.122 mmol) and NaHCO3 (51.2 mg, 0.610 
mmol) in CH2Cl2 (4.8 mL) was added Dess–Martin periodinane (129.8 mg, 0.306 
mmol) in one portion at r.t. After stirring for 1.5 h the reaction mixture was filtered 
through a Celite pad. The filtrate was concentrated, then taken up in diethyl ether (50 
mL) and filtered again. The etheral solution was washed with saturated NaHCO3/10% 
Na2S2O3 mixture solution (1:2 v/v, 5 × 6 mL) and brine (10 mL), dried over anhydrous 
Na2SO4, filtered and concentrated. The crude product (50.0 mg) was used directly 
without further purification. 
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A mixture of dialdehyde (50.0 mg, 0.119 mmol) and dibenzylammonium 
trifluoroacetate (40.9 mg, 0.131 mmol) in toluene (2.4 mL) was heated at 55 °C for 16 
h, while the reaction solution turned to light yellow gradually.  After that period of 
time, the reaction was cooled to r.t. and concentrated. The residue was taken up in 
diethyl ether and the solid was filtered off. The filtrate was concentrated again, then 
loaded onto a short silica gel pad and eluted with 30% ethyl acetate/hexanes. The 
eluate was concentrated to afford a colorless oil (50.9 mg), which was used directly in 
the next step. 
 
To a solution of aldehyde (50.9 mg, 0.127 mmol) in CH2Cl2 (2.3 mL) was 
added DIBAL (1.0 M in CH2Cl2, 0.25 mL) dropwise at -78 °C. The reaction was 
stirred at -78 °C for 1.5 h then quenched by 10% Rochelle's salt solution (5.0 mL). 
The mixture was warmed to r.t. and stirred vigorously until two clear layers formed. 
The organic layer was separated and the aqueous layer was extracted with ethyl 
acetate (3 × 10 mL). The combined organic layers were washed with brine (15 mL), 
dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by 
column chromatography (30% ethyl acetate/hexanes) to provide a white solid (31.3 
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mg, 64% yield over 3 steps). 
1
H NMR (400 MHz, CDCl3) δ 5.71 (dp, J = 7.2, 1.5 Hz, 
1H), 4.04 (s, 2H), 3.69 – 3.56 (m, 2H), 3.43 – 3.34 (m, 2H), 3.33 (s, 3H), 2.42 (m, 
1H), 2.38 – 2.30 (m, 1H), 2.36 (s, 1H), 2.27 (dt, J = 11.5, 2.7 Hz, 1H), 2.19 (dd, J = 
7.2, 3.0 Hz, 1H), 2.12 (q, J = 7.2 Hz, 1H), 1.80 – 1.72 (m, 1H), 1.61 (dqd, J = 10.4, 
7.4, 3.3 Hz, 1H), 1.42 – 1.23 (m, 5H), 1.20 (d, J = 7.2 Hz, 3H), 0.98 (d, J = 7.2 Hz, 
3H); 
13
C NMR (125 MHz, CDCl3) δ 142.08, 124.35 (q, J = 278.7 Hz), 116.52, 108.17, 
80.55, 79.56, 66.48, 60.31 (q, J = 34.3 Hz), 50.18, 47.48, 44.65, 43.04, 41.88, 37.29, 
34.86, 29.81, 28.59, 26.86, 25.43, 22.23, 9.17; IR (film) 3427, 2978, 2929, 2891, 
1456, 1386, 1280, 1165, 1151, 1120, 968, 864, 732 cm
-1
; HRMS (ESI) m/z calcd. for 
C21H30F3O4 [M+H]
+
: 403.2091, found: 403.2096. 
 
To an ice-water cooled solution of diol (2.03 g, 7.47 mmol) in CH2Cl2 (30.0 
mL) was added lead (IV) acetate (3.64 g, 8.21 mmol) in portions. After the addition 
was completed, the reaction mixture was allowed to warm to r.t. and stirred for 1.0 h. 
The reaction mixture was poured directly over a silica gel pad, filtered and the filter 
cake was washed with ethyl acetate. The filtrate was concentrated on rotovap and the 
residue was taken up in ether and filtered through a Celite pad and washed with ethyl 
ether. The filtrate was concentrated again on rotovap and then placed under high 
vacuum briefly to remove residual solvents and formaldehyde. The resultant aldehyde 
crude product was used immediately.  
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To a solution of phosphonate
4
 (11.43 g, 41.1 mmol) in THF (10 mL), n-BuLi 
(2.5 M in hexane, 14.9 mL, 37.4 mmol) was added dropwise at -78 °C with stirring. 
After 2.0 h, the aforementioned aldehyde in THF (5.0 mL) was added dropwise and 
the stirring was continued for 6.0 h. The reaction was quenched by saturated NH4Cl 
solution (5 mL), warmed to r.t., diluted with water (10 mL) and extracted with ethyl 
acetate (3 × 15 mL). The combined extracts were washed with brine (20 mL), dried 
over anhydrous Na2SO4, filtered and concentrated. The residue was purified by 
column chromatography (10% ethyl acetate/hexanes to straight ethyl acetate) to afford 
the desired product mixture (colorless oil, 2.24 g, E/Z 1.6:1, yield 82%) and recovered 
phosphonate. The E/Z mixture was further separated by column chromatography (5% 
ethyl ether/hexanes): high Rf fraction, Z isomer, colorless oil, 0.86 g; low Rf fraction, 
E isomer, colorless oil, 1.38 g. 
Z isomer: 
1
H NMR (400 MHz, CDCl3) δ 6.34 (td, J = 1.4, 0.7 Hz, 1H), 5.85 – 
5.71 (m, 2H), 5.01 (ddt, J = 17.1, 2.0, 1.5 Hz, 1H), 4.96 (ddt, J = 10.2, 2.0, 1.2 Hz, 
1H), 4.24 (q, J = 7.1 Hz, 2H), 3.90 (d, J = 1.4 Hz, 2H), 3.39 (dq, J = 7.5, 0.8 Hz, 2H), 
3.31 (s, 3H), 2.37 (ddt, J = 8.7, 6.2, 1.0 Hz, 2H), 2.23 – 2.13 (m, 2H), 1.33 (t, J = 7.1 
Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 167.78, 146.41, 137.81, 136.17, 133.71, 
115.29, 79.41, 75.10, 60.48, 58.24, 35.79, 34.12, 33.31, 14.44; IR (film) 2980, 2927, 
1708, 1639, 1448, 1377, 1201, 1095, 1026, 912, 785 cm
-1 
; HRMS (ESI) m/z calcd. for 
C14H21INaO3 [M+Na]
+
: 387.0428, found: 387.0429. 
E isomer: 
1
H NMR (400 MHz, CDCl3) δ 6.64 (tt, J = 7.5, 0.6 Hz, 1H), 6.40 (td, 
J = 1.3, 0.6 Hz, 1H), 5.84 (ddt, J = 17.1, 10.2, 6.8 Hz, 1H), 5.04 (ddt, J = 17.1, 2.0, 1.5 
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Hz, 1H), 4.97 (ddt, J = 10.2, 2.0, 1.1 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 3.90 (d, J = 1.3 
Hz, 2H), 3.31 (s, 3H), 3.14 (dd, J = 7.5, 0.6 Hz, 2H), 2.54 – 2.45 (m, 2H), 2.25 – 2.15 
(m, 2H), 1.30 (t, J = 7.1 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 167.51, 145.69, 
137.97, 137.21, 134.03, 115.25, 80.49, 74.98, 60.66, 58.11, 34.70, 33.37, 26.72, 14.37; 
IR (film) 2978, 2929, 2819, 1708, 1639, 1448, 1371, 1261, 1199, 1095, 912, 783 cm
-1 
; HRMS (ESI) m/z calcd. for C14H22IO3 [M+H]
+
: 365.0608, found: 365.0603. 
 
To a solution of ester (10.1 g, 27.8 mmol) in CH2Cl2 (200 mL) was added 
DIBAL (1.0 M in CH2Cl2, 69.5 mL) dropwise at -78 °C. The reaction was stirred at -
78 °C for 6.5 h then quenched by 10% Rochelle's salt solution (150 mL), diluted with 
CH2Cl2 (200 mL), warmed to r.t. and stirred vigorously until two clear layers formed. 
The organic layer was separated and the aqueous layer was extracted with ethyl 
acetate (3 × 150 mL). The combined organic layers were washed with brine (200 mL), 
dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by 
column chromatography (10-25% ethyl acetate/hexanes) to provide a colorless oil 
(7.54 g, 83% yield). 
1
H NMR (400 MHz, CDCl3) δ 6.30 (td, J = 1.4, 0.6 Hz, 1H), 5.85 
(ddt, J = 17.1, 10.2, 6.5 Hz, 1H), 5.39 (dddt, J = 7.3, 6.7, 1.2, 0.8 Hz, 1H), 5.06 (ddt, J 
= 17.1, 2.0, 1.5 Hz, 1H), 4.98 (ddt, J = 10.2, 2.0, 1.2 Hz, 1H), 4.07 (dq, J = 6.1, 1.2 
Hz, 2H), 3.89 (d, J = 1.4 Hz, 2H), 3.30 (s, 3H), 3.02 (dq, J = 7.3, 0.8 Hz, 2H), 2.34 – 
2.25 (m, 2H), 2.20 (dddt, J = 8.3, 6.5, 5.7, 1.4 Hz, 2H), 1.33 (t, J = 6.1 Hz, 1H); 
13
C 
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NMR (100 MHz, CDCl3) δ 147.03, 141.10, 138.31, 121.76, 115.11, 79.12, 74.90, 
66.85, 58.08, 33.71, 32.70, 27.84; IR (film) 3385, 2926, 2856, 2819, 1639, 1448, 
1087, 1064, 912 cm
-1 
; HRMS (ESI) m/z calcd. for C12H19INaO2 [M+Na]
+
: 345.0322, 
found: 345.0318. 
 
To an ice-water cooled solution of alcohol (2.39g, 7.42 mmol), phenol (1.57 g, 
8.90 mmol) and triphenylphosphine (2.33 g, 8.90 mmol) in THF (50 mL) was added 
diisopropyl azodicarboxylate (1.73 mL, 8.90 mmol) slowly. After the addition was 
completed, stirring continued for 1.0 h at 0 °C and then the reaction mixture was 
warmed to r.t. naturally and stirred overnight. The reaction was concentrated and the 
residue was taken up in ethyl acetate. After the solid was filtered off, the filtrate was 
concentrated again and the residue was purified by column chromatography (20% 
ethyl acetate/hexanes) to provide a light yellow oil (3.61 g, 98% yield). 
1
H NMR (400 
MHz, CDCl3) δ 7.40 (t, J = 8.4 Hz, 1H), 6.59 (dd, J = 8.4, 0.9 Hz, 1H), 6.54 (dd, J = 
8.4, 0.9 Hz, 1H), 6.31 – 6.26 (m, 1H), 5.87 (ddt, J = 17.1, 10.2, 6.6 Hz, 1H), 5.65 (ddt, 
J = 8.4, 7.3, 1.1 Hz, 1H), 5.07 (ddt, J = 17.1, 2.0, 1.5 Hz, 1H), 4.97 (ddt, J = 10.2, 2.0, 
1.2 Hz, 1H), 4.58 (q, J = 1.1 Hz, 2H), 3.90 (d, J = 1.4 Hz, 2H), 3.30 (s, 3H), 3.07 (d, J 
= 7.3 Hz, 2H), 2.41 (dd, J = 9.2, 6.3 Hz, 2H), 2.34 – 2.20 (m, 2H), 1.70 (s, 6H); 13C 
NMR (100 MHz, CDCl3) δ 160.55, 157.89, 157.85, 146.88, 138.29, 136.23, 136.14, 
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124.26, 115.13, 109.30, 106.96, 105.23, 103.73, 79.06, 74.86, 72.67, 58.14, 33.85, 
32.38, 27.83, 25.74 (2C); IR (film) 3074, 2993, 2927, 2821, 1735, 1606, 1583, 1479, 
1330, 1259, 1203, 1080, 918, 802, 761, 690 cm
-1 
; HRMS (ESI) m/z calcd. for 
C22H28IO5 [M+H]
+
: 499.0976, found: 499.0982. 
 
To a solution of acetonide (4.19 g, 8.41 mmol) in toluene (70 mL) cooled at -
78 °C, DIBAL/PhMe (1.2M, 14.7 mL, 17.7 mmol) was added dropwise. After stirring 
at -78 °C for 3 h, the reaction was quenched by 10% Rochelle's salt solution (100 mL), 
diluted with ethyl acetate (200 mL), warmed to r.t. and vigorously stirred overnight. 
The organic layer was separated and the aqueous layer was extracted with ethyl 
acetate (5 × 100 mL). The combined organic layers were washed with brine (200 mL) 
and dried over anhydrous Na2SO4. After filtration and concentration, the crude product 
was purified by column chromatography (10% ethyl acetate/hexanes) to afford a light 
yellow oil (3.48g, 94% yield). 
1
H NMR (400 MHz, CDCl3) δ 11.95 (s, 1H), 10.37 (d, J 
= 0.6 Hz, 1H), 7.38 (t, J = 8.4, 1H), 6.52 (dt, J = 8.4, 0.8 Hz, 1H), 6.37 (dd, J = 8.4, 
0.8 Hz, 1H), 6.33 (dq, J = 1.3, 0.7 Hz, 1H), 5.85 (ddt, J = 17.1, 10.2, 6.6 Hz, 1H), 5.54 
(ddt, J = 7.3, 6.4, 1.0 Hz, 1H), 5.07 (dq, J = 17.1, 1.6 Hz, 1H), 5.01 (ddt, J = 10.2, 1.9, 
1.2 Hz, 1H), 4.52 (q, J = 1.0 Hz, 2H), 3.88 (d, J = 1.3 Hz, 2H), 3.29 (s, 3H), 3.07 (d, J 
= 7.3 Hz, 2H), 2.42 – 2.33 (m, 2H), 2.31 – 2.19 (m, 2H); 13C NMR (100 MHz, CDCl3) 
δ 194.32, 163.80, 161.75, 146.60, 138.45, 137.84, 136.17, 125.64, 115.49, 111.18, 
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110.05, 102.27, 79.70, 75.01, 72.65, 58.10, 33.86, 32.45, 28.00; IR (film) 3074, 3061, 
2926, 2887, 1639, 1618, 1456, 1240, 1074, 914, 783, 717 cm
-1 
; HRMS (ESI) m/z 
calcd. for C19H23INaO4 [M+Na]
+
: 465.0533, found: 465.0542. 
 
In a high-pressure flask was charged phenol (9.94 g, 22.5 mmol), cesium 
carbonate (7.33 g, 22.5 mmol), 2, 2, 2-trifluoroethyl trifluoromethanesulfonate (4.86 
mL, 33.7 mmol) and dry acetonitrile (112 mL). The flask was flushed with N2 for 5 
minutes, capped and heated at 85 °C (bath temperature) for 2.0 h. The reaction 
solution gradually turned from light yellow to colorless. After cooling to r.t., the 
reaction mixture was diluted with ethyl acetate (150 mL) and filtered through a Celite 
pad. The filtrate was washed with saturated NaHCO3 solution (3 × 100 mL) and brine 
(150 mL), dried over anhydrous Na2SO4 and concentrated. The residue was purified 
by column chromatography (15% ethyl acetate/hexanes) to afford a light yellow oil 
(11.5 g, 98% yield). 
1
H NMR (400 MHz, CDCl3) δ 10.52 (s, 1H), 7.43 (t, J = 8.4 Hz, 
1H), 6.70 (d, J = 8.4, 1H), 6.56 (d, J = 8.4 Hz, 1H), 6.31 (td, J = 1.4, 0.6 Hz, 1H), 5.85 
(ddt, J = 17.1, 10.2, 6.6 Hz, 1H), 5.58 (tt, J = 7.3, 1.1 Hz, 1H), 5.06 (dq, J = 17.1, 1.6 
Hz, 1H), 4.99 (ddt, J = 10.2, 1.9, 1.2 Hz, 1H), 4.54 (q, J = 1.1 Hz, 2H), 4.42 (q, J = 8.1 
Hz, 2H), 3.88 (d, J = 1.4 Hz, 2H), 3.29 (s, 3H), 3.06 (d, J = 7.3 Hz, 2H), 2.42 – 2.34 
(m, 2H), 2.29 – 2.20 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 188.30, 161.38, 159.50, 
146.70, 138.00, 136.15, 135.58, 125.07, 123.25 55 (q, J = 278.72 Hz), 116.08, 115.31, 
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107.77, 106.89, 79.37, 74.92, 72.84, 67.37 (q, J = 35.8 Hz), 58.09, 33.84, 32.36, 
27.84; IR (film) 3076, 2978, 2927, 2877,2823, 2779, 1693, 1598, 1473, 1288, 1246, 
1166, 1122, 777 cm
-1 
; HRMS (ESI) m/z calcd. for C21H24F3INaO4 [M+Na]
+
: 
547.0564, found: 547.0566. 
 
In a high-pressure flask, 10 M sulfuric acid (3.9 mL, 39.3 mmo) was added to a 
suspension of boric acid (1.21 g, 19.6 mmol) in THF (30 mL) with stirring. Heat was 
generated during addition. After the flask had been cooled to r.t. in air, hydrogen 
peroxide (30 wt% in water, 0.98 mL, 8.65 mmol) was added slowly. After stirring at 
r.t. for 1.0 h, phenyl aldehyde (2.06 g, 3.93 mmol) in THF (10 mL) was added. The 
high-pressure flask was capped and immersed in 50 °C oil bath and heated for 4.0h. 
The reaction mixture turned from colorless to light yellow gradually. After the 
reaction was cooled to r.t., ethyl acetate (100 mL) was added and the mixture was 
washed with water (3 × 50 mL) and brine (50 mL). The organic phase was dried over 
anhydrous Na2SO4, filtered and concentrated. The crude product was purified by 
column chromatography (10% ethyl acetate/hexanes) to yield a colorless oil (1.63 g, 
81%). 
1
H NMR (400 MHz, CDCl3) δ 6.74 (dd, J = 8.3, 8.3 Hz, 1H), 6.65 (dd, J = 8.3, 
1.4 Hz, 1H), 6.62 (dd, J = 8.3, 1.4 Hz, 1H), 6.31 (td, J = 1.3, 0.6 Hz, 1H), 5.85 (ddt, J 
= 17.1, 10.2, 6.5 Hz, 1H), 5.57 (s, 1H), 5.51 (tt, J = 7.3, 1.0 Hz, 1H), 5.07 (dq, J = 
17.1, 1.4 Hz, 1H), 5.00 (ddt, J = 10.2, 1.9, 1.1 Hz, 1H), 4.52 (q, J = 1.0 Hz, 2H), 4.43 
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(q, J = 8.3 Hz, 2H), 3.84 (d, J = 1.3 Hz, 2H), 3.27 (s, 3H), 3.05 (d, J = 7.3, 2H), 2.40 – 
2.31 (m, 2H), 2.30 – 2.19 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 146.99, 146.65, 
145.27, 138.00, 136.78, 136.64, 125.52, 123.55 (q, J = 278.72 Hz), 119.21, 115.38, 
110.01, 108.54, 79.46, 74.90, 73.42, 67.84 (q, J = 35.3 Hz), 58.03, 33.87, 32.52, 
27.90; IR (film) 3535, 3076, 2978, 2931, 2823, 1612, 1479, 1280, 1163, 1087, 1031, 
966, 914, 777, 717 cm
-1 
; HRMS (ESI) m/z calcd. for C20H24F3INaO4 [M+Na]
+
: 
535.0564, found: 535.0570. 
 
To a solution of phenol (440.7 mg, 0.860 mmol) and 2,6-lutidine (0.5 mL, 4.30 
mmol)  in 2,2,2-triflouroethanol (76 mL) was added a solution of iodobenzene 
diacetate (290.9 mg, 0.903 mmol) in MeOH (10 mL) dropwise at -40 °C 
(acetonitrile/dry ice bath). After the addition was completed, the reaction was stirred at 
the same temperature for 1.0 h then transferred via cannula to pre-heated (70 °C) 
toluene (340 mL) in a 1 L 3-neck round-bottom flask equipped with a condenser. The 
resultant solution was stirred at 60 °C for 16 h while the reaction solution turned from 
yellow to light yellow gradually. After that period of time, the reaction was cooled to 
r.t., the solvent was removed on rotovap and the residue was placed under vacuum for 
a few hours to remove residual 2, 6-lutidine. Purification of the crude product by 
column chromatography (10-15% ethyl acetate/hexanes) gave a light yellow oil, 298.2 
mg (64% yield). 
1
H NMR (600 MHz, CDCl3) δ 6.27 (m, 2H), 5.77 (ddt, J = 17.1, 10.2, 
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6.3 Hz, 1H), 5.05 (dq, J = 17.1, 1.7 Hz, 1H), 5.00 (dq, J = 10.2, 1.5 Hz, 1H), 4.31 (dq, 
J = 11.3, 8.6 Hz, 1H), 4.13 (dq, J = 11.3, 8.6 Hz, 1H), 4.09 (d, J = 8.3 Hz, 1H), 4.04 
(dd, J = 12.2, 0.9 Hz, 1H), 3.99 (dd, J = 12.2, 1.3 Hz, 1H), 3.85 (d, J = 8.3 Hz, 1H), 
3.53 (s, 3H), 3.26 (s, 3H), 3.14 (dd, J = 5.5, 3.0 Hz, 1H), 2.81 (t, J = 7.1 Hz, 1H), 2.47 
(ddd, J = 15.6, 6.6, 1.3 Hz, 1H), 2.35 (ddd, J = 15.6, 7.7, 1.1 Hz, 1H), 2.11 (dddt, J = 
13.1, 7.8, 6.3, 1.5 Hz, 2H), 1.63 – 1.55 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 
198.95, 146.95, 137.48, 129.97, 128.60, 123.64 (q, J = 277.5 Hz), 115.50, 99.64, 
86.83, 80.72, 78.18, 75.50, 63.59 (q, J = 35.1 Hz), 57.68, 51.93, 50.24, 47.04, 45.38, 
32.53, 30.73, 29.48; IR (film) 3074, 2976, 2937, 2893, 1755, 1641, 1454, 1284, 1161, 
1093, 968, 889, 783, 688 cm
-1 
; HRMS (ESI) m/z calcd. for C21H27F3IO5 [M+H]
+
: 
543.0850, found: 543.0841. 
 
In a high-pressure flask charged with vinyl iodide (600 mg, 1.11 mmol) in 
trifluorotoluene (110 mL) was added triphenylphosphine (349.4 mg, 1.33 mmol) and 
triethylamine (0.77 mL, 5.55 mmol). The solution was purged with N2 for 30 min and 
palladium (II) acetate (24.8 mg, 0.111 mmol) was added. After addition, the solution 
was purged with N2 again for 30 min before the flask was capped and immersed in 
150 °C oil bath. The reaction solution was stirred at 150 °C for 2 h and turned from 
light yellow to yellow over time.  After cooling to r.t. the reaction mixture was filtered 
through a Celite pad and the filtrate was concentrated. The residue was purified by 
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column chromatography (10-15% ethyl acetate/hexanes) to afford two white solids, 
the higher Rf product being exo-olefin 3.63 (257.6 mg, 56% yield) and the lower Rf 
product being endo-olefin 3.64 (50.6 mg, 11% yield).  
Exo-olefin 3.63: 
1
H NMR (400 MHz, CDCl3) δ 5.58 (dq, J = 7.1, 1.5 Hz, 1H), 4.83 
(m, 1H), 4.77 (tt, J = 1.7, 0.9 Hz, 1H), 4.10 (dq, J = 10.7, 8.6 Hz, 1H), 3.89 (d, J = 
12.3 Hz, 1H), 3.86 (dq, J = 10.7, 8.6 Hz, 1H), 3.83 (d, J = 7.4 Hz, 1H), 3.75 (d, J = 
12.3 Hz, 1H), 3.71 (d, J = 7.4 Hz, 1H), 3.59 (s, 3H), 3.29 (s, 3H), 3.21 (dd, J = 11.3, 
2.8 Hz, 1H), 2.79 (ddd, J = 10.9, 7.1, 3.0 Hz, 1H), 2.51 (dt, J = 5.7, 2.5 Hz, 1H), 2.42 
– 2.26 (m, 3H), 2.21 (dd, J = 17.1, 8.1 Hz, 1H), ), 2.08 (dd, J = 13.7, 7.7 Hz, 1H), 1.91 
(d, J = 2.8 Hz, 1H), 1.48 (ddd, J = 13.7, 12.3, 8.3 Hz, 1H); 
13
C NMR (100 MHz, 
CDCl3) δ 204.99, 145.34, 137.70, 123.82 (q, J = 277.6 Hz), 119.42, 113.29, 103.14, 
82.85, 80.05, 76.02, 63.05 (q, J = 34.8 Hz), 58.23, 52.19, 48.39, 45.45, 40.15, 37.72, 
36.11, 28.24, 28.03, 24.88; IR (film) 3072, 2978, 2922, 2873, 1749, 1639, 1462, 1284, 
1161, 1107, 972, 896, 734, 682 cm
-1 
; HRMS (ESI) m/z calcd. for C21H26F3O5 [M+H]
+
: 
415.1727, found: 415.1729. 
Endo-olefin 3.64: 
1
H NMR (400 MHz, CDCl3) δ 5.55 (dt, J = 6.5, 1.6 Hz, 1H), 5.35 
(ddd, J = 4.3, 2.8, 1.5 Hz, 1H), 4.14 (dq, J = 10.7, 8.5 Hz, 1H), 3.89 (d, J = 7.3 Hz, 
1H), 3.88 (dq, J = 10.7, 8.5 Hz, 1H), 3.84 (d, J = 7.3 Hz, 1H), 3.79 (s, 2H), 3.61 (s, 
3H), 3.24 (s, 3H), 2.85 – 2.71 (m, 2H), 2.45 – 2.34 (m, 2H), 2.24 (d, J = 2.8 Hz, 1H), 
2.26 – 2.16 (m, 1H), 2.11 – 2.01 (m, 2H), 1.54 (dt, J = 2.8, 1.5 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 204.66, 138.57, 137.60, 123.82 (q, J = 277.6 Hz), 121.09, 
117.78, 103.15, 82.36, 79.61, 76.01, 63.10 (q, J = 34.8 Hz), 57.33, 52.17, 45.61, 
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44.51, 38.24, 36.84, 36.09, 30.43, 25.01, 24.83; IR (film) 2929, 2845, 1749, 1454, 
1284, 1157, 1107, 1066, 993, 883, 844, 736 cm
-1 
; HRMS (MALDI) m/z calcd. for 
C21H25F3O5Li [M+Li]
+
: 421.1809, found: 421.1804. 
 
In a 4-mL clear vial, palladium on carbon (10 wt%, 6.9 mg, 0.00647 mmol) 
was added to a solution of diene (exo- or endo-olefin form the previous step, 26.8 mg, 
0.0647 mmol) in ethyl acetate (2.0 mL). Six of this vial were placed in a 
hydrogenation bomb and stirred at r.t. under 1000 psi H2 for 8.0 h. The reaction 
mixtures were filtered through a Celite pad and the filtrates were combined and 
concentrated to afford a white solid (161.0 mg, 92% yield). This solid was used 
without further purification. (Note: The hydrogenation of the endo-olefin usually 
requires high pressure, however for the exo-olefin, the pressure requirement varies 
depending on the suppliers and batches of the palladium catalyst. In some cases the 
reaction was conducted under a hydrogen balloon.) 
1
H NMR (600 MHz, CDCl3) δ 
5.76 (dt, J = 7.0, 1.7 Hz, 1H), 4.10 (dq, J = 10.7, 8.6 Hz, 1H), 3.88 (d, J = 12.8, 1H), 
3.79 (dq, J = 10.7, 8.6 Hz, 1H), 3.79 (d, J = 7.3 Hz, 1H), 3.77 (d, J = 12.8, 1H), 3.71 
(d, J = 7.3 Hz, 1H), 3.61 (s, 2H), 3.32 (s, 3H), 2.76 (ddd, J = 10.7, 7.3, 3.1 Hz, 1H), 
2.50 – 2.43 (m, 2H), 2.29 (dd, J = 19.0, 7.7 Hz, 1H), 2.20 (dt, J = 19.0, 1.1 Hz, 1H), 
2.09 (dd, J = 13.5, 6.0 Hz, 1H), 1.83 (d, J = 2.4 Hz, 1H), 1.67 (dddd, J = 12.8, 7.0, 5.8, 
3.7 Hz, 1H), 1.63 – 1.54 (m, 1H), 1.47 – 1.42 (m, 1H), 1.42 – 1.35 (m, 2H), 1.12 (d, J 
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= 7.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 205.88, 137.96, 123.87 (d, J = 277.6 
Hz), 118.91, 103.09, 82.92, 80.72, 76.00, 63.08 (q, J = 34.7 Hz), 58.48, 52.44, 51.13, 
45.58, 37.76, 37.52, 35.94 (2C), 28.87, 25.77, 24.59, 21.18; IR (film) 2980, 2914, 
2875, 2827, 1751, 1284, 1157, 1103, 1070, 975, 885, 732 cm
-1 
; HRMS (MALDI) m/z 
calcd. for C21H27F3O5Li [M+Li]
+
: 423.1965, found: 423.1954. 
 
Magnesium bromide diethyl etherate (1.59 g, 6.16 mmol) in a flask was dried 
by heating gently under vacuum. After the flask was cooled to r.t., anhydrous diethyl 
ether (15 mL) was added. Magnesium bromide dissolved in ether and two layers of 
liquid were resulted. Ketone (854.8 mg, 2.05 mmol) in diethyl ether (25 mL) was then 
added. A white cloudy suspension was formed with a sticky layer of oil on the bottom 
of the flask. The mixture was cooled to 0 °C with vigorous stirring. Grignard reagent 
(3.0 M, 2.06 mL, 6.18 mmol) was added dropwise while the suspension turned to a 
clear solution and the oil layer still existed. After the addition was completed, the 
reaction mixture was warmed to r.t. and stirred for 1.5 h, during that period of time a 
white precipitate formed again and the oil layer gradually disappeared. While the 
reaction was completed it was cooled to 0 °C, quenched by saturated NH4Cl solution 
(30 mL) and diluted with water (30 mL) and ethyl acetate (50 mL). The organic layer 
was separated and the aqueous layer was extracted with ethyl acetate (3 × 50 mL). The 
combined organic layers were washed with brine (50 mL), dried over anhydrous 
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Na2SO4, filtered and concentrated under reduced pressure. The crude product was 
purified by column chromatography (10% ethyl acetate/hexanes) to afford a colorless 
oil (868.8 mg, 98% yield). 
1
H NMR (400 MHz, CDCl3) δ 5.77 (dt, J = 7.2, 1.6 Hz, 
1H), 4.17 (dq, J = 10.8, 8.8 Hz, 1H), 3.86 (ddd, J = 12.5, 1.5, 0.7 Hz, 1H), 3.75 (ddd, J 
= 12.5, 1.5, 0.7 Hz, 1H), 3.57 (d, J = 6.8 Hz, 1H), 3.48 (dq, J = 10.8, 8.8 Hz, 1H), 3.42 
(d, J = 6.8 Hz, 1H), 3.34 (s, 3H), 3.31 (s, 3H), 3.12 (ddt, J = 10.6, 7.4, 3.1 Hz, 1H), 
2.91 (s, 1H), 2.40 – 2.25 (m, 2H), 2.11 – 1.89 (m, 3H), 1.76 – 1.51 (m, 2H), 1.48 (d, J 
= 2.2 Hz, 1H), 1.34 – 1.20 (m, 2H), 1.23 (s, 3H), 1.11 (d, J = 6.9 Hz, 3H); 13C NMR 
(125 MHz, CDCl3) δ 138.88, 124.50 (q, J = 277.5 Hz), 120.44, 106.63, 82.18, 80.98, 
78.53, 76.30, 62.82 (q, J = 33.9 Hz), 58.44, 49.59, 44.29, 44.04, 40.40, 37.87, 36.15, 
28.75, 28.55, 26.12, 25.60, 21.45, 16.92; IR (film) 3552, 2981, 2933, 2912, 2872, 
1463, 1375, 1282, 1165, 1147, 989, 862 cm
-1 
; HRMS (MALDI) m/z calcd. for 
C22H31F3O5Li [M+Li]
+
: 439.2278, found: 439.2275. 
 
Potassium hydride (30 wt% in mineral oil, 1.06 g, 7.95 mmol) was washed 
with dry pentane three times under N2 then suspended in THF (10 mL). Alcohol (0.86 
g, 1.99 mmol) in THF (10 mL) was added dropwise at 0 °C. After stirring at 0 °C for 
2.0 h, freshly distilled carbon disulfide (1.20 mL, 19.9 mmol) was added dropwise. 
The reaction was stirred at 0 °C for 1.0 h and r.t. 6.0h.  After that period of time, the 
reaction was cooled to 0 °C again and methyl iodide (1.24 mL, 19.9 mmol) was added 
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dropwise. The resultant mixture was allowed to warm up to r.t. and stirred for 12 h. 
The reaction was quenched by water (10 mL) at 0 °C and diluted with ethyl acetate 
(20 mL). The organic layer was separated and the aqueous layer was extracted with 
ethyl acetate (3 × 15 mL). The combined organic layers were washed with brine (20 
mL), dried over anhydrous Na2SO4, filtered and concentrated.  
The crude product from the previous operation was dissolved in toluene (200 
mL, 0.01 M) and heated at 110 °C for 2.0 h. After cooling to r.t. the reaction mixture 
was concentrated. The residue was purified by column chromatography (10% ethyl 
acetate/hexanes) to afford a light yellow solid (0.65 g, 79% yield over 2 steps). (Note: 
To assure the success of the subsequent iridium catalyzed hydrogenation, this solid 
should be further purified by trituration with hexanes and filtration to remove the tiny 
amount of colored impurities.) 
1
H NMR (400 MHz, CDCl3) δ 5.76 (dt, J = 7.5, 1.4 Hz, 
1H), 5.53 (d, J = 1.1 Hz, 1H), 5.14 (t, J = 0.9 Hz, 1H), 3.94 (dq, J = 10.8, 8.8 Hz, 1H), 
3.91 (d, J = 12.5 Hz, 1H), 3.75 (d, J = 12.5Hz, 1H), 3.70 (dq, J = 10.8, 8.8 Hz, 1H), 
3.66 (d, J = 7.1 Hz, 1H), 3.52 (d, J = 7.1 Hz, 1H), 3.39 (s, 3H), 3.30 (s, 3H), 2.48 – 
2.39 (m, 1H), 2.32 – 2.12 (m, 4H), 2.03 (dd, J = 13.2, 5.5 Hz, 1H), 1.71 (d, J = 2.2 Hz, 
1H), 1.68 – 1.50 (m, 2H), 1.44 – 1.25 (m, 2H),1.07 (d, J = 6.7 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 149.23, 135.85, 124.15 (q, J = 277.3 Hz), 122.80, 106.65, 105.52, 
82.11, 79.29, 76.29, 61.60 (q, J = 34.3 Hz), 57.82, 49.53, 46.57, 44.69, 41.17, 38.40, 
37.42, 36.78, 29.00, 26.06, 24.84, 21.30; IR (film) 2980, 2916, 2873, 1276, 1161, 
1103, 1083, 964, 866 cm
-1 
; HRMS (ESI) m/z calcd. for C22H30F3O4 [M+H]
+
: 
415.2091, found: 415.2086. 
 175 
 
To a solution of diene (464.0 mg, 1.12 mmol) in CH2Cl2 (11.2 mL), iridium 
catalyst
3
 (16.9 mg, 0.0112 mmol) was added in one portion. Hydrogen was bubbled 
into the resultant pink solution for 5.0 min. The color was quickly discharged and the 
solution turned to light yellow. The reaction was stirred at r.t. under H2 balloon for 22 
h. After removal of solvent, the residue was purified by column chromatography (15% 
ethyl acetate/hexanes) to afford a white solid (439.4 mg, 94% yield). 
1
H NMR (500 
MHz, CDCl3) δ 5.76 (dt, J = 7.2, 1.5 Hz, 1H), 3.88 (d, J = 12.1 Hz, 1H), 3.74 (d, J = 
12.1 Hz, 1H), 3.72 (dq, J = 10.8, 8.8 Hz, 1H), 3.63 (dq, J = 10.8, 8.8 Hz, 1H), 3.58 (d, 
J = 6.9 Hz, 1H), 3.40 (d, J = 6.9 Hz, 1H), 3.33 (s, 3H), 3.29 (s, 3H), 2.56 (ddd, J = 
10.5, 7.2, 2.8 Hz, 1H), 2.28 (ddd, J = 11.3, 3.5, 2.1 Hz, 1H), 2.19 (q, J = 7.2 Hz, 1H), 
2.15 – 2.08 (m, 3H), 1.95 (dd, J = 13.4, 6.3 Hz, 1H), 1.74 – 1.62 (m, 1H), 1.58 (dddd, 
J = 12.5, 7.0, 5.5, 3.5 Hz, 1H), 1.41 (d, J = 2.1 Hz, 1H), 1.37 – 1.18 (m, 2H), 1.09 (d, J 
= 7.0 Hz, 3H), 0.97 (d, J = 7.2 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 135.87, 
124.18 (q, J = 277.7 Hz), 123.50, 107.97, 81.39, 79.85, 76.45, 60.58 (q, J = 34.4 Hz), 
57.83, 49.98, 46.49, 44.15, 43.46, 39.06, 37.46, 36.06, 33.16, 28.19, 26.21, 25.25, 
21.40, 9.02; IR (film) 2980, 2926, 2875, 1463, 1384, 1280, 1161, 1109, 1020, 862, 
678 cm
-1 
; HRMS (ESI) m/z calcd. for C22H32F3O4 [M+H]
+
: 417.2247, found: 
417.2250. 
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To a solution of diene (138.2 mg, 0.334 mmol) in CH2Cl2 (6.7 mL) Crabtree 
catalyst (13.4 mg, 0.0167 mmol) was added in one portion. Hydrogen was bubbled 
into the resultant pink solution for 5.0 min. The color was quickly discharged and the 
solution turned to bright yellow. The reaction was stirred at r.t. under H2 balloon for 2 
h. After concentration, the residue was purified by column chromatography (15% 
ethyl acetate/hexanes) to afford two white solids: 3.69 (higher Rf, 74.5 mg, 54% yield) 
and 3.68 (lower Rf, 60.2 mg, 43% yield). Undesired diastereomer 3.69: 
1
H NMR (600 
MHz, CDCl3) δ 5.73 (dt, J = 6.9, 1.6 Hz, 1H), 3.85 (d, J = 12.7 Hz, 1H), 3.74 (d, J = 
12.7 Hz, 1H), 3.59 (d, J = 6.9 Hz, 1H), 3.54 (dq, J = 10.1, 8.3 Hz, 1H), 3.45 (d, J = 6.9 
Hz, 1H), 3.39 (dq, J = 10.1, 8.3 Hz, 1H), 3.30 (s, 3H), 3.30 (s, 3H), 2.36 (ddd, J = 
10.4, 6.8, 3.0 Hz, 1H), 2.33 – 2.25 (m, 2H), 2.11 (dd, J = 7.6, 3.1 Hz, 1H), 2.05 (d, J = 
18.6 Hz, 1H), 1.97 (m, 2H), 1.64 – 1.56 (m, 2H), 1.51 (d, J = 2.2 Hz, 1H), 1.35 – 1.24 
(m, 2H), 1.10 (d, J = 6.6 Hz, 3H), 0.95 (d, J = 6.8 Hz, 3H); 
13
C NMR (125 MHz, 
CDCl3) δ 139.08, 124.18 (q, J = 277.6 Hz), 119.84, 108.96, 82.07, 78.44, 76.15, 60.94 
(q, J = 34.3 Hz), 58.28, 49.20, 45.14, 43.60, 43.47, 38.99, 37.51, 36.29, 36.07, 28.93, 
26.19, 25.35, 21.39, 6.89; IR (film) 2981, 2911, 2875, 2829, 1462, 1451, 1279, 1165, 
1130, 1120, 1088, 1013, 970 cm
-1 
; HRMS (ESI) m/z calcd. for C22H32F3O4 [M+H]
+
: 
417.2247, found: 417.2242.  
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A high-pressure tube charged with a solution of vinyl ether (110 mg, 0.264 
mmol) in benzene (5.0 mL), selenium dioxide (146.5 mg, 1.32 mmol) and pyridine 
(0.21 mL, 2.64 mmol) was sealed and heated to 80 °C. The reaction solution turned 
from colorless to light yellow and a pink precipitate formed on the flask wall and 
turned black over time. After 42 h the reaction mixutre was cooled to r.t. and filtered 
through a Celite pad. The filtrate was concentrated and purified by column 
chromatography (20% ethyl acetate/hexanes) to afford a white solid (101.8 mg, 96% 
yield). 
1
H NMR (600 MHz, CDCl3) δ 9.48 (s, 1H), 7.00 (dt, J = 7.3, 1.8 Hz, 1H), 3.69 
(dq, J = 11.0, 8.4 Hz, 1H), 3.63 (d, J = 7.1 Hz, 1H), 3.57 (dq, J = 10.9, 8.5 Hz, 1H), 
3.44 (d, J = 7.2 Hz, 1H), 3.35 (s, 3H), 2.84 (ddd, J = 11.1, 7.3, 3.2 Hz, 1H), 2.50 – 
2.44 (m, 2H), 2.28 (ddt, J = 19.5, 7.6, 1.1 Hz, 1H), 2.25 – 2.19 (m, 2H), 1.97 – 1.89 
(m, 1H), 1.62 (ddt, J = 14.3, 7.0, 3.7 Hz, 1H), 1.47 (d, J = 2.1 Hz, 1H), 1.38 – 1.19 (m, 
3H), 1.10 (d, J = 7.1 Hz, 3H), 0.99 (d, J = 7.1 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 
192.87, 150.60, 142.77, 123.90 (q, J = 277.7 Hz), 107.71, 81.20, 79.90, 60.45 (q, J = 
34.6 Hz), 50.09, 46.26, 44.17, 43.29, 38.08, 37.23, 36.92, 34.82, 27.96, 26.09, 21.62, 
21.11, 8.95; IR (film) 2981, 2933, 2877, 1678, 1282, 1163, 1147, 1111, 1018, 731 cm
-
1 
; HRMS (ESI) m/z calcd. for C21H28F3O4 [M+H]
+
: 401.1934, found: 401.1936. 
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To a  solution of aldehyde (156.6 mg, 0.391 mmol) in toluene (7.8 mL) was 
added DIBAL (1.0 M in toluene, 0.59 mL) dropwise at -78 °C. The reaction was 
stirred at -78 °C for 1.0 h then quenched by 15% Rochelle's salt solution (10 mL). The 
mixture was diluted with ethyl acetate (10 mL), warmed to r.t. and stirred vigorously 
until two clear layers formed. The organic layer was separated and the aqueous layer 
was extracted with ethyl acetate (3 × 10 mL). The combined organic layers were 
washed with brine (15 mL), dried over anhydrous Na2SO4, filtered and concentrated. 
The residue was purified by column chromatography (30% ethyl acetate/hexanes) to 
afford a white solid (151.3 mg, 96% yield). 
1
H NMR (600 MHz, CDCl3) δ 5.79 (dt, J 
= 6.9, 1.5 Hz, 1H), 4.08 – 3.97 (m, 2H), 3.70 (dq, J = 10.9, 8.5 Hz, 1H), 3.62 (dq, J = 
10.9, 8.5 Hz, 1H), 3.59 (d, J = 6.9 Hz, 1H), 3.41 (d, J = 6.9 Hz, 1H), 3.34 (s, 3H), 2.55 
(ddd, J = 10.7, 7.1, 2.8 Hz, 1H), 2.29 (dt, J = 11.2, 2.7 Hz, 1H), 2.22 – 2.11 (m, 4H), 
1.96 (dd, J = 13.7, 6.3 Hz, 1H), 1.70 – 1.54 (m, 2H), 1.42 (d, J = 2.1 Hz, 1H), 1.37 – 
1.24 (m, 3H), 1.09 (d, J = 6.9 Hz, 3H), 0.97 (d, J = 7.1 Hz, 3H); 
13
C NMR (125 MHz, 
CDCl3) δ 138.42, 124.26 (q, J = 277.8 Hz), 121.84, 108.07, 81.41, 79.79, 66.78, 60.60 
(q, J = 34.2 Hz), 50.05, 46.42, 44.11, 43.62, 38.89, 37.47, 36.01, 33.04, 28.22, 26.35, 
24.81, 21.45, 9.04; IR (film) 3429, 2980, 2929, 2875, 1463, 1280, 1161, 1116, 1055, 
1037, 1018, 862, 734 cm
-1 
; HRMS (ESI) m/z calcd. for C21H30F3O4 [M+H]
+
: 
403.2091, found: 403.2089. 
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A mixture of allylic alcohol (82.2 mg, 0.204 mmol), NaHCO3 (51.4 mg, 0.612 
mmol) in CH2Cl2 (4.0 mL) was cooled to 0 °C, to which m-CPBA (70-75 wt% in 
water, 75.6 mg, 0.306 mmol) was added in one portion. The reaction was allowed to 
warm to r.t. naturally and stirred for total 15 h. After that period of time, the reaction 
mixture became cloudy, and then water (2 mL) and ethyl acetate (10 mL) were added. 
The organic phase was separated and washed with saturated NaHSO3 (3 × 2 mL), 
saturated NaHCO3 (3 × 2 mL) and brine (2 mL), dried over anhydrous Na2SO4, 
filtered and concentrated. The crude product was purified by column chromatography 
(50% ethyl acetate/hexanes) to afford a white solid (75.8 mg, 89% yield). 
1
H NMR 
(500 MHz, CDCl3) δ 3.82 (dd, J = 12.7, 2.4 Hz, 1H), 3.77 – 3.59 (m, 4H), 3.51 (d, J = 
6.9 Hz, 1H), 3.35 (d, J = 6.9 Hz, 1H), 3.32 (s, 3H), 2.70 (dt, J = 10.8, 2.7 Hz, 1H), 
2.41 (dt, J = 10.8, 2.4 Hz, 1H), 2.12 (q, J = 7.2 Hz, 1H), 2.00 (dd, J = 16.0, 6.8 Hz, 
1H), 1.96 – 1.89 (m, 2H), 1.86 – 1.75 (m, 3H), 1.69 – 1.47 (m, 3H), 1.47 – 1.44 (m, 
1H), 1.21 (d, J = 7.2 Hz, 3H), 1.03 (d, J = 7.3 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 
124.21 (q, J = 278.1 Hz), 107.00, 81.22, 81.00, 63.38, 60.20 (q, J = 34.7 Hz), 58.36, 
56.38, 50.12, 49.06, 44.14, 44.01, 39.52, 37.27, 34.17, 32.38, 27.00, 26.90, 23.21, 
21.70, 8.97; IR (film) 3449, 2932, 2880, 1736, 1464, 1279, 1166, 1149, 1118, 1049, 
1012, 964, 931, 782 cm
-1 
; HRMS (ESI) m/z calcd. for C21H30F3O5 [M+H]
+
: 419.2040, 
found: 419.2032. 
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To a solution of alcohol (75.8 mg, 0.181 mmol) in THF (3.6 mL) 
triphenylphosphine (71.1 mg, 0.272 mmol), imidazole (24.4 mg, 0.363 mmol) and 
iodine (69.1 mg, 0.272 mmol) were added in sequence. The reaction mixture were 
stirred at 65 °C for 16 h then cooled to r.t. and diluted with ethyl acetate (10 mL). 
After washing with 10% Na2S2O3 (5 mL) and brine (5 mL) the solution was dried over 
anhydrous Na2SO4, filtered and concentrated. Purification of the crude product by 
column chromatography (20% ethyl acetate/hexanes) gave a white solid (90.0 mg, 
94% yield). 
1
H NMR (400 MHz, CDCl3) δ 3.80 – 3.57 (m, 5H), 3.51 (d, J = 6.9 Hz, 
1H), 3.39 – 3.32 (m, 1H), 3.31 (s, 3H), 3.10 (d, J = 10.1 Hz, 1H), 2.59 (dt, J = 10.9, 
2.7 Hz, 1H), 2.41 (dt, J = 10.8, 2.4 Hz, 1H), 2.31 – 2.20 (m, 1H), 2.10 (q, J = 7.2 Hz, 
1H), 2.00 – 1.74 (m, 3H), 1.74 – 1.59 (m, 1H), 1.58 – 1.42 (m, 3H), 1.23 (d, J = 7.2 
Hz, 3H), 1.01 (d, J = 7.2 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 124.14 (q, J = 278.3 
Hz), 106.94, 81.11, 80.26, 63.74, 60.26 (q, J = 34.7 Hz), 55.97, 50.16, 49.06, 44.10, 
44.08, 40.16, 37.34, 34.02, 33.61, 27.43, 27.11, 26.81, 21.80, 15.12, 9.05; IR (film) 
2975, 2932, 2878, 1462, 1279, 1150, 1116, 1014, 965, 732 cm
-1 
; HRMS (ESI) m/z 
calcd. for C21H29F3IO4 [M+H]
+
: 529.1057, found: 529.1058. 
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In a high-pressure tube a mixture of epoxide (90.0 mg, 0.170 mmol), zinc 
powder (111.0 mg, 1.70 mmol, used as received from commercial supplier and no 
further treatment) in MeOH (8.5 mL) was heated at 65 °C for 20 h then cooled to r.t. 
The unreacted zinc solid was filtered off over a Celite pad and the filtrate was 
concentrated then purified by column chromatography (15% ethyl acetate/hexanes) to 
afford a white solid (68.4 mg, 99% yield). 
1
H NMR (600 MHz, CDCl3) δ 5.32 (s, 1H), 
5.12 (s, 1H), 4.78 (d, J = 11.7 Hz, 1H), 3.79 (dq, J = 11.0, 8.3 Hz, 1H), 3.66 (dq, J = 
11.0, 8.3 Hz, 1H), 3.51 (d, J = 6.9 Hz, 1H), 3.37 (d, J = 6.9 Hz, 1H), 3.31 (s, 2H), 3.06 
(d, J = 11.7 Hz, 1H), 2.71 (dq, J = 18.8, 1.8 Hz, 1H), 2.67 – 2.59 (m, 1H), 2.51 (dd, J 
= 12.2, 3.1 Hz, 1H), 2.37 (dt, J = 12.2, 2.4 Hz, 1H), 2.17 (q, J = 7.2 Hz, 1H), 2.07 – 
2.02 (m, 1H), 1.98 – 1.90 (m, 1H), 1.77 – 1.62 (m, 2H), 1.47 – 1.39 (m, 1H), 1.45 (d, J 
= 2.0 Hz, 1H), 1.33 (ddd, J = 14.0, 12.0, 6.9 Hz, 1H), 1.22 (d, J = 6.9 Hz, 3H), 1.01 (d, 
J = 7.2 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 146.94, 123.94 (q, J = 277.9 Hz), 
114.97, 107.79, 83.16, 80.80, 68.70, 59.95 (q, J = 34.8 Hz), 50.14, 48.61, 43.77, 
43.50, 40.32, 39.24, 37.66, 34.38, 28.61, 27.39, 26.35, 21.74, 9.05; IR (film) 3564, 
2926, 2881, 2858, 1454, 1282, 1273, 1165, 1109, 1024, 979, 678 cm
-1 
; HRMS (ESI) 
m/z calcd. for C21H30F3O4 [M+H]
+
: 403.2090, found: 403.2091. 
 182 
 
A mixture of allylic alcohol (15.0 mg, 0.0373 mmol), pyridine (0.03 mL, 0.373 
mmol) and selenium dioxide (20.7 mg, 0.186 mmol) in p-dioxane (1.2 mL) was heated 
to 90 °C and stirred for 16 h. After cooling to r.t., the reaction mixture was filtered 
through a Celite pad and the filtrate was concentrated. The residue was dissolved in 
ethyl acetate (10 mL) and washed with saturated NaHCO3 (3 × 5 mL) and brine (5 
mL). The organic phase was dried over anhydrous Na2SO4, filtered and concentrated 
to afford the aldehyde product. The aqueous phase was acidified to pH 1.0 by 1 N 
HCl, and then extracted with ethyl acetate (3 × 10 mL). The extracts were combined 
and washed with brine (10 mL), dried over anhydrous Na2SO4, filtered and 
concentrated to afford the acid product. Both crude products were converted to alcohol 
and purified afterward. 
 
The aforementioned crude aldehyde was dissolved in CH2Cl2 (0.30 mL) and 
cooled to -78 °C, DIBAL (1.0 M in CH2Cl2, 0.11 mL) was added dropwise. The 
reaction was stirred at -78 °C for 2 h then quenched by 10% Rochelle's salt solution (1 
mL). The mixture was diluted with ethyl acetate (5 mL), warmed to r.t. and stirred 
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vigorously until two clear layers formed. The organic layer was separated and the 
aqueous layer was extracted with ethyl acetate (3 × 2 mL). The combined organic 
layers were washed with brine (3 mL), dried over anhydrous Na2SO4, filtered and 
concentrated. The residue was purified by flash column chromatography (40% ethyl 
acetate/hexanes) to provide a colorless oil (3.2 mg, 20% yield over 2 steps). 
1
H NMR 
(500 MHz, CDCl3) δ 5.80 (d, J = 7.2 Hz, 1H), 4.56 (d, J = 11.4 Hz, 1H), 4.30 (m, 2H), 
3.71 – 3.60 (dq, J = 10.7, 8.4 Hz, 1H), 3.62 (d, J = 7.1 Hz, 1H), 3.47 (dq, J = 10.7, 8.4 
Hz, 1H), 3.33 (d, J = 7.1 Hz, 1H), 3.32 (s, 3H), 3.03 (d, J = 11.4 Hz, 1H), 2.56 – 2.46 
(m, 2H), 2.36 (dt, J = 11.9, 2.6 Hz, 1H), 2.26 (dd, J = 7.2, 2.9 Hz, 1H), 2.18 (q, J = 7.2 
Hz, 1H), 1.80 – 1.58 (m, 2H), 1.45 – 1.37 (m, 2H), 1.36 – 1.26 (m, 2H), 1.23 (d, J = 
7.2 Hz, 3H), 1.03 (d, J = 7.2 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 142.21, 123.91 
(q, J = 277.6 Hz), 119.12, 107.66, 81.60, 80.29, 67.43, 65.33, 59.68 (q, J = 34.7 Hz), 
50.23, 49.05, 44.03, 42.87, 42.19, 40.61, 37.03, 33.62, 28.26, 26.88, 22.16, 9.16; IR 
(film) 3553, 3441, 2975, 2927, 2878, 1281, 1165, 1110, 1017, 733 cm
-1 
; HRMS (ESI) 
m/z calcd. for C21H30F3O5 [M+H]
+
: 419.2039, found: 419.2043. 
 
The aforementioned crude acid was dissolved in methanol (0.30 mL) and 
cooled to 0 °C, and then trimethylsilyldiazomethane (2.0 M in diethyl ether, 0.10 mL) 
was added dropwise. The reaction was stirred at 0 °C for 1 h then diluted with ethyl 
acetate and concentrated in vacuo. The residue was re-dissolved in CH2Cl2 (0.30 mL) 
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and cooled to -78 °C, DIBAL (1.0 M in CH2Cl2, 0.20 mL) was added dropwise. The 
reaction was stirred at -78 °C for 2 h then warmed to 0 °C and stirred for 1 h. The 
reaction was quenched by 10% Rochelle's salt solution (1 mL), diluted with ethyl 
acetate (5 mL), warmed to r.t. and stirred vigorously until two clear layers formed. 
The organic layer was separated and the aqueous layer was extracted with ethyl 
acetate (3 × 2 mL). The combined organic layers were washed with brine (3 mL), 
dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by 
flash column chromatography (40% ethyl acetate/hexanes) to provide the same 
alcohol (4.4 mg, 28% yield over 3 steps). 
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Table A2.1. 2D-NMR Data of Compound 3.17 
 
 
 
 
 
 
 
Position δ 13C 
(ppm) 
δ 1H 
(ppm) 
Type COSY correlations HMBC correlations ROESY correlations 
1 104.5  Cq    
2a 80.9 3.84 CH2 H-2b C-1, C-3, C-4, C-5 H-4 
2b  3.74 CH2 H-2a C-3, C-4 H-5, H-10b 
3 41.0  Cq    
4 42.2 2.55 CH H-17a  H-2a, H-14b, H-17b 
5 48.0 2.24 CH H-6 C-1, C-4, C-7, C-9 H-2b, H-6 
6 36.4 3.23 CH H-5, H-7  H-5, H-13 
7 14.6 0.81 CH H-4, H-6  H-6 
8 122.1  Cq    
9 201.4  Cq    
10a 29.3 3.12 CH2 H-10b, H-11  H-10b, H-11 
10b  2.31 CH2 H-10a, H-11, H-13  H-10a 
11 117.7 6.05 CH H-10a, H-10b, H-13  H-10a, H-10b, H-13 
12 86.3  Cq    
13 26.3 2.12 CH3 H-11 C-6, C-11, C-12 H-6, H-11 
14a 61.5 3.86 CH2 H-14b C-8, C-15 H-14b 
14b  3.33 CH2 H-14a C-8, C-15 H-4, H-14a 
15 123.9  Cq    
16 52.2 3.54 CH3  C-1 H-5 
17a 69.9 5.72 CH2 H-4, H-17b C-3, C-4 H-10a, H-17b 
17b  3.92 CH2 H-17a  H-4, H-11, H-14b, H-18b 
18a 73.4 4.91 CH2 H-18b C-17, C-19, C-20 H-17a, H-18b 
18b  4.64 CH2 H-18a C-17, C-19, C-20 H-17a, H-17b, H-18a 
19 138.1  Cq    
20 127.5 7.39 CH  C-19 H-18b 
21 128.5 7.37 CH    
22 128.3 7.36 CH    
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23 129.7  Cq    
23 128.2 7.32 CH H-25, H-26 C-25, C-26 H-13 
25 134.8 7.61 CH H-24, H-26 C-26 H-7, H-13, H-17a, H-17b 
26 130.6 7.41 CH H-24, H-25 C-25  
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Table A2.2. 2D-NMR Data of Compound 3.18 
 
 
 
 
 
Position δ 13C 
(ppm) 
δ 1H 
(ppm) 
Type COSY correlations HMBC correlations ROESY correlations 
1 103.4  Cq    
2a 82.0 3.90 CH2 H-2b C-1, C-4, C-5 H-4 
2b  3.79 CH2 H-2a C-3, C-4 H-5, H-10b 
3 42.1  Cq    
4 43.7 2.47 CH H-7, H-19a, H-19b  H-2a, H-16b, H-19a 
5 45.4 2.25 CH H-6 C-3, C-4 H-2b, H-6, H-18 
6 35.3 2.70 CH H-5, H-7  H-5, H-13 
7 46.4 2.80 CH H-4, H-6, H-14  H-15a 
8 78.8  Cq    
9 203.2  Cq    
10a 29.8 2.62 CH2 H-10b, H-11, H-13  H-10b, H-19b 
10b  2.07 CH2 H-10a, H-13  H-2b, H-10a 
11 123.7 5.55 CH H-10a, H-13  H-10a, H-10b, H-13 
12 134.9  Cq    
13 25.2 1.71 CH3 H-10a, H-10b, H-11 C-6, C-11, C-12 H-6, H-11, H-14 
14 133.6 5.34 CH H-7, H-15a, H-15b  H-19b 
15a 120.9 5.17 CH2 H-14, H-15b  H-7 
15b  5.15 CH2 H-14, H-15a C-7  
16a 61.7 4.20 CH2 H-16b   
16b  3.97 CH2 H-16a  H-4 
17 123.7  Cq    
18 52.0 3.59 CH3  C-1  
19a 68.2 3.67 CH2 H-4, H-19b C-3 H-4, H-20b 
19b  3.56 CH2 H-4, H-19a C-4, C-8 H-10a, H-14, H-2a 
20a 73.1 4.48 CH2 H-20b, H-23 C-19, C-21, C-22 H-19a 
20b  4.46 CH2 H-20a, H-23 C-19, C-21, C-22 H-19b 
21 138.0  Cq    
22 127.9 7.30 CH H-20b, H-23 C-23  
23 128.5 7.35 CH H-22, H-24 C-21, C-24  
24 127.9 7.31 CH H-23   
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Table A2.3. 2D-NMR Data of Compound 3.28 
 
 
 
 
 
 
Position δ 13C 
(ppm) 
δ 1H 
(ppm) 
Type COSY correlations HMBC correlations NOESY correlations 
1 108.77  Cq    
2a 81.06 3.54 CH2 H-2b C-9, C-3, C-8 H-15, H-81, H-4 
2b  3.77  H-2a C-1, C-9, C-3 H-8b, H-10, H-9 
3 39.00  Cq    
4 40.14 1.88 CH H-5 C-1, C-2, C-11, C-10, C-4, 
C-3, C-5, C-8 
H-2a, H-15, H-5 
5 34.78 2.42 CH H-7, H-12, H-8a, H-17  H-17, H-4 
6 136.05  Cq    
7 122.26 5.44 CH H-8b, H-8a, H-17  H-28a, H-8b, H-8a, H-17 
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8a 29.77 2.01 CH2 H-7, H-5, H-17  H-7, H-2a 
8b  2.43   C-6, C-7, C-11, C-4, C-3, 
C-17 
H-7, H-28a 
9 47.97 2.12 CH H-28a, H-28b, H-12 C-2, C-11, C-10, C-4, C-3 H-2b 
10 47.66 2.24 CH H-16 C-1, C-11, C-9, C-4, C-3, 
C-16 
H-13b, H-9, H-16 
11 77.01  Cq    
12 38.97 2.72 CH H-18, H-5, H-9 C-6, C-19, C-18, C-11, C-
10, C-5 
H-19, H-18, H-5, H-16 
13a 59.23 3.55 CH2  C-14 H-10 
13b  3.61   C-14 H-10, H-16 
14 124.03  Cq    
15 49.87 3.32 CH3  C-1 H-4, H-16 
16 9.07 0.96 CH3 H-10 C-1, C-11, C-10 H-13b, H-15, H-12,H- 5, 
H-10 
17 25.26 1.66 CH3 H-7, H-5, H-8a C-6, C-7, C-5 H-7, H-18, H-5 
18 130.47 5.27 CH H-19, H-20a, H-20b, 
H-12 
C-20, C-12, C-5 H-20a, H-20b, H-28b, H-
28a, H-12, H-17 
19 131.73 5.62 CH H-18, H-20a, H-20b, 
H-12 
C-20, C-12 H-12 
20a 70.42 3.96 CH2 H-19, H-18 C-19, C-18, C-21 H-18, H-19 
20b  4.02  H-19. H-18 C-19, C-18, C-21 H-18, H-19 
21a 71.08 4.42 CH2  C-22, C-23, C-27, C-20 H-23, H-27, H-20a, H-
20b 
21b  4.49   C-22, C-23, C-27, C-20 H-23, H-27, H-20a, H-
20b 
22 138.94  Cq    
23 127.50 7.34 CH    
24 128.50  CH    
25 127.50  CH    
26 128.50  CH    
27 127.50 7.34 CH    
28a 68.32 3.36 CH2 H-9, H-28b C-29, C-9, C-3 H-18, H-29a, H-29b, H-9 
28b  3.5  H-9, H-28a C-11, C-29, C-9, C-3 H-18, H-29a, H-29b, H-9, 
H-8b 
29a 73.11 4.37 CH2  C-30, C-31, C-35, C-28 H-31, H-35, H-28a, H-
28b 
29b  4.44   C-30, C-31, C-35, C-28 H-31, H-35, H-28a, H-
28b 
30 138.07  Cq    
31 127.77 7.26 CH    
32 127.86  CH    
33 127.77  CH    
34 127.86  CH    
35 127.77 7.26 CH    
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APPENDIX 3 
A3.1 Experimental Procedures for Chapter 4  
 
A mixture of acetal (0.35 g, 0.841 mmol) and lithium tetrafluoroborate (0.39 g, 
4.160 mmol) in 2% H2O/CH3CN (42 mL) was heated at 83 °C for 24 h. The reaction 
mixture was cooled to r.t., diluted with ethyl acetate (100 mL) and washed with 
saturated NaHCO3 solution (3 × 30 mL) and brine (30 mL). The organic phase was 
dried over anhydrous Na2SO4, filtered and concentrated. The resultant solid was 
triturated with 15% ethyl acetate/hexanes to give a white solid (0.34 g), which was 
used without further purification. 
1
H NMR (500 MHz, CDCl3) δ 5.83 (dt, J = 7.3, 1.6 
Hz, 1H), 3.91 (d, J = 12.2 Hz, 1H), 3.79 (d, J = 12.2 Hz, 1H), 3.80 – 3.66 (m, 2H), 
3.32 (s, 3H), 3.29 (d, J = 4.0 Hz, 2H), 2.71 (ddd, J = 10.7, 7.1, 3.1 Hz, 1H), 2.62 (q, J 
= 7.3 Hz, 1H), 2.35 (dt, J = 4.8, 3.3 Hz, 1H), 2.22 – 2.18 (m, 2H), 2.10 (ddd, J = 11.2, 
3.7, 1.9 Hz, 1H), 1.94 – 1.77 (m, 3H), 1.68 (m, 2H), 1.34 (dt, J = 13.4, 6.8 Hz, 1H), 
1.23 (ddd, J = 14.3, 12.2, 7.6 Hz, 1H), 1.16 (d, J = 7.3 Hz, 3H), 1.09 (d, J = 7.1 Hz, 
3H); 
13
C NMR (125 MHz, CDCl3) δ 216.02, 136.75, 124.06 (q, J = 277.6 Hz), 122.65, 
79.48, 76.42, 72.44, 60.94 (q, J = 34.6 Hz), 58.14, 56.97, 46.05, 40.63, 39.46, 35.76, 
35.45, 34.17, 29.23, 26.14, 25.25, 21.32, 9.92; IR (film) 3425, 3390, 2943, 2914, 
 237 
2873, 2812, 1705, 1278, 1153, 1105, 1074, 958, 906, 727, 617 cm
-1 
; HRMS (ESI) m/z 
calcd. for C21H30F3O4 [M+H]
+
: 403.2091, found: 403.2089. 
 
To a solution of alcohol (0.40 g, 0.99 mmol) in dichloromethane (50 mL), 
Dess-Martin periodinane (505.9 mg, 1.19 mmol) was added at r.t. in portions. After 
stirring for 2 h, the reaction mixture was diluted with ethyl acetate (100 mL), washed 
with a 1:1 mixture of saturated NaHCO3 solution and 10% Na2S2O3 solution (4 × 30 
mL) and brine (30 mL), dried over anhydrous Na2SO4, filtered and concentrated in 
vacuo. The crude product was purified by column chromatography (30% ethyl 
acetate/hexanes) to give a white solid (0.34 g, 86% over 2 steps). 
1
H NMR (600 MHz, 
CDCl3) δ 9.28 (s, 1H), 5.84 (dt, J = 7.1, 1.6 Hz, 1H), 3.90 (d, J = 12.2 Hz, 1H), 3.79 
(d, J = 12.2 Hz, 1H), 3.79 (dq, J = 10.6, 8.3 Hz, 1H), 3.71 (dq, J = 10.6, 8.3 Hz, 1H), 
3.32 (s, 3H), 2.94 (dd, J = 7.2, 3.2 Hz, 1H), 2.75 (ddd, J = 10.7, 7.1, 3.2 Hz, 1H), 2.33 
(q, J = 7.3 Hz, 1H), 2.28 (dd, J = 19.5, 7.4 Hz, 1H), 2.21 (ddd, J = 11.1, 3.8, 2.1 Hz, 
1H), 2.15 (d, J = 19.5 Hz, 1H), 2.10 (d, J = 2.1 Hz, 1H), 1.99 – 1.85 (m, 2H), 1.80 – 
1.72 (m, 1H), 1.69 (ddd, J = 13.6, 12.1, 7.4 Hz, 1H), 1.49 (ddd, J = 13.3, 7.4, 6.0 Hz, 
1H), 1.14 (d, J = 7.3 Hz, 3H), 1.13 (d, J = 7.1 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 
212.03, 202.52, 136.57, 123.89 (d, J = 277.5 Hz), 122.02, 78.93, 76.15, 61.03 (q, J = 
34.8 Hz), 58.31, 53.93, 50.22, 46.56, 38.30, 35.27, 34.49, 31.88, 26.79, 25.24, 24.87, 
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21.25, 9.73; IR (film) 2980, 2924, 2877, 2823, 1728, 1452, 1280, 1163, 1124, 1109, 
966, 727 cm
-1 
; HRMS (ESI) m/z calcd. for C21H28F3O4 [M+H]
+
: 401.1934, found: 
401.1934. 
 
To a solution of aldehyde (7.3 mg, 0.0182 mmol) in THF (0.36 mL), 
methylmagnesium bromide (1.4 M in 3:1 THF/toluene, 0.06 mL, 0.084 mmol) was 
added dropwise at 0 °C. After stirring at 0 °C for 1.0 h, the reaction was quenched by 
saturated NH4Cl solution (0.5 mL), diluted with water (1.0 mL) and extracted with 
ethyl acetate (3 × 1.5 mL). The extracts were combined, washed with brine (2.0 mL), 
dried over anhydrous Na2SO4, filtered and concentrated to afford a colorless oil. 
1
H-
NMR analysis indicated a mixture of two diastereomers (dr 2:1). The crude product 
was used in the next step without further purification.  
The crude product from the previous step was dissolved in dichloromethane 
(0.36 mL), to which Dess-Martin periodinane (11.6 mg, 0.0273 mmol) was added at 
r.t. After stirring for 2 h, the reaction mixture was diluted with ethyl acetate (5 mL), 
washed with a 1:1 mixture of saturated NaHCO3 and 10% Na2S2O3 (4 × 3 mL) and 
brine (3 mL), dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The 
crude product was purified by prep-TLC (50% ethyl acetate/hexanes) to give a white 
solid (5.7 mg, 75% over 2 steps). 
1
H NMR (500 MHz, CDCl3) δ 5.83 (d, J = 7.1 Hz, 
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1H), 3.92 (d, J = 12.1 Hz, 1H), 3.80 (d, J = 12.1 Hz, 1H), 3.77 – 3.61 (m, 2H), 3.33 (s, 
3H), 2.69 (ddd, J = 11.0, 7.0, 2.9 Hz, 1H), 2.55 (dt, J = 5.9, 2.6 Hz, 1H), 2.40 – 2.26 
(m, 3H), 2.19 – 2.11 (m, 3H), 2.15 (s, 3H), 1.91 (qd, J = 12.9, 6.5 Hz, 1H), 1.73 (dtd, J 
= 13.0, 6.6, 3.6 Hz, 1H), 1.60 – 1.50 (m, 1H), 1.43 (dt, J = 13.8, 6.7 Hz, 1H), 1.15 (d, 
J = 7.2 Hz, 3H), 1.10 (d, J = 7.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 212.37, 
210.36, 136.45, 123.89 (q, J = 278.8 Hz), 122.26, 79.42, 76.28, 61.17 (q, J = 34.5 Hz), 
58.39, 54.82, 52.21, 46.72, 39.68, 35.51, 35.22, 33.88, 29.28, 26.03, 25.47, 24.97, 
21.14, 9.58; IR (film) 2980, 2932, 2913, 2878, 1725, 1281, 1161, 1119, 965 cm
-1 
; 
HRMS (ESI) m/z calcd. for C22H30F3O4 [M+H]
+
: 415.2090, found: 415.2086. 
 
Preparation of SmI2/HMPA/THF solution (0.10 M): samarium filings (48.4 
mg, 0.322 mmol) in a dry two-neck flask, sealed with a septum on one neck, were 
flame-dried, evacuated and back-filled with N2 for three times. 1, 2-diiodoethane (45.3 
mg, 0.161 mmol) in THF (1.6 mL) was added via syringe under N2. The solution 
turned from light yellow to dark blue in a few seconds. After 2 h, HMPA (0.22 mL, 
1.26 mmol) was added dropwise under N2. The color of the solution changed quickly 
from dark blue to purple. After the mixture was stirred for 10 min., it was allowed to 
settle for 10 min before use.  
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Diketone (5.4 mg, 0.0130 mmol) was dissolved in t-BuOH/THF (1:20 v/v, 
0.26 mL) and cooled to 0°C. N2 was flushed for 10 min before SmI2/HMPA/THF 
solution (0.10 M, 1.30 mL) was added dropwise. The purple reaction solution was 
stirred at 0 °C for 3.0 h before being opened to air and stirred vigorously for 1 min 
while the purple color faded away. The reaction was further quenched by 10% 
Na2S2O3 (1 mL) and diluted with water (10 mL), extracted with ethyl acetate (3 × 5 
mL). The extracts were combined and washed with brine (3 × 10 mL), dried over 
anhydrous Na2SO4 and concentrated. The crude product was purified by prep-TLC 
(60% ethyl acetate/hexanes) to give a white solid (5.0 mg, 92% yield). 
1
H NMR (600 
MHz, CD3OD) δ 5.79 (d, J = 7.3 Hz, 1H), 3.93 – 3.83 (m, 2H), 3.82 – 3.70 (m, 2H), 
3.29 (s, 3H), 3.20 (dd, J = 7.8, 3.2 Hz, 1H), 2.58 (ddd, J = 10.7, 7.2, 3.2 Hz, 1H), 2.52 
(q, J = 7.1 Hz, 1H), 2.40 (dt, J = 10.9, 2.8 Hz, 1H), 2.13 (dd, J = 19.3, 7.8 Hz, 1H), 
2.04 (d, J = 19.3 Hz, 1H), 1.74 (dd, J = 12.8, 5.7 Hz, 1H), 1.66 – 1.57 (m, 2H), 1.34 (s, 
3H), 1.33 – 1.24 (m, 2H), 1.06 (d, J = 2.1 Hz, 1H), 1.02 (d, J = 7.1 Hz, 3H), 0.95 (d, J 
= 7.0 Hz, 3H); 
13
C NMR (CD3OD, extracted from HSQC and HMBC) δ 133.99, 
126.65, 125.79, 81.85, 80.67, 77.43, 77.30, 61.12, 57.70, 46.27, 44.21, 40.00, 39.88, 
35.60, 34.08, 29.58, 28.55, 27.57, 26.28, 22.04, 18.73, 9.02; IR (film) 3345, 2935, 
2910, 1277, 1150, 1112, 1027, 970 cm
-1
; HRMS (ESI) m/z calcd. for C22H31F3NaO4 
[M+Na]
+
: 439.2066, found: 439.2068. 
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 To a mixture of aldehyde (6.0 mg, 0.0150 mmol) and sodium dihydrogen 
phosphate (6.4 mg, 0.0533 mmol) in t-BuOH/THF/H2O (3:3:1 v/v/v, 0.5 mL) was 
added 2-methyl-2-butene (0.03 mL, 0.284 mmol), followed by sodium chlorite (5.6 
mg, 0.0621 mmol). The reaction mixture was stirred at r.t. for 1.5 h then diluted with 
saturated NH4Cl solution (1.0 mL), extracted with ethyl acetate (3 × 1.0 mL). The 
extracts were combined and washed with brine (2.0 mL), dried over anhydrous 
Na2SO4, filtered and concentrated to give a light yellow oil, which was used directly in 
the next step.  
The crude product from the previous step was dissolved in toluene/methanol 
(20:1 v/v, 0.50 mL) then cooled to 0°C. Trimethylsilyldiazomethane (2.0 M in diethyl 
ether, 0.05 mL) was added dropwise. After stirring at 0 °C for 30 min., the reaction 
was concentrated and purified by column chromatography (30% ethyl 
acetate/hexanes) to give a white solid (4.8 mg, 75% yield for two steps). 
1
H NMR 
(500 MHz, CDCl3) δ 5.81 (d, J = 6.9 Hz, 1H), 3.91 (d, J = 12.4, 1H), 3.79 (d, J = 12.4 
Hz, 1H), 3.76 – 3.65 (m, 2H), 3.68 (s, 3H), 3.32 (s, 3H), 2.70 (m, 2H), 2.51 (q, J = 7.2 
Hz, 1H), 2.34 – 2.28 (m, 2H), 2.28 – 2.21 (m, 1H), 2.21 (d, J = 2.0 Hz, 1H), 2.12 (ddd, 
J = 11.2, 4.0, 2.2 Hz, 1H), 1.90 – 1.79 (m, 1H), 1.77 – 1.63 (m, 2H), 1.38 (dt, J = 13.7, 
6.6 Hz, 1H), 1.17 (d, J = 7.2 Hz, 3H), 1.08 (d, J = 7.0 Hz, 3H); 
13
C NMR (125 MHz, 
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CDCl3) δ 212.37, 177.63, 136.56, 123.92 (q, J = 277.6 Hz), 121.99, 79.09, 76.18, 
61.14 (q, J = 34.7 Hz), 58.31, 55.30, 52.84, 46.65, 46.38, 39.52, 37.28, 35.43, 33.70, 
29.99, 25.98, 25.34, 21.15, 9.67; IR (film) 2979, 2926, 2878, 1729, 1454, 1436, 1281, 
1250, 1161, 1120, 1103, 967 cm
-1
; HRMS (ESI) m/z calcd. for C22H30F3O5 [M+H]
+
: 
431.2039, found: 431.2038. 
 
Ketoester (5.6 mg, 0.0130 mmol) was dissolved in t-BuOH/THF (1:20 v/v, 
0.26 mL) and cooled to 0°C. N2 was flushed for 10 min before SmI2/HMPA/THF 
solution (0.10 M, 1.30 mL) was added dropwise. The purple reaction solution was 
stirred at 0 °C for 3.0 h before being opened to air and stirred vigorously for 1 min 
while the purple color faded away. The reaction was further quenched by 10% 
Na2S2O3 (1 mL) and diluted with water (10 mL), extracted with ethyl acetate (3 × 5 
mL). The extracts were combined and washed with brine (3 × 10 mL), dried over 
anhydrous Na2SO4 and concentrated. The residue was purified by prep-TLC (60% 
ethyl acetate/hexanes) to give product 4.14 (higher Rf, white solid, 1.0 mg, 19% yield), 
4.15 (lower Rf, colorless oil, 0.7 mg, 13% yield) and starting material (white solid, 2.0 
mg, 36%). 
Lactone 4.14: 
1
H NMR (600 MHz, CDCl3) δ 5.78 (d, J = 7.2 Hz, 1H), 4.31 (d, 
J = 5.7 Hz, 1H), 3.88 (d, J = 12.2 Hz, 1H), 3.75 (d, J = 12.2 Hz, 1H), 3.70 (dq, J = 
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10.9, 8.4 Hz, 1H), 3.60 (dq, J = 10.9, 8.4 Hz, 1H), 3.30 (s, 3H), 2.60 (ddd, J = 10.6, 
7.2, 2.9 Hz, 1H), 2.36 (dt, J = 11.3, 2.7 Hz, 1H), 2.25 – 2.11 (m, 5H), 1.85 (dd, J = 
5.6, 2.2 Hz, 1H), 1.69 – 1.55 (m, 2H), 1.48 (m, 1H), 1.44 – 1.37 (m, 1H), 1.10 (d, J = 
6.6 Hz, 3H), 1.05 (d, J = 7.4 Hz, 3H); 
13
C NMR (CDCl3, extracted from HSQC and 
HMBC) δ 180.27, 135.14, 123.8, 122.12, 81.67, 78.27, 75.98, 60.79, 58.1, 44.9, 42.9, 
37.42, 37.07, 36.34, 35.32, 32.54, 26.01, 25.72, 24.73, 21.13, 12.41; IR (film) 2981, 
2925, 2851, 1766, 1283, 1163, 1152, 1112, 1099, 1024, 956, 858 cm
-1
; HRMS (ESI) 
m/z calcd. for C21H28F3O4 [M+H]
+
: 401.1934, found: 401.1935. 
Alcohol 4.15: 
1
H NMR (600 MHz, CDCl3) δ 5.77 (d, J = 7.0 Hz, 1H), 4.02 (dt, 
J = 10.5, 3.1 Hz, 1H), 3.87 (d, J = 12.2 Hz, 1H), 3.75 (d, J = 12.2 Hz, 1H), 3.72 – 3.66 
(m, 2H), 3.70 (s, 3H), 3.30 (s, 3H), 2.87 (dt, J = 4.8, 3.5 Hz, 1H), 2.60 (ddd, J = 10.7, 
7.1, 3.2 Hz, 1H), 2.49 (ddd, J = 11.4, 3.8, 2.1 Hz, 1H), 2.19 – 2.11 (m, 3H), 2.02 – 
1.97 (m, 1H), 1.88 – 1.76 (m, 2H), 1.74 – 1.63 (m, 2H), 1.44 – 1.40 (m, 1H), 1.35 – 
1.27 (m, 1H), 1.08 (d, J = 7.0 Hz, 3H), 0.99 (d, J = 7.3 Hz, 3H); 
13
C NMR (CDCl3, 
extracted from HSQC and HMBC) δ 179.14, 135.8, 124.3, 123.51, 78.32, 76.61, 
66.39, 60.58, 58.03, 52.38, 48.06, 45.36, 36.19, 35.38, 35.05, 34.85, 33.45, 32.25, 
26.75, 25.33, 21.48, 7.59; IR (film) 3474, 2925, 1723, 1281, 1158, 1102, 1005, 863 
cm
-1
; HRMS (ESI) m/z calcd. for C22H31F3NaO5 [M+Na]
+
: 455.2015, found: 
455.2016. 
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To a solution of aldehyde (150.0 mg, 0.374 mmol) in CH2Cl2 (7.5 mL), meta-
chloroperoxybenzoic acid (70-75 wt%, with benzoic acid and water, 98.0 mg, 0.412 
mmol) were added at r.t. in one portion. After stirring for 17 h, the reaction mixture 
was diluted with ethyl acetate (20 mL), washed with 10% NaHSO3 solution (10 mL), 
saturated NaHCO3 solution (3 × 10 mL) and brine (10 mL), dried over anhydrous 
Na2SO4, filtered and concentrated in vacuo. The crude product was purified by column 
chromatography (20% ethyl acetate/hexanes) to give a white foam (141.2 mg, 91% 
yield). 
1
H NMR (400 MHz, CDCl3) δ 7.86 (d, J = 0.9 Hz, 1H), 5.79 (ddd, J = 7.1, 2.0, 
1.2 Hz, 1H), 3.91 (ddd, J = 12.4, 1.5, 0.7 Hz, 1H), 3.80 (ddd, J = 12.4, 1.5, 0.7 Hz, 
1H), 3.73 – 3.63 (m, 2H), 3.33 (s, 3H), 3.04 – 2.97 (m, 1H), 2.82 – 2.69 (m, 2H), 2.52 
– 2.47 (m, 1H), 2.49 (q, J = 7.3 Hz, 1H), 2.38 – 2.28 (m, 1H), 2.31 (d, J = 2.1 Hz, 1H), 
2.27 – 2.18 (m, 1H), 1.95 – 1.70 (m, 2H), 1.59 – 1.41 (m, 2H), 1.20 (d, J = 7.3 Hz, 
3H), 1.09 (d, J = 6.9 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 211.28, 159.77, 137.18, 
123.67 (q, J = 277.8 Hz), 120.85, 85.02, 78.82, 75.69, 61.11 (q, J = 34.8 Hz), 58.61, 
58.24, 46.65, 43.09, 39.14, 35.14, 33.49, 31.70, 27.02, 24.95, 20.30, 9.93; IR (film) 
2980, 2929, 2877, 2823, 2249, 1712, 1452, 1375, 1282, 1165, 968, 867, 734 cm
-1
; 
HRMS (ESI) m/z calcd. for C21H27F3NaO5 [M+Na]
+
: 439.1703, found: 439.1706. 
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To a solution of keto-ester (488.4 mg, 1.17 mmol) in CH2Cl2 (10 mL) was 
added DIBAL (1.0 M in CH2Cl2, 3.51 mL) dropwise at -78 °C. The reaction was 
stirred at -78 °C for 2.0 h then quenched by 10% Rochelle's salt solution (20 mL). The 
mixture was diluted with ethyl acetate (40 mL), warmed to r.t. and stirred vigorously 
until two clear layers formed. The organic layer was separated and the aqueous layer 
was extracted with ethyl acetate (3 × 20 mL). The combined organic layers were 
washed with brine (30 mL), dried over anhydrous Na2SO4, filtered and concentrated. 
The residue was purified by column chromatography (60% ethyl acetate/hexanes) to 
give a white solid (415.7 mg, 91% yield). 
1
H NMR (600 MHz, CDCl3) δ 5.72 (d, J = 
7.1 Hz, 1H), 3.86 (d, J = 12.2 Hz, 1H), 3.78 (br s, 1H), 3.74 (d, J = 12.2 Hz, 1H), 3.72 
(dq, J = 10.8, 8.5 Hz, 1H), 3.64 (dq, J = 10.8, 8.5 Hz, 1H), 3.51 (s, 1H), 3.29 (s, 3H), 
3.14 (br s, 1H), 2.47 (ddd, J = 10.8, 7.1, 3.1 Hz, 1H), 2.30 (dd, J = 7.4, 3.1 Hz, 1H), 
2.25 (d, J = 18.9 Hz, 1H), 2.20 – 2.08 (m, 2H), 1.98 (tt, J = 7.2, 3.5 Hz, 1H), 1.94 (dt, 
J = 11.0, 2.7 Hz, 1H), 1.82 – 1.62 (m, 2H), 1.53 – 1.42 (m, 2H), 1.35 (dt, J = 13.5, 6.3 
Hz, 1H), 1.09 (d, J = 7.2 Hz, 3H), 1.05 (d, J = 6.7 Hz, 3H); 
13
C NMR (125 MHz, 
CDCl3) δ 136.06, 124.15 (q, J = 277.6 Hz), 123.19, 79.79, 78.60, 78.32, 76.25, 60.69 
(q, J = 34.5 Hz), 57.97, 48.17, 45.58, 42.56, 41.29, 37.51, 36.76, 32.77, 27.37, 24.79, 
20.88, 15.16; IR (film) 3346, 2980, 2914, 2875, 1452, 1379, 1282, 1155, 1001, 966, 
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920, 854, 734 cm
-1
; HRMS (ESI) m/z calcd. for C20H29F3NaO4 [M+Na]
+
: 413.1910, 
found: 413.1916. 
 
To a solution of diol (349.6 mg, 0.895 mmol) in water-saturated 
dichloromethane (18 mL), Dess-Martin periodinane (455.7 mg, 1.07 mmol) were 
added at r.t. in one portion. After stirring for 2 h, another portion of Dess-Martin 
periodinane (380 mg, 0.895 mmol) was added and the reaction was stirred for further 
7 h. The reaction mixture was diluted with ethyl acetate (120 mL), washed with a 1:1 
mixture of saturated NaHCO3 solution and 10% Na2S2O3 (4 × 30 mL) solution and 
brine (30 mL), dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The 
crude product was triturated with 50% ethyl acetate/hexanes and a white solid was 
collected by vacuum filtration. Purification of the filtrate by column chromatography 
(35% ethyl acetate/hexanes) gave another crop of white solid. Combined white solids 
weighed 326.8 mg (94% yield). 
1
H NMR (600 MHz, CDCl3) δ 5.78 (d, J = 7.1 Hz, 
1H), 3.91 (d, J = 12.3 Hz, 1H), 3.78 (d, J = 12.3 Hz, 1H), 3.71 (q, J = 8.4 Hz, 2H), 
3.32 (s, 3H), 2.71 (ddd, J = 10.6, 7.1, 2.9 Hz, 1H), 2.53 (q, J = 7.4 Hz, 1H), 2.39 – 
2.17 (m, 6H), 2.04 (d, J = 2.1 Hz, 1H), 1.87 – 1.64 (m, 2H), 1.52 – 1.38 (m, 2H), 1.16 
(d, J = 7.3 Hz, 3H), 1.07 (d, J = 7.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 214.19, 
136.66, 123.93 (d, J = 277.6 Hz), 122.16, 79.14, 76.08, 74.03, 61.89, 61.06 (q, J = 
34.7 Hz), 58.17, 45.91, 43.56, 40.33, 37.03, 35.38, 33.65, 27.57, 24.83, 20.70, 9.79; IR 
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(film) 3396, 2981, 2927, 2879, 2825, 1712, 1456, 1280, 1161, 1120, 1020, 966, 920, 
732 cm
-1
; HRMS (ESI) m/z calcd. for C20H27F3NaO4 [M+Na]
+
: 411.1754, found: 
411.1756. 
 
To a solution of keto-alcohol (173.4 mg, 0.446 mmol) in acetonitrile (5 mL) 
and acetic acid (10 mL), was added a suspension of tetramethylammonium 
triacetoxyborohydride (587.4 mg, 2.23 mmol) in acetonitrile (5 mL) at r.t. The 
reaction mixture was stirred for 3 h before it was quenched by saturated NH4Cl 
solution (5 mL). After effervescence had ceased, the solution was diluted with water 
(10 mL) and ethyl acetate (30 mL). The organic phase was separated and the aqueous 
phase was extracted with ethyl acetate (3 × 20 mL). The combined organic extracts 
were washed with brine (30 mL), dried over anhydrous Na2SO4, filtered and 
concentrated in vacuo. The crude product was triturated with hexanes and a white 
solid was collected by vacuum filtration. Purification of the filtrate by column 
chromatography (75% ethyl acetate/hexanes) gave another crop of white solid. The 
combined white solids weighed 165.4 mg (95% yield). 
1
H NMR (500 MHz, CDCl3) δ 
5.74 (dt, J = 7.0, 1.5 Hz, 1H), 4.58 (dd, J = 10.4, 3.2 Hz, 1H), 3.87 (d, J = 12.2 Hz, 
1H), 3.74 (d, J = 12.2 Hz, 1H), 3.73 (dq, J = 10.8, 8.5 Hz, 1H), 3.61 (dq, J = 10.8, 8.5 
Hz, 1H), 3.29 (s, 3H), 2.60 (ddd, J = 10.4, 7.0, 2.9 Hz, 1H), 2.55 – 2.47 (m, 1H), 2.33 
(dq, J = 10.4, 7.3 Hz, 1H), 2.27 – 2.03 (m, 4H), 1.80 (m, 1H), 1.67 (m, 1H), 1.44 – 
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1.33 (m, 3H), 1.05 (d, J = 7.0 Hz, 3H), 1.01 (d, J = 7.3 Hz, 3H); 
13
C NMR (125 MHz, 
CDCl3) δ 135.87, 124.23 (d, J = 277.8 Hz), 123.76, 79.02, 76.44, 74.78, 64.27, 60.58 
(q, J = 34.3 Hz), 58.03, 51.29, 43.78, 38.46, 36.55, 36.45, 35.46, 33.52, 28.11, 24.82, 
21.12, 7.74; IR (film) 3373, 2981, 2926, 2833, 1448, 1280, 1161, 1105, 1002, 966, 
916, 864, 732 cm
-1
; HRMS (ESI) m/z calcd. for C20H29F3NaO4 [M+Na]
+
: 413.1910, 
found: 413.1909. 
 
To a solution of diol (276.0 mg, 0.707 mmol) in anhydrous pyridine (12.0 mL), 
methanesulfonyl chloride (0.55 mL, 7.07 mmol) was added dropwise at 0 °C. The 
reaction was stirred at 0 °C for 15 h then quenched by 1 N HCl solution (10 mL) and 
diluted with ethyl acetate (200 mL). The mixture was washed with 1 N HCl solution 
(3 × 50 mL) and brine (50 mL), dried over anhydrous Na2SO4, filtered and 
concentrated in vacuo. The crude product was triturated with 10% ethyl 
acetate/hexanes and a white solid was collected by vacuum filtration. Purification of 
the filtrate by column chromatography (60% ethyl acetate/hexanes) gave another crop 
of white solid. The combined white solids weighed 321.3 mg (97% yield). 
1
H NMR 
(500 MHz, CDCl3) δ 5.73 (dt, J = 6.9, 1.5 Hz, 1H), 5.48 (dd, J = 10.6, 3.4 Hz, 1H), 
3.86 (dd, J = 12.2, 1.1 Hz, 1H), 3.74 (dd, J = 12.2, 1.1 Hz, 1H), 3.72 (dq, J = 10.6, 8.4 
Hz, 1H), 3.62 (dq, J = 10.6, 8.4 Hz, 1H), 3.29 (s, 3H), 3.05 (s, 3H), 2.62 (ddd, J = 
10.6, 7.0, 2.9 Hz, 1H), 2.52 (dq, J = 11.0, 7.5 Hz, 1H), 2.47 (ddd, J = 11.4, 3.7, 2.1 Hz, 
 249 
1H), 2.25 (d, J = 18.0 Hz, 1H), 2.20 (dd, J = 12.8, 6.3 Hz, 1H), 2.16 – 2.06 (m, 2H), 
2.00 (s, 1H), 1.84 – 1.74 (m, 1H), 1.69 (m, 1H), 1.62 (dd, J = 3.4, 2.1 Hz, 1H), 1.47 – 
1.34 (m, 2H), 1.06 (d, J = 7.0 Hz, 3H), 1.05 (d, J = 7.5 Hz, 3H); 
13
C NMR (125 MHz, 
CDCl3) δ 136.13, 124.03 (d, J = 277.6 Hz), 122.96, 78.48, 77.01, 76.24, 74.28, 60.70 
(q, J = 34.6 Hz), 58.13, 49.80, 43.53, 38.17, 38.01, 36.86, 36.09, 34.61, 33.23, 27.85, 
24.70, 20.97, 8.91; IR (film) 3412, 2983, 2926, 1448, 1350, 1330, 1282, 1168, 1107, 
966, 927, 918, 871, 732, 528 cm
-1
; HRMS (ESI) m/z calcd. for C21H31F3NaO6S 
[M+Na]
+
: 491.1686, found: 491.1684. 
 
To a solution of mesylate (220.8 mg, 0.471 mmol) in anhydrous tert-butanol 
(44 mL), potassium tert-butoxide (1.0 M in THF, 1.41 mL) was added dropwise at r.t. 
The solution became cloudy and turned yellow. After stirring for 1.5 h, the reaction 
was quenched by saturated NH4Cl solution (10 mL) and diluted with ethyl acetate (50 
mL) and water (50 mL). The organic phase was separated and the aqueous phase was 
extracted with ethyl acetate (3 × 50 mL). The combined organic phases were washed 
with brine (50 mL), dried over anhydrous Na2SO4, filtered and concentrated in vacuo. 
The crude product was triturated with hexanes and a white solid was collected by 
vacuum filtration. Purification of the filtrate by column chromatography (15% ethyl 
acetate/hexanes) gave another crop of white solid. The combined white solids weighed 
161.4 mg (92% yield). 
1
H NMR (500 MHz, CDCl3) δ 5.93 (dt, J = 5.7, 1.5 Hz, 1H), 
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5.58 – 5.47 (m, 2H), 3.99 (d, J = 11.8, 1H), 3.85 (d, J = 11.8 Hz, 1H), 3.82 – 3.67 (m, 
2H), 3.33 (s, 3H), 2.95 (d, J = 7.2 Hz, 1H), 2.83 – 2.78 (m, 1H), 2.74 (ddd, J = 14.9, 
7.1, 4.0 Hz, 1H), 2.65 (qd, J = 7.0, 3.4 Hz, 1H), 2.60-2.53 (m, 1H), 2.46 – 2.38 (m, 
1H), 2.25 (d, J = 18.6 Hz, 1H), 2.30-2.17 (m, 1H), 1.90 – 1.72 (m, 2H), 1.72 – 1.54 
(m, 1H), 1.09 (d, J = 7.0 Hz, 3H), 1.04 (d, J = 7.1 Hz, 3H); 
13
C NMR (125 MHz, 
C6D6) δ 211.79, 132.60, 131.32, 130.87, 125.45, 124.84 (d, J = 277.8 Hz), 78.93, 
76.65, 60.91 (q, J = 33.8 Hz), 57.99, 54.19, 44.17, 38.23, 38.10, 37.56, 34.86, 29.76, 
25.92, 23.46, 16.33; IR (film) 2927, 2875, 1676, 1280, 1155, 1105, 968, 856 cm
-1
; 
HRMS (ESI) m/z calcd. for C20H28F3O3 [M+H]
+
: 373.1985, found: 373.1983. 
 
To a solution of diol (15.8 mg, 0.0404 mmol) in anhydrous pyridine (0.80 mL) 
methanesulfonyl chloride (0.03 mL, 0.404 mmol) was added dropwise at 0 °C. The 
reaction was stirred at 0 °C for 3 h then quenched by water (2 mL) and diluted with 
ethyl acetate (10 mL). The mixture was washed with 1 N HCl (5 × 2 mL) and brine (2 
mL), dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The crude 
product was purified by column chromatography (50% ethyl acetate/hexanes) to 
afford a white solid (18.9 mg, quantitative yield). 
1
H NMR (600 MHz, CDCl3) δ 5.71 
(d, J = 7.2 Hz, 1H), 4.54 (dd, J = 4.6, 2.7 Hz, 1H), 3.86 (d, J = 12.3 Hz, 1H), 3.74 (d, J 
= 12.3 Hz, 1H), 3.67 (qd, J = 8.3, 2.5 Hz, 2H), 3.29 (s, 3H), 3.08 (s, 3H), 2.52 (ddd, J 
= 10.7, 7.1, 3.1 Hz, 1H), 2.34 (s, 1H), 2.32 – 2.20 (m, 3H), 2.19 – 2.12 (m, 2H), 2.09 – 
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1.97 (m, 1H), 1.84 – 1.74 (m, 2H), 1.69 (qd, J = 13.0, 6.3 Hz, 1H), 1.49 – 1.40 (m, 
1H), 1.37 (m, 1H), 1.15 (d, J = 7.0 Hz, 3H), 1.06 (d, J = 6.9 Hz, 3H); 
13
C NMR (125 
MHz, CDCl3) δ 136.59, 123.96 (q, J = 277.7 Hz), 122.03, 88.47, 78.16, 76.58, 76.10, 
60.97 (q, J = 34.5 Hz), 58.21, 47.81, 45.32, 41.82, 39.23, 39.07, 37.69, 36.72, 32.96, 
27.47, 24.91, 20.80, 14.32; IR (film) 3529, 2925, 2876, 1456, 1333, 1281, 1170, 966, 
935, 916, 845 cm
-1
; HRMS (ESI) m/z calcd. for C21H31F3NaO6S [M+Na]
+
: 491.1686, 
found: 491.1689. 
 
To a solution of mesylate (18.9 mg, 0.0404 mmol) in anhydrous tert-butanol 
(5.3 mL), potassium tert-butoxide (1.0 M in THF, 0.16 mL) was added dropwise at r.t. 
The reaction solution became cloudy and turned yellow. After stirring for 18 h, the 
reaction was quenched by saturated NH4Cl (1 mL) and diluted with ethyl acetate (5 
mL) and water (5 mL). The organic phase was separated and the aqueous phase was 
extracted with ethyl acetate (3 × 5 mL). The combined organic phases were washed 
with brine (10 mL), dried over anhydrous Na2SO4, filtered and concentrated in vacuo. 
The crude product was purified by column chromatography (10% ethyl 
acetate/hexanes) to afford a white solid (12.8 mg, 85% yield over 2 steps). 
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Cerium (III) chloride heptahydrate
1
 (58.8 mg, 0.158 mmol) was grounded to a 
fine powder and placed in a flask equipped with a stirring bar. The flask was heated 
slowly to 90 °C with evacuation and the powder was stirred at 90 °C for 3.5 h. The 
temperature was increased to 140 °C and maintained for 15 h. After the flask was 
cooled to r.t., nitrogen was introduced and THF (0.50 mL) was added. The resultant 
slurry was stirred vigorously under N2 for 1 h and then cooled to -78°C. 
Isopropenylmagnesium bromide (0.5 M in THF, 0.26 mL) was added and after stirring 
for 1 h, ketone (9.8 mg, 0.0263 mmol) in THF (0.50 mL) was added. The reaction 
mixture was stirred at -78 °C for 8 h, and then warmed to r.t. naturally overnight. The 
reaction was quenched by saturated NH4Cl solution (2 mL) at 0 °C and diluted with 
water (2 mL) and ethyl acetate (5 mL). The organic layer was separated and the 
aqueous layer was extracted with ethyl acetate (3 × 5 mL). The combined organic 
layers were washed with brine (10 mL), dried over anhydrous Na2SO4, filtered and 
concentrated. The residue was purified by column chromatography (10% ethyl 
acetate/hexanes) to give a colorless oil (9.5 mg, 87% yield). 
1
H NMR (500 MHz, 
CDCl3) δ 5.79 (ddd, J = 9.8, 5.7, 2.5 Hz, 1H), 5.74 – 5.65 (m, 2H), 4.91 (p, J = 1.3 Hz, 
1H), 4.88 (s, 1H), 3.85 (dt, J = 12.1, 1.3 Hz, 1H), 3.83 – 3.69 (m, 4H), 3.26 (s, 3H), 
2.74 – 2.67 (m, 1H), 2.64 (m, 1H), 2.34 (m, 2H), 2.08 – 1.80 (m, 5H), 1.86 (d, J = 1.2 
Hz, 3H), 1.57 (bs, 1H), 1.45 – 1.35 (m, 1H), 1.11 (d, J = 7.3 Hz, 3H), 1.10 (d, J = 7.4 
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Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 153.94, 132.94, 132.77, 132.36, 124.53, 
124.52 (d, J = 278.8 Hz), 112.18, 83.32, 79.34, 77.00, 61.21 (q, J = 33.7 Hz), 57.64, 
45.21, 43.64, 37.43, 36.42, 35.75, 28.92, 27.27, 24.96, 22.50, 19.45, 16.69; IR (film) 
3412, 2929, 2875, 1635, 1456, 1373, 1274, 1157, 1107, 972, 902, 850, 734 cm
-1
; 
HRMS (ESI) m/z calcd. for C23H33F3NaO3 [M+Na]
+
: 437.2274, found: 437.2270. 
 
To a solution of diene (247.3 mg, 0.664 mmol) in ethyl acetate (13.3 mL) was 
added palladium on carbon (10 wt%, 35.3 mg, 0.0332 mmol). The mixture was 
bubbled with H2 for 5 min. then stirred at r.t. under H2 balloon for 3.0 h. After that 
period of time the reaction mixture was filtered through a Celite pad and the filtrate 
was concentrated and then purified by column chromatography (15% ethyl 
acetate/hexanes) to give a colorless oil (243.6 mg, 98% yield). 
1
H NMR (500 MHz, 
CDCl3) δ 5.87 (ddd, J = 4.6, 2.4, 1.2 Hz, 1H), 3.97 (d, J = 11.9 Hz, 1H), 3.91 – 3.76 
(m, 3H), 3.36 (s, 3H), 2.99 (dq, J = 5.9, 1.4 Hz, 1H), 2.73 (ddd, J = 12.1, 8.4, 3.9 Hz, 
1H), 2.60 (q, J = 4.1 Hz, 1H), 2.44 (ddt, J = 18.2, 5.7, 2.7 Hz, 1H), 2.25 – 2.11 (m, 
2H), 1.99 – 1.83 (m, 3H), 1.82 – 1.71 (m, 1H), 1.68 – 1.57 (m, 1H), 1.53 – 1.28 (m, 
4H), 1.02 (d, J = 6.9 Hz, 3H), 0.94 (d, J = 6.7 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 
215.76, 132.95, 127.03, 124.25 (q, J = 278.3 Hz), 78.93, 76.60, 61.98 (q, J = 34.0 Hz), 
58.45, 54.04, 42.15, 38.83, 37.96, 37.44, 33.88, 31.44, 27.70, 27.09, 25.95, 24.03, 
14.69; IR (film) 2933, 2873, 2821, 1674, 1454, 1377, 1280, 1153, 1103, 972, 850, 
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667, 536 cm
-1
; HRMS (MALDI) m/z calcd. for C20H29F3O3Li [M+Li]
+
: 381.2224, 
found: 381.2235. 
 
Cerium (III) chloride heptahydrate
1 
(190 mg, 0.510 mmol ) was grounded to a 
fine powder and placed in a flask equipped with a stir bar. The flask was heated slowly 
to 90 °C with evacuation and maintained at 90 °C for 3.5 h. After that period of time, 
the temperature was increased to 140 °C and the flask was heated at 140 °C for 15 h. 
The flask was then cooled to r.t., nitrogen was introduced and THF (2.5 mL) was 
added. The resultant slurry was stirred vigorously under N2 for 2 h.  
In a separate flask, t-BuLi (1.7 M in pentane, 1.5 mL, 2.5 mmol) was added 
dropwise to a solution of ethyl vinyl ether (0.57 mL, 6.0 mmol) in THF (3.0 mL) at -
78 °C. The solution turned yellow and a precipitate formed. After the addition was 
completed, the cooling bath was removed and the mixture was allowed to warm to 0 
°C over an ice-water bath and stirred at 0 °C for 15 min. while the yellow color was 
gradually discharged. 
The resultant colorless 1-ethoxyvinyllithium solution (0.5 M, 0.80 mL) was 
added via syringe to the CeCl3 suspension (cooled to -78 °C before the addition). A 
canary yellow mixture was formed and stirred for 1.0 h before ketone (45.0 mg, 0.134 
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mmol) in THF (0.50 mL) was added. The reaction mixture was stirred at -78 °C for 45 
min. and quenched by saturated NH4Cl solution (3 mL) and extracted with ethyl 
acetate (5 × 6 mL). The combined organic layers were washed with brine (6 mL) and 
split into two portions; each was diluted with ethyl acetate to 50 mL and washed with 
cold 1N HCl solution (10 mL) and brine (5 mL).  The combined organic phases were 
dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by 
column chromatography (15% ethyl acetate/hexanes) to give a colorless oil (44.3 mg, 
79% yield). (Note: Prolonged exposure of the vinyl ether intermediate to acid during 
work-up could lead to its decomposition.) 
1
H NMR (500 MHz, CDCl3)
 δ 5.71 (t, J = 
3.2 Hz, 1H), 3.92 – 3.67 (m, 4H), 3.30 (s, 3H), 2.85 (ddt, J = 13.4, 11.4, 6.8 Hz, 1H), 
2.64 (s, 1H), 2.57 (s, 1H), 2.37 (d, J = 8.1 Hz, 1H), 2.34 – 2.27 (m, 1H), 2.33 (s, 3H), 
2.27 – 2.20 (m, 1H), 2.20 – 2.11 (m, 1H), 2.07 (ddt, J = 15.4, 7.5, 2.3 Hz, 1H), 1.97 
(ddd, J = 15.6, 7.9, 2.2 Hz, 1H), 1.81 – 1.72 (m, 2H), 1.55 (d, J = 17.9 Hz, 1H), 1.48 – 
1.36 (m, 3H), 1.32 – 1.23 (m, 1H), 1.08 (d, J = 7.4 Hz, 3H), 1.05 (d, J = 6.8 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 213.45, 132.02, 126.42, 124.49 (q, J = 278.7 Hz), 
82.45, 82.30, 76.80, 62.07 (q, J = 33.8 Hz), 58.20, 43.08, 41.02, 39.38, 36.82, 36.27, 
30.63, 27.79, 25.82, 25.31, 24.71, 22.22, 22.19, 15.42; IR (film) 3441, 2931, 2872, 
2825, 1703, 1456, 1377, 1357, 1280, 1157, 1107, 972, 910, 734 cm
-1
; HRMS (ESI) 
m/z calcd. for C22H33F3O4Li [M+Li]
+
: 425.2485, found: 425.2486. 
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In a high-pressure tube, Burgess’s reagent (37.8 mg, 0.159 mmol) was added 
to a solution of hydroxy ketone (33.2 mg, 0.0793 mmol) in benzene (8.0 mL) under 
N2. The tube was then capped and heated at 80 °C for 1.0 h. The reaction solution 
turned from colorless to light yellow over time. After cooling to r.t. the reaction was 
concentrated, diluted with diethyl ether (30 mL) and washed with brine (3 × 10 mL). 
The aqueous phase was back-extracted with ether (3 × 10 mL). The combined organic 
phases were dried over anhydrous Na2SO4, filtered and concentrated. The residue was 
purified by column chromatography (10% ethyl acetate/hexanes) to afford a white 
solid (22.4 mg, 71% yield). 
1
H NMR (600 MHz, CDCl3) δ 7.06 (t, J = 9.0 Hz, 1H), 
5.72 (dt, J = 5.1, 1.6 Hz, 1H), 4.05 (d, J = 9.8 Hz, 1H), 3.97 – 3.79 (m, 3H), 3.77 (d, J 
= 12.1 Hz, 1H), 3,29 – 3.22 (m, 1H), 3.27 (s, 3H), 2.59 (t, J = 6.1 Hz, 1H), 2.46 (ddt, J 
= 19.1, 10.2, 2.4 Hz, 1H), 2.39 (s, 3H), 2.03 – 1.93 (m, 2H), 1.90 – 1.83 (m, 1H), 1.81 
(d, J = 19.1 Hz, 1H), 1.72 (ddd, J = 13.0, 9.2, 2.6 Hz, 1H), 1.70 – 1.62 (m, 1H), 1.56 – 
1.47 (m, 1H), 1.29 (dq, J = 13.7, 5.4 Hz, 1H), 1.14 (dtd, J = 13.7, 5.1, 2.4 Hz, 1H), 
1.09 (d, J = 7.0 Hz, 3H), 0.91 (d, J = 7.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 
200.08, 146.73, 145.62, 136.10, 125.76, 124.58 (q, J = 278.2 Hz), 81.97, 76.71, 60.94 
(q, J = 33.8 Hz), 57.70, 42.64, 41.24, 41.10, 33.22, 31.63, 31.52, 30.86, 28.51, 28.48, 
27.79, 26.03, 15.43; IR (film) 2954, 2927, 2875, 1662, 1448, 1375, 1274, 1244, 1157, 
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1109, 968, 856 cm
-1
; HRMS (ESI) m/z calcd. for C22H31F3O3Na [M+Na]
+
: 423.2118, 
found: 423.2113. 
 
To a solution of α, β-unsaturated ketone (1.9 mg, 0.00474 mmol) in ethyl 
acetate (0.40 mL) was added palladium on activated alumina (10 wt%, 2.0 mg, 
0.00188 mmol). The mixture was bubbled with H2 for 5 min. then stirred at r.t. under 
H2 balloon for 16 h.  After that period of time the reaction mixture was filtered 
through a Celite pad, the filtrate was concentrated and purified by column 
chromatography (25% ethyl acetate/hexanes) to give a colorless oil (1.3 mg, 68% 
yield). 
1
H NMR (500 MHz, CDCl3) δ 5.66 (s, 1H), 3.92 – 3.74 (m, 4H), 3.32 (s, 3H), 
3.00 (dd, J = 7.4, 3.2 Hz, 1H), 2.73 – 2.63 (m, 1H), 2.51 (dt, J = 6.5, 3.2 Hz, 2H), 2.22 
(s, 3H), 2.04 – 1.88 (m, 3H), 1.81 – 1.50 (m, 6H), 1.44 – 1.22 (m, 3H), 1.02 (d, J = 6.8 
Hz, 3H), 1.00 (d, J = 6.5 Hz, 3H); 
13
C NMR (C6D6, extracted from HSQC and 
HMBC) δ 208.61, 134.38, 125.63, 125.35, 82.38, 77.04, 62.48, 59.97, 58.18, 41.78, 
39.07, 37.54, 37.05, 36.04, 32.83, 29.64, 28.23, 28.00, 27.63, 22.91, 20.82, 16.41; IR 
(film) 2927, 2874, 1706, 1462, 1279, 1157, 1105, 973, 857 cm
-1
; HRMS (ESI) m/z 
calcd. for C22H33F3NaO3 [M+Na]
+
: 425.2274, found: 425.2274. 
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Enone (70.0 mg, 0.175 mmol) was dissolved in absolute ethanol (8.8 mL) 
containing potassium hydroxide (28.0 mg), to which palladium on carbon (10 wt%, 
18.6 mg, 0.0175 mmol) was added. The mixture was bubbled with H2 for 5 min. then 
stirred at r.t. under H2 balloon for 27 h. The reaction was filtered through a Celite pad 
and the filter cake was washed with ethyl acetate. After brine (20 mL) was added to 
the filtrate, the mixture was extracted with ethyl acetate (3 × 15 mL). The combined 
extracts were dried over anhydrous Na2SO4, filtered and concentrated. The residue 
was purified by column chromatography (15% ethyl acetate/hexanes) to give a 
colorless oil (66.2 mg, 94% yield). 
1
H NMR (600 MHz, CDCl3) δ 5.64 (m, 1H), 3.93 – 
3.85 (m, 2H), 3.82 – 3.75 (m, 2H), 3.33 (s, 3H), 2.78 (d, J = 11.7 Hz, 1H), 2.44 (s, 
1H), 2.35 (d, J = 6.8 Hz, 1H), 2.23 – 2.12 (m, 2H), 2.20 (s, 3H), 2.02 – 1.94 (m, 1H), 
1.91 (d, J = 18.0 Hz, 1H), 1.68 – 1.43 (m, 6H), 1.34 (m, 3H), 1.03 (d, J = 6.8 Hz, 3H), 
0.91 (d, J = 6.5 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 211.07, 133.68, 124.48 (q, J 
= 276.8 Hz), 124.66, 81.42, 76.14, 62.56 (q, J = 33.9 Hz), 58.34, 49.86, 42.62, 38.13, 
37.23, 36.60, 33.29, 30.73, 29.16, 28.23, 26.88, 24.18, 24.04, 21.93, 14.53; IR (film) 
2956, 2933, 2872, 2821, 1708, 1460, 1377, 1354, 1280, 1157, 1126, 1105, 972, 927, 
850 cm
-1
; HRMS (ESI) m/z calcd. for C22H33F3O3Na [M+Na]
+
: 425.2274, found: 
425.2270. 
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In a high-pressure tube, n-BuLi (1.6 M in hexanes, 0.39 mL, 0.624 mmol) was 
added dropwise to a suspension of methyltriphenylphosphonium bromide (277.4 mg, 
0.739 mmol) in toluene (3.5 mL) at 0 °C. The mixture turned to light yellow 
gradually. After stirring for 15 min., ketone (99.2 mg, 0.246 mmol) in toluene (1.0 
mL) was added. The reaction tube was then sealed, warmed to r.t. and heated to 80 °C. 
After 20 h at 80 °C, the reaction was cooled to r.t., quenched by saturated NH4Cl 
solution (5.0 mL), and extracted with ethyl acetate (3 × 10 mL). The combined 
extracts were washed with brine (15 mL), dried over anhydrous Na2SO4, filtered and 
concentrated. The crude product was loaded on a silica gel plug and eluted with 5% 
ethyl acetate/hexanes. To remove the trace amount of triphenylphosphine, the eluate 
was concentrated, to which acetone (9.0 mL), sodium iodide (540 mg) and Merrifield 
resin (600 mg) were added. The resultant slurry was stirred at r.t. for 24 h then filtered 
through a Celite pad and washed with small amount of ethyl acetate. The filtrate was 
concentrated, re-dissolved in ethyl acetate, washed with water and brine and 
concentrated again. The residue was purified by column chromatography (5% ethyl 
ether/hexanes) to give a colorless oil (79.8 mg, 81% yield). 
1
H NMR (500 MHz, 
CDCl3) δ 5.62 (m, 1H), 4.76 (t, J = 1.5 Hz, 1H), 4.62 (d, J = 1.3 Hz, 1H), 3.95 – 3.83 
(m, 2H), 3.83 – 3.72 (m, 2H), 3.33 (s, 3H), 2.42 (s, 1H), 2.32 – 2.17 (m, 2H), 2.17 – 
2.08 (m, 1H), 2.06 (d, J = 7.0 Hz, 1H), 2.03 – 1.89 (m, 2H), 1.83 – 1.78 (s, 3H), 1.62 
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(m, 1H), 1.56 – 1.28 (m, 8H), 0.99 (d, J = 6.9 Hz, 3H), 0.89 (d, J = 6.4 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 152.22, 134.01, 124.63 (q, J = 278.4 Hz), 125.25, 110.04, 
81.89, 76.65, 62.56 (q, J = 33.8 Hz), 58.25, 42.88, 42.02, 38.88, 38.39, 36.75, 32.99, 
31.78, 28.34, 27.04, 25.98, 24.43, 24.21, 23.78, 14.58; IR (film) 2933, 2870, 1280, 
1155, 1124, 1105, 1089, 974, 891 cm
-1
; HRMS (ESI) m/z calcd. for C23H35F3O2Li 
[M+Li]
+
: 407.2744, found: 407.2739. 
 
To a solution of diene (89.0 mg, 0.222 mmol) in ethyl acetate (2.2 mL) was 
added palladium on carbon (10 wt%, 23.6 mg, 0.0222 mmol). The mixture was 
bubbled with H2 for 5 min. then stirred at r.t. for 36 h under H2 balloon. After that 
period of time the reaction mixtures were filtered through a Celite pad and washed 
with ethyl acetate. The filtrate was concentrated to give a colorless oil (87.8 mg, 98% 
yield), which solidified in freezer to a white solid. (Note: The Rf of the product is as 
same as that of the starting material in ethyl acetate/hexanes solvent system, therefore 
the reaction was monitored by 
1
H-NMR of aliquots.) 
1
H NMR (600 MHz, CDCl3) δ 
5.60 (m, 1H), 3.92 – 3.83 (m, 2H), 3.81 – 3.72 (m, 2H), 3.31 (s, 3H), 2.41 (m, 1H), 
2.24 (m, 1H), 2.19 – 2.09 (m, 2H), 2.00 – 1.94 (m, 1H), 1.91 (d, J = 17.8 Hz, 1H), 
1.75 – 1.63 (m, 1H), 1.54 – 1.25 (m, 9H), 1.25 – 1.14 (m, 1H), 0.96 (d, J = 6.8 Hz, 
3H), 0.94 (d, J = 6.1 Hz, 3H), 0.90 (d, J = 6.4 Hz, 3H), 0.88 (d, J = 6.6 Hz, 3H); 
13
C 
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NMR (125 MHz, CDCl3) δ 134.11, 124.72 (d, J = 278.5 Hz), 125.63, 82.09, 76.81, 
62.38 (q, J = 33.7 Hz), 58.07, 42.62, 40.98, 38.21, 37.75, 37.48, 36.14, 33.12, 31.73, 
28.85, 27.59, 25.47, 25.43, 24.44, 22.18, 20.94, 14.64; IR (film) 2956, 2933, 2872, 
2819, 1463, 1456, 1375, 1280, 1155, 1122, 1101, 975, 850, 659 cm
-1
; HRMS (ESI) 
m/z calcd. for C23H37F3O2Li [M+Li]
+
: 409.2900, found: 409.2900. 
 
In a high-pressure tube, a mixture of methylvinylether (18.0 mg, 0.0447 
mmol), selenium dioxide (24.8 mg, 0.224 mmol) and benzene (1.0 mL) was heated at 
80 °C for 60 h. The reaction was cooled to r.t., filtered through a Celite pad and 
washed with ethyl acetate. The filtrate was concentrated and purified by column 
chromatography (10% ethyl acetate/hexanes) to give a white solid (12.6 mg, 73% 
yield). 
1
H NMR (600 MHz, CDCl3) δ 9.50 (s, 1H), 6.77 (m, 1H), 3.85 (dq, J = 10.8, 
8.4 Hz, 1H), 3.75 (dq, J = 10.8, 8.4 Hz, 1H), 2.70 (m, 1H), 2.40 (d, J = 17.8 Hz, 1H), 
2.35 – 2.24 (m, 2H), 2.21 (ddp, J = 13.8, 6.9, 3.7 Hz, 1H), 2.06 (dtt, J = 12.2, 6.0, 2.9 
Hz, 1H), 1.75 (td, J = 9.2, 4.4 Hz, 1H), 1.63 –1.32 (m, 10H), 0.99 (d, J = 6.9 Hz, 3H), 
0.95 (d, J = 6.5 Hz, 3H), 0.93 (d, J = 6.6 Hz, 3H), 0.91 (d, J = 6.1 Hz, 3H); 
13
C NMR 
(125 MHz, CDCl3) δ 193.65, 152.46, 139.88, 124.19 (q, J = 278.7 Hz), 82.21, 62.01 
(q, J = 34.0 Hz), 43.28, 40.84, 40.18, 37.26, 36.71, 35.88, 33.00, 32.19, 28.60, 27.55, 
25.30, 24.19, 22.13, 20.92, 20.61, 14.68; IR (film) 2956, 2933, 2872, 1681, 1649, 
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1278, 1157, 1118, 972 cm
-1
; HRMS (ESI) m/z calcd. for C22H33F3O2Li [M+Li]
+
: 
393.2587, found: 393.2581. 
 
To a  solution of aldehyde (53.3 mg, 0.138 mmol) in toluene (10 mL) was 
added DIBAL (1.0 M in toluene, 0.21 mL) dropwise at -78 °C. The reaction was 
stirred at -78 °C for 1.5 h then quenched by 10% Rochelle's salt solution (5 mL). The 
mixture was diluted with ethyl acetate (5 mL), warmed to r.t. and stirred vigorously 
until two clear layers formed. The organic layer was separated and the aqueous layer 
was extracted with ethyl acetate (3 × 10 mL). The combined organic layers were 
washed with brine (15 mL), dried over anhydrous Na2SO4, filtered and concentrated. 
The residue was purified by column chromatography (10% ethyl acetate/hexanes) to 
give a colorless oil (52.5 mg, 98% yield). 
1
H NMR (600 MHz, CDCl3) δ 5.62 (m, 1H), 
4.06 (q, J = 13.1 Hz, 2H), 3.86 (dq, J = 10.7, 8.6 Hz, 1H), 3.76 (dq, J = 10.7, 8.6 Hz, 
1H), 2.46 – 2.37 (m, 1H), 2.29 (ddt, J = 17.8, 6.5, 2.9 Hz, 1H), 2.21 – 2.09 (m, 2H), 
2.03 – 1.90 (m, 2H), 1.76 – 1.62 (m, 1H), 1.62 – 1.15 (m, 11H), 0.96 (d, J = 6.8 Hz, 
3H), 0.95 (d, J = 6.5 Hz, 3H), 0.91 (d, J = 6.4 Hz, 3H), 0.89 (d, J = 6.5 Hz, 3H); 
13
C 
NMR (125 MHz, CDCl3) δ 136.37, 124.72 (d, J = 278.6 Hz), 124.29, 82.12, 67.15, 
62.31 (q, J = 33.7 Hz), 42.62, 40.86, 38.06, 37.71, 37.49, 36.19, 33.11, 31.77, 28.83, 
27.58, 25.52, 25.16, 24.47, 22.14, 20.90, 14.66; IR (film) 3342, 2956, 2933, 2872, 
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2358, 2341, 1466, 1278, 1155, 1124, 975, 734 cm
-1
; HRMS (ESI) m/z calcd. for 
C22H35F3O2Li [M+Li]
+
: 395.2744, found: 395.2730. 
 
A mixture of allylic alcohol (40.0 mg, 0.103 mmol) and NaHCO3 (43.3 mg, 
0.515 mmol) in CH2Cl2 (2.0 mL) was cooled to 0 °C, to which meta-
chloroperoxybenzoic acid (70-75 wt%, with benzonic acid and water, 36.8 mg, 0.154 
mmol) was added in one portion. The mixture was allowed to warm to r.t. naturally 
and stirred for total 18 h. After water (2 mL) and ethyl acetate (10 mL) were added to 
the mixture, the organic phase was separated and washed with saturated NaHSO3 
solution (3 × 2 mL), saturated NaHCO3 solution (3 × 2 mL) and brine (2 mL), dried 
over anhydrous Na2SO4, filtered and concentrated. The resultant solid (43.4 mg) was 
used in the next step without further purification. An analytical sample was obtained 
by triturating the solid with hexanes. 
1
H NMR (600 MHz, CDCl3) δ 4.19 (m, 1H), 3.81 
– 3.70 (m, 2H), 3.65 (dd, J = 12.3, 9.7 Hz, 1H), 3.38 (s, 1H), 2.69 (d, J = 3.9 Hz, 1H), 
2.26 (dd, J = 15.8, 8.0 Hz, 1H), 2.14 (dqd, J = 13.7, 7.2, 3.9 Hz, 1H), 2.09 – 1.99 (m, 
1H), 1.97 (d, J = 8.0 Hz, 1H), 1.75 (d, J = 9.2 Hz, 1H), 1.69 (td, J = 9.8, 4.0 Hz, 1H), 
1.63 – 1.43 (m, 7H), 1.43 – 1.23 (m, 4H), 0.95 – 0.89 (m, 12H); 13C NMR (125 MHz, 
CDCl3) δ 124.75 (q, J = 278.3 Hz), 80.78, 62.59, 61.89 (q, J = 33.6 Hz), 60.63, 59.00, 
42.25, 40.77, 37.44, 36.90, 35.35, 34.74, 33.23, 29.93, 28.78, 28.29, 26.37, 24.59, 
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23.25, 21.87, 21.16, 14.23; IR (film) 3431, 2954, 2937, 2873, 1456, 1278, 1155, 1122, 
974 cm
-1
; HRMS (ESI) m/z calcd. for C22H35F3O3Li [M+Li]
+
: 411.2693, found: 
411.2693. 
 
In a high-pressure tube, a mixture of triphenylphosphine (32.6 mg, 0.124 
mmol), imidazole (11.2 mg, 0.165 mmol), iodine (31.5 mg, 0.124 mmol) and alcohol 
(33.5 mg, 0.0828 mmol) in THF (1.5 mL) was heated to 65 °C and stirred for 5.0 h. 
The reaction was cooled to r.t., diluted with ethyl acetate (5 mL), washed with 10% 
Na2S2O3 solution (2 × 3 mL) and brine (3 mL), dried over anhydrous Na2SO4, filtered 
and concentrated on rotovap. The residue was loaded on a silica gel column and eluted 
with 5% diethyl ether/hexanes. The eluate was collected, concentrated on rotovap and 
placed under high vacuum briefly to give a white solid (27.8 mg, 68% for two steps). 
The product was used immediately afterward. (Note: This product was unstable when 
concentrated; partial decomposition was observed after it was dried under high 
vacuum overnight at room temperature.)  
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Commercial zinc powder was stirred with 1 N HCl solution for 5 min, and then 
the acid solution was removed by a pipette. The zinc residue was washed with water 
(3 ×), absolute ethanol (3 ×) and dry diethyl ether (3 ×). (The wash solutions were 
removed each time by a pipette.) The material was then dried under high vacuum 
overnight.  The pre-treated zinc powder (73.4 mg, 1.12 mmol) and copper(I) iodide 
(106.6 mg, 0.560 mmol) are sonicated under N2 in aqueous ethanol (4.5 ml, 40% H2O, 
v/v) for 5 min. A mixture of iodide (28.8 mg, 0.0560 mmol) in ethanol (2.0 ml) was 
added to the resultant black suspension and the sonication was continued for 1.5 h. 
The reaction was quenched by saturated NH4Cl solution (1.0 mL), filtered through a 
Celite pad and washed with diethyl ether. The filtrate was extracted with ether (3 × 5 
mL), and the combined extracts were washed with brine (5 mL), dried over anhydrous 
Na2SO4, filtered and concentrated. The residue was purified by column 
chromatography (10% diethyl ether/hexanes) to give a colorless oil (16.7 mg, 77%). 
1
H NMR (600 MHz, CDCl3) δ 5.09 (s, 1H), 5.03 (s, 1H), 4.26 (d, J = 7.9 Hz, 1H), 
4.05 (dq, J = 10.3, 8.3 Hz, 1H), 3.81 (dq, J = 10.3, 8.3 Hz, 1H), 2.75 (d, J = 7.8 Hz, 
1H), 2.71 – 2.62 (m, 1H), 2.41 (d, J = 4.8 Hz, 1H), 2.31 (d, J = 16.2 Hz, 1H), 2.16 (pd, 
J = 7.1, 4.1 Hz, 1H), 2.06 (d, J = 7.6 Hz, 1H), 1.93 (dq, J = 13.6, 7.0 Hz, 1H), 1.84 
(dtd, J = 14.0, 6.8, 4.3 Hz, 1H), 1.78 (m, 1H), 1.71 (m, 1H), 1.68 – 1.46 (m, 4H), 1.46 
– 1.21 (m, 4H), 1.05 (d, J = 7.0 Hz, 3H), 0.97 – 0.91 (m, 9H); 13C NMR (126 MHz, 
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CDCl3) δ 148.36, 124.50 (q, J = 277.9 Hz), 113.11, 84.37, 75.62, 60.78 (q, J = 33.8 
Hz), 47.92, 44.98, 40.61, 38.69, 36.02, 36.00, 33.35, 31.23, 29.04, 28.89, 28.56, 26.67, 
25.36, 21.66, 20.76, 15.87; IR (film) 3417, 2954, 2931, 2875, 1454, 1393, 1276, 1159, 
1118, 972, 906, 879, 734 cm
-1
; HRMS (ESI) m/z calcd. for C22H35F3O2Li [M+Li]
+
: 
395.2744, found: 395.2734. 
 
A mixture of olefin (12.0 mg, 0.0309 mmol) and selenium dioxide (17.1 mg, 
0.154 mmol) in CH2Cl2 (3.0 mL) was stirred at r.t. for 6 h then hydrogen peroxide (30 
wt% in water, 0.035 mL, 0.309 mmol) was added and stirred for 16 h. The reaction 
was diluted with ethyl acetate (6 mL) and washed with 10% NaHSO3 solution (2 mL), 
saturated NaHCO3 solution (2 mL) and brine (2 mL), dried over anhydrous Na2SO4, 
filtered and concentrated. The residue was purified by column chromatography (15% 
ethyl acetate/hexanes) to give a colorless oil (6.3 mg, 50% yield). 
1
H NMR (600 MHz, 
CDCl3) δ 5.72 (d, J = 5.8 Hz, 1H), 4.34 – 4.16 (m, 2H), 4.06 (d, J = 11.1 Hz, 1H), 3.71 
– 3.52 (m, 2H), 2.84 (d, J = 11.2 Hz, 1H), 2.60 (s, 1H), 2.40 (d, J = 4.6 Hz, 1H), 2.27 
(d, J = 5.7 Hz, 1H), 2.22 – 2.07 (m, 2H), 2.06 – 1.96 (m, 1H), 1.88 (ddt, J = 25.5, 12.9, 
4.8 Hz, 2H), 1.66 (pd, J = 6.8, 3.9 Hz, 1H), 1.60 – 1.49 (m, 1H), 1.49 – 1.31 (m, 4H), 
1.31 – 1.12 (m, 2H), 1.10 (d, J = 7.0 Hz, 3H), 0.98 (d, J = 6.8 Hz, 3H), 0.96 (d, J = 7.0 
Hz, 3H), 0.94 (d, J = 6.8 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 139.93, 124.47, 
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124.38 (q, J = 278.3 Hz), 83.60, 72.61, 66.83, 59.81 (q, J = 33.8 Hz), 50.87, 45.86, 
40.27, 37.64, 35.85, 33.80, 33.28, 30.63, 29.82, 28.91, 28.46, 26.52, 21.14, 19.73, 
17.54; IR (film) 3429, 2953, 2927, 2358, 2345, 1269, 1161, 1111, 1006, 974, 894 cm
-
1
; HRMS (ESI) m/z calcd. for C22H35F3O3Li [M+Li]
+
: 411.2693, found: 411.2682. 
 
To a mixture of diol (50.0 mg, 0.118 mmol) in diethyl ether (5.0 mL) cooled to 
-40 °C, was added tert-butyllithium (1.7 M in pentane, 1.0 mL) dropwise. After the 
addition was completed, the reaction mixture was allowed to warm up to 0 °C 
naturally (over 2.0 h). The reaction was stirred at 0 °C for further 30 min. then 
quenched with methanol (0.5 mL) and saturated NH4Cl solution (1.0 mL). The 
mixture was extracted with ethyl acetate (3 × 2 mL) and the combined extracts were 
washed with brine (2 mL), dried over anhydrous Na2SO4, filtered and concentrated. 
1
H-NMR analysis of the crude product indicated 50% conversion of starting material 
to product. The crude product was re-subjected to the same reaction conditions and 
1
H-NMR analysis indicated complete consumption of the starting material. The crude 
product was purified by column chromatography (40% ethyl acetate/hexanes) to 
afford a white solid (15.4 mg, 31% yield). 
1
H NMR (600 MHz, CDCl3) δ 4.07 (dd, J = 
11.0, 3.6 Hz, 1H), 3.95 – 3.85 (m, 1H), 3.65 (d, J = 6.7 Hz, 1H), 3.60 (m, 2H), 3.39 (d, 
J = 6.7 Hz, 1H), 3.31 (s, 3H), 2.56 (q, J = 7.2 Hz, 1H), 2.32 (dt, J = 9.4, 2.7 Hz, 1H), 
2.29 – 2.24 (m, 1H), 2.22 (dt, J = 11.8, 2.7 Hz, 1H), 2.07 – 1.98 (m, 1H), 1.76 – 1.59 
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(m, 5H), 1.53 – 1.43 (m, 3H), 1.43 – 1.30 (m, 3H), 1.19 (s, 9H), 1.18 (d, J = 7.5 Hz, 
3H), 0.93 (d, J = 7.2 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 108.34, 89.16, 83.42, 
81.29, 62.66, 59.75, 51.53, 51.09, 49.96, 49.05, 47.61, 41.96, 38.32, 35.08, 34.82, 
33.62, 32.16 (3C), 28.68, 28.00, 26.90, 21.39, 19.62, 9.50; IR (film) 3425, 2957, 2927, 
2867, 1464, 1205, 1138, 1046, 985, 958, 910, 732 cm
-1
; HRMS (ESI) m/z calcd. for 
C25H41O5 [M+H]
+
: 421.2948, found: 421.2948. 
 
Alkynyl ether (13.3 mg, 0.0316 mmol) was dissolved in dichloromethane (1.5 
mL) and treated with 1 N HCl (1.5 mL) for 2.0 h with vigorous stirring. The organic 
layer was separated and the aqueous layer was extracted with ethyl acetate (3 × 2 mL). 
The combined organic phase was washed with saturated NaHCO3 solution (3 × 3 mL) 
and brine (3 mL), dried over anhydrous Na2SO4, filtered and concentrated. The crude 
product was purified by prep-TLC (75% ethyl acetate/hexanes) to afford a white solid 
(5.7 mg, 41%). 
1
H NMR (500 MHz, CDCl3) δ 3.93 (t, J = 10.9 Hz, 1H), 3.74 (dd, J = 
11.2, 3.3 Hz, 1H), 3.69 – 3.56 (m, 3H), 3.37 (d, J = 6.7 Hz, 1H), 3.30 (s, 2H), 3.18 (dt, 
J = 10.2, 2.6 Hz, 1H), 3.05 (q, J = 7.2 Hz, 1H), 2.32 – 2.24 (m, 1H), 2.21 (dt, J = 11.4, 
2.0 Hz, 1H), 2.18 (s, 2H), 2.02 (m, 1H), 1.80 – 1.67 (m, 1H), 1.67 – 1.58 (m, 6H), 1.53 
(m, 1H), 1.48 (d, J = 2.6 Hz, 1H), 1.43 – 1.27 (m, 3H), 1.21 – 1.17 (m, 3H), 1.04 (s, 
9H), 0.90 (d, J = 7.2 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 171.78, 108.43, 87.31, 
81.56, 62.90, 60.26, 50.43, 50.11, 49.08, 47.76, 46.95, 41.95, 38.38, 36.07, 35.54, 
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32.94, 30.91, 29.85 (3C), 28.76, 27.81, 21.38, 20.34, 9.95; IR (film) 3438, 2954, 2871, 
1725, 1475, 1228, 1134, 1046, 1012, 986, 916, 732 cm
-1
; HRMS (ESI) m/z calcd. for 
C25H43O6 [M+H]
+
: 439.3054, found: 439.3054. 
 
To a solution of ester (5.7 mg, 0.0130 mmol) in dichloromethane (0.80 mL) 
cooled at -78 °C, DIBAL/CH2Cl2 (1.0M, 0.13 mL) was added dropwise. The reaction 
solution was stirred at -78 °C for 30 min. then warmed to 0 °C and stirred for 2 h. The 
reaction was quenched with saturated Rochelle's salt solution (0.50 mL) and diluted 
with ethyl acetate (2.0 mL). The mixture was warmed to r.t. and stirred vigorously for 
30 min. A clear two layers were formed and the upper organic layer was separated and 
the rest aqueous layer was extracted with ethyl acetate (3 × 2 mL). The combined 
organic layers were washed with brine (3.0 mL), dried over anhydrous Na2SO4, 
filtered and concentrated. The residue was purified by prep-TLC (10% 
MeOH/CH2Cl2) to give a colorless oil (3.2 mg, 72% yield). 
1
H NMR (600 MHz, 
CDCl3) δ 4.24 (dd, J = 10.6, 7.3 Hz, 1H), 3.88 – 3.70 (m, 3H), 3.62 (dt, J = 9.5, 4.4 
Hz, 2H), 3.48 (d, J = 10.1 Hz, 1H), 3.32 (d, J = 10.2 Hz, 1H), 3.26 (s, 3H), 2.89 (bs, 
1H), 2.38 (dt, J = 11.9, 2.6 Hz, 1H), 2.14 – 2.07 (m, 1H), 2.07 – 2.01 (m, 1H), 1.97 
(dq, J = 10.3, 7.2 Hz, 1H), 1.92 – 1.83 (m, 1H), 1.83 – 1.70 (m, 2H), 1.69 – 1.53 (m, 
4H), 1.45 (m, 2H), 1.32 (m, 1H), 1.15 (d, J = 5.8 Hz, 3H), 0.97 (d, J = 7.2 Hz, 3H); 
13
C NMR (125 MHz, C6D6) δ 76.91, 76.00, 73.16, 61.48, 60.88, 57.22, 55.06, 46.94, 
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42.51, 38.69, 38.06, 35.83, 34.10, 33.55, 31.79, 29.60, 21.68, 19.58, 8.14; IR (film) 
3340, 2921, 2875, 1458, 1375, 1193, 1062, 1015, 909, 731 cm
-1
; HRMS (ESI) m/z 
calcd. for C19H35O5 [M+H]
+
: 343.2479, found: 343.2478. 
 
To a solution of trifluoroethyl ether (0.7 mg, 0.0017 mmol) in THF (0.15 mL), 
freshly prepared LDA (0.5 M in THF, 0.27 mL, 0.136 mmol) was added slowly at -78 
°C. After the addition was completed, the reaction was stirred at -78 °C for 30 min. 
then quenched by saturated NH4Cl solution (0.5 mL) and extracted with ethyl acetate 
(3 × 1.0 mL). The combined extracts were washed with brine (1.5 mL), dried over 
anhydrous Na2SO4, filtered and concentrated. 
1
H-NMR analysis of crude product 
indicated 25% conversion of starting material to product. The crude product was 
purified by prep-TLC (60% diethyl ether/hexanes) to provide the unreacted starting 
material and the product.  The isolated starting material was re-subjected to the same 
reaction conditions. After three iterations, approximate 0.6 mg of desired product was 
obtained (judging by the integration of the 
1
H-NMR peaks of solvent and product). 
The resultant difluorovinyl ether was dissolved in pyridine (0.30 mL) and 
osmium tetroxide (2.5 wt% in tert-butanol, 0.05 mL, 0.0039 mmol) was added at r.t. 
After stirring for 30 min., the reaction was quenched by saturated NaHSO3 solution 
(1.5 mL), diluted with THF (1.0 mL) and stirred vigorously at r.t. for 8.0 h. The 
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reaction mixture was extracted with ethyl acetate (3 × 2.0 mL), washed with brine (2.0 
mL), dried over anhydrous Na2SO4, filtered and concentrated. The crude product was 
purified by a short column (50% acetonitrile/benzene) to give approximate 0.4 mg of 
product (judging by the integration of the 
1
H-NMR peaks of solvent and product, 70% 
yield for two steps). 
1
H NMR (600 MHz, CDCl3) δ 5.84 (d, J = 5.6 Hz, 1H), 4.30 (AB 
q, J = 12.0 Hz,  2H), 4.19 (s, 1H), 3.30 (bs, 1H), 2.45 (bs, 1H), 2.30 (d, J = 5.6 Hz, 
1H), 2.26 (d, J = 3.9 Hz, 1H), 2.15 – 2.09 (m, 1H), 2.03 – 1.93 (m, 2H), 1.81 – 1.71 
(m, 2H), 1.66 – 1.53 (m, 3H), 1.40 – 1.10 (m, 6H), 1.00 – 0.95 (m, 9H), 0.90 (d, J = 
6.8 Hz, 3H); 
13C NMR (extracted from HSQC and HMBC spectra) δ 136.8, 128.4, 
75.6, 72.8, 67.9, 51.3, 45.8, 44.2, 40.4, 35.9, 34.7, 33.1, 29.6, 29.0, 28.7, 27.3, 24.9, 
21.5, 20.6, 15.4; IR (film) 3405, 2954, 2925, 2869, 2855, 1559, 1462, 1386, 1106, 
1017, 998, 904, 736, 701 cm
-1
; HRMS (ESI) m/z calcd. for C20H34O3Li [M+Li]
+
: 
329.2662, found: 329.2662. 
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Table A3.1. 2D-NMR Data of Compound 4.10 
 
 
 
 
Position δ 13C 
(ppm) 
δ 1H 
(ppm) 
Type COSY correlations HMBC correlations NOESY correlations 
1 77.30  Cq    
2 80.67  Cq    
3 44.21  Cq    
4 46.27 1.06 CH H-5 C-2, C-1, C-3, C-6, C- 
13, C-15, C-9, C-7, C-16 
H-22 
5 40.00 2.40 CH H-13, H-4 C-3 H-6, H-19, H-16 
6 39.88 1.61 CH H-19, H-5 C-13 H-5, H-8a 
7a 27.57 1.62 CH2 H-8a, H-8b, H-7b C-4, C-3, C-8, C-9  
7b  1.75  H-7a, H-8a, H-8b C-4,C-3, C-8, C-9 H-10a 
8a 28.55 1.30 CH2 H-7b, H-7a   
8b  1.30   C-1, C-2, C-3  
9 29.58 3.20 CH H-13, H-10a, H-10b C-11, C-14, C-2, C-3, C-
4, C-13, C-15, C-10 
H-17a, H-15, H-10b, H-
10a 
10a 26.28 2.04 CH2 H-12, H-9, H-10b C-11, C-12, C-3, C-9 H-8a, H-7b 
10b  2.13  H-12, H-9, H-10b C-11, C-12, C-3, C-9  
11 133.99  Cq    
12 126.65 5.79 CH H-20a, H-20b, H-13, H-
10a, H-10b 
C-14, C-20, C-13, C-10 H-20a, H-20b,  H-13, 
H-19 
13 35.60 2.57 CH H-12, H-9, H-5 C-11, C-12, C-14, C-5, 
C-15, C-9 
H-12, H-5, H-16 
14 81.85  Cq    
15 34.08 2.52 CH H-16 C-14, C-2, C-1, C-4, C-
13, C-16 
H-17b, H-16 
16 9.02 0.95 CH3 H-15 C-14, C-1, C-15  
17a 61.12 3.77 CH2 H-17b C-14, C-18 H-9, H-15 
17b  3.89  H-17a C-14, C-18 H-9, H-15 
18 125.79  Cq    
19 22.04 1.02 CH3 H-6 C-6, C-18 H-5 
20a 77.43 3.74 CH2 H-10a, H-12, H-20b C-11, C-12, C-21, C-10 H-12, H-21, H-10a 
20b  3.86  H-10a, H-12, H-20a C-11, C-12, C-21, C-10 H-12, H-21, H-10a 
21 57.70 3.29 CH3  C-20  
22 18.73 1.34 CH3  C-2, C-1, C-3  
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Table A3.2. 2D-NMR Data of Compound 4.14 
 
 
 
 
Position δ 13C 
(ppm) 
δ 1H 
(ppm) 
Type COSY correlations HMBC correlations NOESY correlations 
1 81.67 4.31 CH H-4 C-2, C-14, C-4, C-3, 
C-16 
H-16 
2 189.27  Cq    
3 42.90  Cq    
4 44.90 1.85 CH H-1, H-5 C-1, C-15, C-9, C-13 H-5, H-6, H-8b, H-7a 
5 37.42 2.36 CH H-13, H-4, H-6  H-4, H-6, H-19, H-16 
6 37.07 1.63 CH H-5, H-19  H-5 
7a 25.72 1.48 CH2 H-7b, H-8b   
7b  2.20  H-8b, H-7a, H-8a   
8a 26.01 1.40 CH2 H-7b, H-8b C-3, C-6  
8b  1.61  H-7b, H-8a C-6  
9 35.32 2.20 CH H-13  H-17a 
10a 24.73 2.20 CH2 H-12, H-20a, H-20b   
10b  2.20  H-12, H-20a, H-20b   
11 135.14  Cq    
12 122.12 5.78 CH H-20a, H-20b, H-13, H-
10a, H-10b 
C-14, C-20, C-13, C-
10 
H-20a, H-20b, H-13 
13 32.54 2.60 CH H-12, H-5, H-9 C-12, C-14 H-12, H-19 
14 78.27  Cq    
15 36.34 2.15 CH H-16 C-1, C-14, C-4, C-9, 
C-13, C-16 
H-17b, H-16 
16 12.41 1.05 CH3 H-15 C-1, C-14, C-15 H-13, H-15 
17a 60.79 3.59 CH2 H-17b C-18 H-9 
17b  3.69  H-17a C-18 H-15 
18 123.80  Cq    
19 21.13 1.10 CH3 H-6 C-6, C-7 H-5 
20a 75.98 3.75 CH2 H-12, H-10a, H-10b, H-
20b 
C-11, C-12, C-21, C-
10 
H-12, H-21, H-10a, H-10b 
20b  3.88  H-12, H-10a, H-10b, H-
20a 
C-11, C-12, C-21, C-
10 
H-12, H-21, H-10a, H-10b 
21 58.10 3.30 CH3  C-20  
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Table A3.3. 2D-NMR Data of Compound 4.15 
 
 
 
 
Position δ 13C 
(ppm) 
δ 1H 
(ppm) 
Type COSY correlations HMBC correlations NOESY correlations 
1 66.39 4.02 CH H-15, H-4, H-23  H-15, H-4 
2 179.14  Cq    
3 48.06  Cq    
4 45.36 1.71 CH H-1, H-5 C-14, C-5 H-5 
5 34.85 2.50 CH H-13, H-6  H-4, H-19, H-16 
6 36.19 1.69 CH H-7b, H-19  H-7a, H-19 
7a 26.75 1.31 CH2 H-8b, H-7b  H-8b, H-6 
7b  1.83  H-8b, H-7a   
8a 32.25 1.81 CH2 H-8b, H-7a   
8b  2.00  H-8a, H-7a  H-10, H-8a, H-7a 
9 35.05 2.87 CH H-13, H-10 C-2, C-11, C-10 H-22, H-15 
10a 25.33 2.17 CH2 H-12, H-9 C-11, C-12, C-3, C-9 H-9 
10b  2.17     
11 135.80  Cq    
12 123.51 5.77 CH H-20a, H-20b, H-13, H-10 C-20 H-20a, H-20b, H-13, H-
19 
13 33.45 2.60 CH H-12, H-9, H-5  H-12, H-16 
14 78.32  Cq    
15 35.38 2.15 CH H-1, H-16 C-14 H-1, H-22, H-9, H-16 
16 7.59 0.99 CH3 H-15 C-14, C-1, C-15 H-13, H-17, H-5, H-15 
17a 60.58 3.69 CH2   H-16 
17b  3.69    H-16 
18 124.30  Cq    
19 21.48 1.08 CH3 H-6 C-6, C-5, C-7  
20a 76.61 3.75 CH2 H-20b, H-10 C-11, C-12, C-21 H-10, H-12 
20b  3.87  H-20a, H-10 C-11, C-12, C-21 H-10, H-12 
21 58.03 3.30 CH3  C-20  
22 52.38 3.70 CH3  C-2 H-9 
23  1.42 OH H-1   
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Table A3.4. 2D-NMR Data of Compound 4.37 
 
 
 
 
Position δ 13C 
(ppm) 
δ 1H 
(ppm) 
Type COSY correlations HMBC correlations ROESY correlations 
1 37.54 2.92 CH H-2, H-14 C-3, C-10 H-14, H-16, H-2a, H-19 
2a 32.83 1.58 CH2 H-2b C-3, C-4, C-10, C-17, 
C-14, C-5 
H-17a, H-17b, H-1, H-2b, 
H-14 
2b  2.72  H-4, H-1, H-5, H-2a C-3, C-14 H-2a 
3 134.38  Cq    
4 125.35 5.44 CH H-17a, H-17b, H-2b, H-
5 
 H-17a, H-17b, H-5, H-6, 
H-12a, H-13a 
5 37.05 2.08 CH H-4, H-17a, H-17b, H-
2b, H-6 
 H-4, H-21b, H-6, H-7, H-8 
6 41.78 1.66 CH   H-4, H-5, H-12a, H-7a, H-
20 
7a 29.64 1.02 CH2 H-8b, H-7b   
7b  1.68  H-8a, H-7a   
8a 28.23 1.04 CH2 H-9, H-7b, H-8b   
8b  1.11  H-8a  H-9, H-7b 
9 36.04 1.55 CH H8a   
10 82.38  Cq    
11 39.07 1.42 CH H-20  H-9 
12a 27.63 1.43 CH2 H-12b, H-13b  H-13b, H-12b 
12b  1.66  H-12a   
13a 20.82 1.62 CH2 H-13b   
13b  1.74  H-14, H-13a, H-12a  H-14, H-12a 
14 59.97 2.04 CH H-1, H-13a, H-13b C-15, C-10, C-1 H-1, H-13b, H-13a, H-2a 
15 208.61  Cq    
16 28.00 1.79 CH3  C-14, C-15  
17a 77.04 3.63 CH2 H-4, H-5 C-3, C-4, C-18, C-2 H-4, H-18, H-2a 
17b  3.71  H-4, H-5 C-3, C-4, C-18, C-2 H-4, H-18, H-2a 
18 58.18 3.15 CH3  C-17  
19 16.41 1.06 CH3 H-9 C-10, C-9, C-8 H-21b, H-1, H-16 
20 22.91 0.99 CH3 H-11 C-6, C-11, C-12 H-4 
21a 62.48 3.49 CH2   H-2b, H-5, H-8 
21b  3.55    H-2b, H-5, H-8 
22 125.63  Cq    
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Table A3.5. 2D-NMR Data of Vinigrol 
 
 
 
 
Position δ 13C (ppm) δ 1H (ppm) Type COSY correlations HMBC correlations 
1 45.8 2.30 CH H-2, H-18a, H-18b C-3, C-2, C-10, C-15 
2 128.4 5.84 CH H-18a, H-18b, H-1 C-10, C-4, C-18, C-1 
3 136.4  Cq   
4 72.8 4.19 CH H-21  
5 51.3 2.26 CH H-4, H-6 C-4, C-1 
6 44.2 1.74 CH H-5, H-7b  
7a 29.6 1.35 CH2 H-7b, H-8b  
7b  1.97  H-6, H-8a, H-8b, H-7a  
8a 27.3 1.59 CH2 H-9, H-7b, H-7a, H-8b  
8b  1.59  H-8a, H-7b, H-7a  
9 33.1 2.12 CH H-8a, H-8b, H-19  
10 75.6  Cq   
11 35.9 1.26 CH H-20  
12a 28.9 1.13 CH2 H-12b  
12b  1.34  H-12a  
13a 28.6 1.19 CH2 H-14, H-13b  
13b  1.35  H-14, H-13a  
14 40.4 1.77 CH H-15, H-13b, H-13a  
15 34.7 1.63 CH H-14, H-16, H-17  
16 21.5 0.98 CH3 H-15 C-14, C-15, C-17 
17 20.5 0.98 CH3 H-15 C-14, C-15, C-16 
18a 67.9 4.26 CH2 H-2, H-18b, H-22, H-1  
18b  4.33  H-2, H-18a, H-22, H-1  
19 15.3 0.98 CH3 H-9 C-10, C-9,C-8 
20 24.9 0.90 CH3 H-11 C-6, C-11, C-12 
21  3.30 OH H-4  
22  2.46 OH H-18a, H-18b  
23  1.99 OH   
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Table A3.6. Vinigrol’s 1H NMR Data Comparison (δ in ppm) 
Our synthetic sample (CDCl3, 600 MHz) 
(multiplicity, coupling constant) 
Baran’s sample (CDCl3, 600 MHz)
 2
 
(multiplicity, coupling constant) 
5.84 (d, 5.6 Hz) 5.83 (d, 5.5 Hz) 
4.30 (AB q, 12.0 Hz) 4.30 (AB q, 12.0 Hz) 
4.19 (s) 4.20 (s) 
3.30 (bs) 3.40 (bs) 
2.45 (bs) 2.65 (bs) 
2.30 (d, 5.6 Hz) 2.30 (d, 5.4 Hz) 
2.26 (d, 3.9 Hz) 2.25 (d, 3.7 Hz) 
2.15 – 2.09 (m) 2.15– 2.09 (m) 
2.03 – 1.93 (m) 1.99 – 1.93 (m) 
1.81 – 1.71 (m) 1.80 – 1.70 (m) 
1.66 – 1.53 (m) 1.65 – 1.50 (m) 
1.40 – 1.10 (m) 1.40 – 1.05 (m) 
1.00 – 0.95 (m) 1.00 – 0.95 (m) 
0.90 (d, 6.8 Hz) 0.90 (d, 6.8 Hz) 
 
Table A3.7. Vinigrol’s 13C NMR Data Comparison (δ in ppm) 
Our synthetic sample (CDCl3)  Baran’s sample (CDCl3, 150 MHz)
2 
136.8 136.5 
128.4 128.4 
75.6 75.5 
72.8 72.8 
67.9 67.9 
51.3 51.1 
45.8 45.5 
44.2 44.2 
40.4 40.2 
35.9 35.8 
34.7 34.5 
33.1 33.0 
29.6 29.6 
29.0 28.9 
28.7 28.6 
27.3 27.2 
24.9 24.8 
21.5 21.5 
20.6 20.5 
15.4 15.3 
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